<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum - Papers of the Week: 1-7 May 2026</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Akt at the crossroads of microglial function: a double-edged sword in Alzheimer&#039;s disease neuroinflammation.</title>
 <link>https://www.alzforum.org/papers/akt-crossroads-microglial-function-double-edged-sword-alzheimers-disease-neuroinflammation</link>
 <description>Int Immunopharmacol. 2026 Jul 15;181:116773.  Epub 2026 May 4&lt;br&gt;Authors: Xu Y, Liang W, Tang Z, Lu F, Xia L, Xie H, Zhong M, Li S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085850&quot;&gt;42085850&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/akt-crossroads-microglial-function-double-edged-sword-alzheimers-disease-neuroinflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/akt-crossroads-microglial-function-double-edged-sword-alzheimers-disease-neuroinflammation#comments</comments>
</item>
<item>
 <title>An aptamer-mediated EXPAR fluorescence biosensor for early and sensitive detection of Aβ42 and Aβ40.</title>
 <link>https://www.alzforum.org/papers/aptamer-mediated-expar-fluorescence-biosensor-early-and-sensitive-detection-av42-and-av40</link>
 <description>Anal Chim Acta. 2026 Jul 8;1406:345513.  Epub 2026 Apr 8&lt;br&gt;Authors: Wu H, Chai C, Islam MS, Sheng S, Xie G, Chen T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067300&quot;&gt;42067300&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aptamer-mediated-expar-fluorescence-biosensor-early-and-sensitive-detection-av42-and-av40#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aptamer-mediated-expar-fluorescence-biosensor-early-and-sensitive-detection-av42-and-av40#comments</comments>
</item>
<item>
 <title>Assessing the Importance of Variation in Diagnostic Coding Among the Three Countries in the UK Biobank.</title>
 <link>https://www.alzforum.org/papers/assessing-importance-variation-diagnostic-coding-among-three-countries-uk-biobank</link>
 <description>Learn Health Syst. 2026 Jul;10:e70083.  Epub 2026 May 5&lt;br&gt;Authors: Clifton L, Liu W, Collister JA, Littlejohns TJ, Goldacre RR, Allen N, Hunter DJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095006&quot;&gt;42095006&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/assessing-importance-variation-diagnostic-coding-among-three-countries-uk-biobank#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/assessing-importance-variation-diagnostic-coding-among-three-countries-uk-biobank#comments</comments>
</item>
<item>
 <title>Neuroimaging of the monoaminergic system in Parkinson&#039;s disease: A narrative review.</title>
 <link>https://www.alzforum.org/papers/neuroimaging-monoaminergic-system-parkinsons-disease-narrative-review</link>
 <description>Neuroimage Rep. 2026 Jun;6(2):100345.  Epub 2026 Apr 23&lt;br&gt;Authors: Samanci Y, Tan S, Temel Y, Jahanshahi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42064680&quot;&gt;42064680&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroimaging-monoaminergic-system-parkinsons-disease-narrative-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroimaging-monoaminergic-system-parkinsons-disease-narrative-review#comments</comments>
</item>
<item>
 <title>Comparability of Centiloid values from [18F]flutemetamol scans using seven commercial and research software.</title>
 <link>https://www.alzforum.org/papers/comparability-centiloid-values-18fflutemetamol-scans-using-seven-commercial-and-research</link>
 <description>Neuroimage Rep. 2026 Jun;6(2):100343.  Epub 2026 Apr 21&lt;br&gt;Authors: Bollack A, Schwarz AJ, Bourgeat P, Doré V, Mejan-Fripp J, Page C, Bonke E, Thurfjell L, Hass M, Balhorn W, Nelson A, Fahmi R, Mattsson-Carlgren N, Palmqvist S, Stomrud E, Smith R, Hansson O, La Joie R, Farrar G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42064679&quot;&gt;42064679&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparability-centiloid-values-18fflutemetamol-scans-using-seven-commercial-and-research#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparability-centiloid-values-18fflutemetamol-scans-using-seven-commercial-and-research#comments</comments>
</item>
<item>
 <title>Investigating Disordered Eating Behaviours Among Individuals Living With Neurodegenerative Disease: A Scoping Review.</title>
 <link>https://www.alzforum.org/papers/investigating-disordered-eating-behaviours-among-individuals-living-neurodegenerative-disease</link>
 <description>J Hum Nutr Diet. 2026 Jun;39(3):e70250. &lt;br&gt;Authors: Buttifant E, Allogmanny S, Probst Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071322&quot;&gt;42071322&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-disordered-eating-behaviours-among-individuals-living-neurodegenerative-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-disordered-eating-behaviours-among-individuals-living-neurodegenerative-disease#comments</comments>
</item>
<item>
 <title>Structural analysis of Cu/Zn-superoxide dismutase linked to neurodegenerative disease by antibody-guided cryo-EM.</title>
 <link>https://www.alzforum.org/papers/structural-analysis-cuzn-superoxide-dismutase-linked-neurodegenerative-disease-antibody</link>
 <description>Protein Sci. 2026 Jun;35(6):e70615. &lt;br&gt;Authors: Shino Y, Muraki N, Kobatake Y, Kamishina H, Kosuge H, Nakakido M, Tsumoto K, Furukawa Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084503&quot;&gt;42084503&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-analysis-cuzn-superoxide-dismutase-linked-neurodegenerative-disease-antibody#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-analysis-cuzn-superoxide-dismutase-linked-neurodegenerative-disease-antibody#comments</comments>
</item>
<item>
 <title>Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt-Jakob Disease MV1 Subtype.</title>
 <link>https://www.alzforum.org/papers/understanding-phenotypic-heterogeneity-within-sporadic-creutzfeldt-jakob-disease-mv1-subtype</link>
 <description>Neuropathol Appl Neurobiol. 2026 Jun;52(3):e70078. &lt;br&gt;Authors: Nemani SK, Cortez LM, Myskiw J, Cali I, Booth SA, Jansen GH, Sim VL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083984&quot;&gt;42083984&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/understanding-phenotypic-heterogeneity-within-sporadic-creutzfeldt-jakob-disease-mv1-subtype#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/understanding-phenotypic-heterogeneity-within-sporadic-creutzfeldt-jakob-disease-mv1-subtype#comments</comments>
</item>
<item>
 <title>Transdermal delivery of pramipexole dihydrochloride using dissolving polymeric microneedle patches for improved Parkinson&#039;s disease management.</title>
 <link>https://www.alzforum.org/papers/transdermal-delivery-pramipexole-dihydrochloride-using-dissolving-polymeric-microneedle</link>
 <description>Int J Pharm X. 2026 Jun;11:100533.  Epub 2026 Apr 3&lt;br&gt;Authors: Thamphiwatana SD, Phetporkha K, Thedrattanawong C, Chantasart D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087889&quot;&gt;42087889&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/transdermal-delivery-pramipexole-dihydrochloride-using-dissolving-polymeric-microneedle#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/transdermal-delivery-pramipexole-dihydrochloride-using-dissolving-polymeric-microneedle#comments</comments>
</item>
<item>
 <title>Alzheimer Plasma Biomarkers in Mild Cognitive Impairment: Each With Distinct Etiologic and Prognostic Roles.</title>
 <link>https://www.alzforum.org/papers/alzheimer-plasma-biomarkers-mild-cognitive-impairment-each-distinct-etiologic-and-prognostic</link>
 <description>Neurology. 2026 May 26;106(10):e218042.  Epub 2026 May 4&lt;br&gt;Authors: Knopman DS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081785&quot;&gt;42081785&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimer-plasma-biomarkers-mild-cognitive-impairment-each-distinct-etiologic-and-prognostic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimer-plasma-biomarkers-mild-cognitive-impairment-each-distinct-etiologic-and-prognostic#comments</comments>
</item>
<item>
 <title>What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?</title>
 <link>https://www.alzforum.org/papers/what-does-positive-alzheimer-disease-blood-based-biomarker-result-mean-people-mild-cognitive</link>
 <description>Neurology. 2026 May 26;106(10):e214953.  Epub 2026 May 4&lt;br&gt;Authors: Hazan J, Liu KY, Isaacs JD, Fox NC, Howard R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081782&quot;&gt;42081782&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/what-does-positive-alzheimer-disease-blood-based-biomarker-result-mean-people-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/what-does-positive-alzheimer-disease-blood-based-biomarker-result-mean-people-mild-cognitive#comments</comments>
</item>
<item>
 <title>Cerebral Amyloid Angiopathy and Risk of Dementia in Patients With Cognitive Complaint.</title>
 <link>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-and-risk-dementia-patients-cognitive-complaint</link>
 <description>Neurology. 2026 May 26;106(10):e218009.  Epub 2026 May 4&lt;br&gt;Authors: Raposo N, Morice Morand M, Genin T, Lepetit M, Conhoc J, Bouteloup V, Mangin JF, Chupin M, Chene G, Dufouil C, Pariente J, Planton M, MEMENTO Study Group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081781&quot;&gt;42081781&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-and-risk-dementia-patients-cognitive-complaint#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-and-risk-dementia-patients-cognitive-complaint#comments</comments>
</item>
<item>
 <title>Amyloid PET Burden, CSF Biomarkers, and APOE Genotype in People With Iatrogenic and Sporadic Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/amyloid-pet-burden-csf-biomarkers-and-apoe-genotype-people-iatrogenic-and-sporadic-cerebral</link>
 <description>Neurology. 2026 May 26;106(10):e214949.  Epub 2026 May 5&lt;br&gt;Authors: Storti B, Capozza A, Marinoni G, Strazzabosco C, Stanziano M, Rifino N, Boncoraglio GB, Scala I, Romoli M, Paccagnella A, Canavero I, Tagliabue L, Bersano A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085649&quot;&gt;42085649&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-pet-burden-csf-biomarkers-and-apoe-genotype-people-iatrogenic-and-sporadic-cerebral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-pet-burden-csf-biomarkers-and-apoe-genotype-people-iatrogenic-and-sporadic-cerebral#comments</comments>
</item>
<item>
 <title>Iatrogenic and Sporadic Cerebral Amyloid Angiopathy: Same Amyloid, Different Pathways?</title>
 <link>https://www.alzforum.org/papers/iatrogenic-and-sporadic-cerebral-amyloid-angiopathy-same-amyloid-different-pathways</link>
 <description>Neurology. 2026 May 26;106(10):e218087.  Epub 2026 May 5&lt;br&gt;Authors: Pasi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085648&quot;&gt;42085648&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/iatrogenic-and-sporadic-cerebral-amyloid-angiopathy-same-amyloid-different-pathways#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/iatrogenic-and-sporadic-cerebral-amyloid-angiopathy-same-amyloid-different-pathways#comments</comments>
</item>
<item>
 <title>Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down Syndrome.</title>
 <link>https://www.alzforum.org/papers/circadian-rest-activity-rhythms-cognition-and-alzheimer-disease-dementia-adults-down-syndrome</link>
 <description>Neurology. 2026 May 26;106(10):e214938.  Epub 2026 May 7&lt;br&gt;Authors: Chung PA, Fleming VL, Reid KJ, Plante DT, Hom CL, Ances BM, Handen BL, Christian BT, Head E, Mapstone M, Hartley SL, Zee PC, Alzheimer&amp;#039;s Biomarkers Consortium-Down Syndrome (ABC-DS) Investigators&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096659&quot;&gt;42096659&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circadian-rest-activity-rhythms-cognition-and-alzheimer-disease-dementia-adults-down-syndrome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circadian-rest-activity-rhythms-cognition-and-alzheimer-disease-dementia-adults-down-syndrome#comments</comments>
</item>
<item>
 <title>Can Targeting Circadian Rhythms Help Prevent Alzheimer Disease?: Lessons From Down Syndrome.</title>
 <link>https://www.alzforum.org/papers/can-targeting-circadian-rhythms-help-prevent-alzheimer-disease-lessons-down-syndrome</link>
 <description>Neurology. 2026 May 26;106(10):e218086.  Epub 2026 May 7&lt;br&gt;Authors: Fang Y, Leng Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096658&quot;&gt;42096658&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/can-targeting-circadian-rhythms-help-prevent-alzheimer-disease-lessons-down-syndrome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/can-targeting-circadian-rhythms-help-prevent-alzheimer-disease-lessons-down-syndrome#comments</comments>
</item>
<item>
 <title>Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/small-rna-sequencing-identifies-serum-tdr-134-gly-gcc-tirna-levels-biomarker-survival</link>
 <description>iScience. 2026 May 15;29(5):115636.  Epub 2026 Apr 7&lt;br&gt;Authors: Demaegd KC, Kool L, Baindoor S, Donovan PD, Su J, Westeneng HJ, van Eijk RP, Geoghegan G, Perez Morrissey E, Halang L, Poesen K, Masrori P, Gibriel HA, Jirström E, Venø MT, Kjems J, Hardiman O, Veldink JH, Kenna K, van den Berg LH, Van Damme P, Prehn JH, van Es MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063547&quot;&gt;42063547&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/small-rna-sequencing-identifies-serum-tdr-134-gly-gcc-tirna-levels-biomarker-survival#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/small-rna-sequencing-identifies-serum-tdr-134-gly-gcc-tirna-levels-biomarker-survival#comments</comments>
</item>
<item>
 <title>Neuromuscular junction innervation and motor function are preserved by restoring muscarinic signaling in perisynaptic glia in ALS.</title>
 <link>https://www.alzforum.org/papers/neuromuscular-junction-innervation-and-motor-function-are-preserved-restoring-muscarinic</link>
 <description>iScience. 2026 May 15;29(5):115565.  Epub 2026 Apr 9&lt;br&gt;Authors: Tremblay E, Arbour D, Vallée J, Piovesana R, Vallières G, Mechichi E, Robitaille R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095090&quot;&gt;42095090&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuromuscular-junction-innervation-and-motor-function-are-preserved-restoring-muscarinic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuromuscular-junction-innervation-and-motor-function-are-preserved-restoring-muscarinic#comments</comments>
</item>
<item>
 <title>Progranulin deficiency in the brain activates an insulin signaling pathway that may promote neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/progranulin-deficiency-brain-activates-insulin-signaling-pathway-may-promote</link>
 <description>iScience. 2026 May 15;29(5):115720.  Epub 2026 Apr 12&lt;br&gt;Authors: Sajan MP, Aggarwal G, Hwang JJ, Smith DM, Cooper DR, Duncan MA, Hansen BC, Nguyen AD, Farese RV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095076&quot;&gt;42095076&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/progranulin-deficiency-brain-activates-insulin-signaling-pathway-may-promote#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/progranulin-deficiency-brain-activates-insulin-signaling-pathway-may-promote#comments</comments>
</item>
<item>
 <title>Erratum: Alzheimer&#039;s disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes.</title>
 <link>https://www.alzforum.org/papers/erratum-alzheimers-disease-brain-derived-tau-extracts-show-differential-processing-and</link>
 <description>iScience. 2026 May 15;29(5):115926.  Epub 2026 Apr 29&lt;br&gt;Authors: Reid MJ, Salazar ML, Troakes C, Lynham S, Srivastava DP, Perez-Nievas BG, Noble W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095074&quot;&gt;42095074&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/erratum-alzheimers-disease-brain-derived-tau-extracts-show-differential-processing-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/erratum-alzheimers-disease-brain-derived-tau-extracts-show-differential-processing-and#comments</comments>
</item>
<item>
 <title>PRKN/parkin-mediated control of SNCA (synuclein alpha) and chaperone-mediated autophagy are defective in cellular, mice models and Parkinson disease-affected brains.</title>
 <link>https://www.alzforum.org/papers/prknparkin-mediated-control-snca-synuclein-alpha-and-chaperone-mediated-autophagy-are</link>
 <description>Autophagy. 2026 May 13;:1-19.  Epub 2026 May 13&lt;br&gt;Authors: Ramos Dos Santos L, Duplan E, Debord J, Fremont G, Minniti J, Lauritzen I, Mutez E, Leghay C, Chartier-Harlin MC, Checler F, Alves da Costa C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083315&quot;&gt;42083315&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prknparkin-mediated-control-snca-synuclein-alpha-and-chaperone-mediated-autophagy-are#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prknparkin-mediated-control-snca-synuclein-alpha-and-chaperone-mediated-autophagy-are#comments</comments>
</item>
<item>
 <title>Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1.</title>
 <link>https://www.alzforum.org/papers/osteoarthritis-and-dementia-contrasting-disorders-driven-mutual-pathways-autophagy-mtor-glp-1</link>
 <description>Expert Rev Clin Pharmacol. 2026 May 11;:1-20.  Epub 2026 May 11&lt;br&gt;Authors: Maiese K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095886&quot;&gt;42095886&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/osteoarthritis-and-dementia-contrasting-disorders-driven-mutual-pathways-autophagy-mtor-glp-1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/osteoarthritis-and-dementia-contrasting-disorders-driven-mutual-pathways-autophagy-mtor-glp-1#comments</comments>
</item>
<item>
 <title>[Native mass spectrometry and ultraviolet photodissociation reveal conformation-selectivity of zinc ion to α-synuclein].</title>
 <link>https://www.alzforum.org/papers/native-mass-spectrometry-and-ultraviolet-photodissociation-reveal-conformation-selectivity</link>
 <description>Se Pu. 2026 May 8;44(5):525-532. &lt;br&gt;Authors: Qin H, Xuan Y, Zhao H, Liu Z, Ding F, Wang F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093278&quot;&gt;42093278&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/native-mass-spectrometry-and-ultraviolet-photodissociation-reveal-conformation-selectivity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/native-mass-spectrometry-and-ultraviolet-photodissociation-reveal-conformation-selectivity#comments</comments>
</item>
<item>
 <title>Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-8</link>
 <description>N Engl J Med. 2026 May 7;394(18):1846.  Epub 2026 May 2&lt;br&gt;Authors: Chen S, Chen X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080669&quot;&gt;42080669&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-8#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-8#comments</comments>
</item>
<item>
 <title>Advancements in Gene Delivery using Nucleic Acid Loaded Nanoparticles for Region Specific Delivery in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/advancements-gene-delivery-using-nucleic-acid-loaded-nanoparticles-region-specific-delivery</link>
 <description>Mol Neurobiol. 2026 May 7;63(1)&lt;br&gt;Authors: Kumar V, Kakoty V, Wadhwa P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091766&quot;&gt;42091766&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advancements-gene-delivery-using-nucleic-acid-loaded-nanoparticles-region-specific-delivery#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advancements-gene-delivery-using-nucleic-acid-loaded-nanoparticles-region-specific-delivery#comments</comments>
</item>
<item>
 <title>Hypoxia-inducible factor-1α: Dual roles in maintaining neuronal homeostasis and neuronal degeneration via regulation of oxidative stress, mitochondrial dynamics, and bioenergetics.</title>
 <link>https://www.alzforum.org/papers/hypoxia-inducible-factor-1a-dual-roles-maintaining-neuronal-homeostasis-and-neuronal</link>
 <description>J Physiol Biochem. 2026 May 7;82(1)&lt;br&gt;Authors: Puthusseri SP, Ravivarma S, Johny M, Vengellur A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091757&quot;&gt;42091757&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hypoxia-inducible-factor-1a-dual-roles-maintaining-neuronal-homeostasis-and-neuronal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hypoxia-inducible-factor-1a-dual-roles-maintaining-neuronal-homeostasis-and-neuronal#comments</comments>
</item>
<item>
 <title>Translation and cultural adaptation of Rowland universal dementia assessment scale (RUDAS) and European cross-cultural neuropsychological test battery (CNTB) into Italian.</title>
 <link>https://www.alzforum.org/papers/translation-and-cultural-adaptation-rowland-universal-dementia-assessment-scale-rudas-and</link>
 <description>Neurol Sci. 2026 May 7;47(6)&lt;br&gt;Authors: Cova I, Maestri G, Forgione A, Canevelli M, Calia C, Leta V, Pomati S, Pantoni L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091724&quot;&gt;42091724&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/translation-and-cultural-adaptation-rowland-universal-dementia-assessment-scale-rudas-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/translation-and-cultural-adaptation-rowland-universal-dementia-assessment-scale-rudas-and#comments</comments>
</item>
<item>
 <title>Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-9</link>
 <description>N Engl J Med. 2026 May 7;394(18):1836-1845. &lt;br&gt;Authors: Greenberg SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090794&quot;&gt;42090794&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-9#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebral-amyloid-angiopathy-9#comments</comments>
</item>
<item>
 <title>Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/early-syndecan-4-upregulation-predicts-cognitive-and-pathological-trajectories-alzheimer</link>
 <description>Alzheimers Res Ther. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Tarawneh R, Moulder KL, Topouza DG, Kar A, Qian HT, Pankratz VS, Timsina J, Franklin EE, Schindler SE, Perrin RJ, Ances BM, Benzinger TL, Hassenstab J, Morris JC, Holtzman DM, Cruchaga C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098850&quot;&gt;42098850&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-syndecan-4-upregulation-predicts-cognitive-and-pathological-trajectories-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-syndecan-4-upregulation-predicts-cognitive-and-pathological-trajectories-alzheimer#comments</comments>
</item>
<item>
 <title>The REACT MCI study: a randomized controlled clinical trial on the effect of repeated advanced cognitive training in mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/react-mci-study-randomized-controlled-clinical-trial-effect-repeated-advanced-cognitive</link>
 <description>Trials. 2026 May 7;27(1)&lt;br&gt;Authors: Hernes SS, Nordnes PR, Hol HR, Ringstad G, Knapskog AB, Emhjellen P, Løhaugen G, Emini M, Edwin TH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098801&quot;&gt;42098801&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/react-mci-study-randomized-controlled-clinical-trial-effect-repeated-advanced-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/react-mci-study-randomized-controlled-clinical-trial-effect-repeated-advanced-cognitive#comments</comments>
</item>
<item>
 <title>Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/impact-apolipoprotein-e4-blood-brain-barrier-integrity-target-replacement-murine-models</link>
 <description>Alzheimers Res Ther. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Laing KK, Fialova N, Wardlaw J, Montagne A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098772&quot;&gt;42098772&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-apolipoprotein-e4-blood-brain-barrier-integrity-target-replacement-murine-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-apolipoprotein-e4-blood-brain-barrier-integrity-target-replacement-murine-models#comments</comments>
</item>
<item>
 <title>Functional relationships linking C99/APP-βCTF dimerization, proteostasis disruption, and organelle dysfunction.</title>
 <link>https://www.alzforum.org/papers/functional-relationships-linking-c99app-vctf-dimerization-proteostasis-disruption-and</link>
 <description>Cell Commun Signal. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Badot C, Bini A, Duplan E, Checler F, Lauritzen I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098771&quot;&gt;42098771&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-relationships-linking-c99app-vctf-dimerization-proteostasis-disruption-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-relationships-linking-c99app-vctf-dimerization-proteostasis-disruption-and#comments</comments>
</item>
<item>
 <title>Integration of glymphatic system function and hippocampal radiomics for diagnosis and conversion prediction of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/integration-glymphatic-system-function-and-hippocampal-radiomics-diagnosis-and-conversion</link>
 <description>BMC Med Imaging. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Mao X, Zhang D, Ying D, Yu J, Ge Y, Jia Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098640&quot;&gt;42098640&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integration-glymphatic-system-function-and-hippocampal-radiomics-diagnosis-and-conversion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integration-glymphatic-system-function-and-hippocampal-radiomics-diagnosis-and-conversion#comments</comments>
</item>
<item>
 <title>Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer&#039;s and Parkinson&#039;s diseases using minimal clinically important difference: systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/evaluating-clinical-effects-glp-1-receptor-agonists-alzheimers-and-parkinsons-diseases-using</link>
 <description>Arch Pharm Res. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Elghanam Y, Kim E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098470&quot;&gt;42098470&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluating-clinical-effects-glp-1-receptor-agonists-alzheimers-and-parkinsons-diseases-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluating-clinical-effects-glp-1-receptor-agonists-alzheimers-and-parkinsons-diseases-using#comments</comments>
</item>
<item>
 <title>Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson&#039;s Disease: ROSSINI Study 6-Month Interim Results.</title>
 <link>https://www.alzforum.org/papers/real-world-safety-and-effectiveness-24-hour-foslevodopafoscarbidopa-parkinsons-disease</link>
 <description>Neurol Ther. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Jost WH, Bergquist F, Evans A, Hassin-Baer S, Hauser RA, Henriksen T, Malaty IA, Mestre TA, Mir P, Rodriguez R, Schwingenschuh P, Simu M, Bergmann L, Zhou TT, Caughlin S, Gopalkrishnan M, Kukreja P, O&amp;#039;Meara M, Parra JC, Shah MB, Aldred J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098450&quot;&gt;42098450&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/real-world-safety-and-effectiveness-24-hour-foslevodopafoscarbidopa-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/real-world-safety-and-effectiveness-24-hour-foslevodopafoscarbidopa-parkinsons-disease#comments</comments>
</item>
<item>
 <title>High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/high-molecular-weight-insoluble-parkin-substantia-nigra-patients-idiopathic-parkinsons</link>
 <description>NPJ Parkinsons Dis. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Tremblay C, Pshevorskiy L, Cottez RJ, Denis HL, Emond V, Morissette M, Rajput AH, Di Paolo T, Rajput A, Calon F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098169&quot;&gt;42098169&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-molecular-weight-insoluble-parkin-substantia-nigra-patients-idiopathic-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-molecular-weight-insoluble-parkin-substantia-nigra-patients-idiopathic-parkinsons#comments</comments>
</item>
<item>
 <title>Mitochondria serve as a holdout compartment for aggregation-prone proteins hindering efficient degradation.</title>
 <link>https://www.alzforum.org/papers/mitochondria-serve-holdout-compartment-aggregation-prone-proteins-hindering-efficient</link>
 <description>Nat Commun. 2026 May 7;17(1)&lt;br&gt;Authors: Gierisch ME, Barchi E, Marogna M, Wallnöfer MH, Ankarcrona M, Naia L, Salomons FA, Dantuma NP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42098118&quot;&gt;42098118&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondria-serve-holdout-compartment-aggregation-prone-proteins-hindering-efficient#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondria-serve-holdout-compartment-aggregation-prone-proteins-hindering-efficient#comments</comments>
</item>
<item>
 <title>Comment on &quot;Association of Gastrointestinal Symptoms With Severity and Progression of Cognitive Impairment in Parkinson&#039;s Disease: A Systematic Review and Meta-Analysis&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-association-gastrointestinal-symptoms-severity-and-progression-cognitive-impairment</link>
 <description>J Gastroenterol Hepatol. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Li SN, Shen XJ, Yao YH, Liu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097856&quot;&gt;42097856&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-association-gastrointestinal-symptoms-severity-and-progression-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-association-gastrointestinal-symptoms-severity-and-progression-cognitive-impairment#comments</comments>
</item>
<item>
 <title>Relationship of Inferior Frontal Sulcal Hyperintensities with Amyloid-Related Imaging Abnormalities.</title>
 <link>https://www.alzforum.org/papers/relationship-inferior-frontal-sulcal-hyperintensities-amyloid-related-imaging-abnormalities</link>
 <description>AJNR Am J Neuroradiol. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Rohatgi S, Omid-Fard N, Zhu S, Martinez Imbett RE, Ford JN, Dowling TP, Kirsch JE, Romero JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097853&quot;&gt;42097853&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/relationship-inferior-frontal-sulcal-hyperintensities-amyloid-related-imaging-abnormalities#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/relationship-inferior-frontal-sulcal-hyperintensities-amyloid-related-imaging-abnormalities#comments</comments>
</item>
<item>
 <title>Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/short-rna-chaperones-promote-aggregation-resistant-tdp-43-conformers-mitigate</link>
 <description>Science. 2026 May 7;392(6798):eadv3301.  Epub 2026 May 7&lt;br&gt;Authors: Copley KE, Mauna JC, Danielson HL, Chen Q, Ozguney B, Ngo M, Xie L, Smirnov A, Davis M, Mayne L, Linsenmeier M, Rubien JD, Bergmann CA, Portz B, Lee BL, Odeh HM, Lai L, Chang YW, Hallegger M, Ule J, Pasinelli P, Poon Y, Mittal J, Fawzi NL, Black BE, Donnelly CJ, Jensen BK, Shorter J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096556&quot;&gt;42096556&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/short-rna-chaperones-promote-aggregation-resistant-tdp-43-conformers-mitigate#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/short-rna-chaperones-promote-aggregation-resistant-tdp-43-conformers-mitigate#comments</comments>
</item>
<item>
 <title>Pooling Alzheimer&#039;s disease: when methodological rigor risks obscuring biological complexity.</title>
 <link>https://www.alzforum.org/papers/pooling-alzheimers-disease-when-methodological-rigor-risks-obscuring-biological-complexity</link>
 <description>Neurol Sci. 2026 May 7;47(6)&lt;br&gt;Authors: Spallazzi M, Zilioli A, Capellari S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096068&quot;&gt;42096068&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pooling-alzheimers-disease-when-methodological-rigor-risks-obscuring-biological-complexity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pooling-alzheimers-disease-when-methodological-rigor-risks-obscuring-biological-complexity#comments</comments>
</item>
<item>
 <title>Label-free paper-based electrochemical aptasensor with tunable selectivity for assessing neurotransmitter imbalance in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/label-free-paper-based-electrochemical-aptasensor-tunable-selectivity-assessing</link>
 <description>Mikrochim Acta. 2026 May 7;193(6)&lt;br&gt;Authors: Dortez S, Chávez M, Montero-Calle A, Barderas R, Pacheco M, Escarpa A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095905&quot;&gt;42095905&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/label-free-paper-based-electrochemical-aptasensor-tunable-selectivity-assessing#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/label-free-paper-based-electrochemical-aptasensor-tunable-selectivity-assessing#comments</comments>
</item>
<item>
 <title>How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.</title>
 <link>https://www.alzforum.org/papers/how-ppmi-enabled-first-interventional-platform-trial-test-therapies-participants-early-stage</link>
 <description>Ann Neurol. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Simuni T, Coffey CS, Kopil CM, Allen-Savietta C, Wendelberger B, Crawford A, Schneider RB, Siderowf A, Kieburtz K, Tanner CM, Tropea TF, Whalen H, Ramia L, Kamp C, Reyes C, Fabrizio K, Willson T, Merriam E, Kuhl MM, Chowdhury S, Marek K, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095573&quot;&gt;42095573&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/how-ppmi-enabled-first-interventional-platform-trial-test-therapies-participants-early-stage#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/how-ppmi-enabled-first-interventional-platform-trial-test-therapies-participants-early-stage#comments</comments>
</item>
<item>
 <title>Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/diffusion-mri-and-synuclein-seed-amplification-status-parkinsons-disease</link>
 <description>Ann Neurol. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Chiu SY, Wang WE, Chen R, DeSimone JC, Archer DB, Adler CH, Mehta SH, Dresler SR, Armstrong MJ, McFarland N, Okun M, Vaillancourt DE, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095555&quot;&gt;42095555&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diffusion-mri-and-synuclein-seed-amplification-status-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diffusion-mri-and-synuclein-seed-amplification-status-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Practical approaches to inclusive recruitment practices in Parkinson&#039;s disease research.</title>
 <link>https://www.alzforum.org/papers/practical-approaches-inclusive-recruitment-practices-parkinsons-disease-research</link>
 <description>J Parkinsons Dis. 2026 May 7;:1877718X261440708.  Epub 2026 May 7&lt;br&gt;Authors: Chahine LM, Louie N, Disbrow E, Marbach A, Augenbraun S, Nguyen BT, Johnson-Turbes A, Parry C, Avripas S, Chandra S, Dean M, Foster ER, Hall D, Hinson V, Kilbane C, Norris SA, Rawls A, Jonas C, Shamim EA, Shulman L, Staisch J, Stimming EF, Xie T, Wilcox M, Ameri A, Breaux S, Padmanaban M, von Coelln R, Singleton A, Blauwendraat C, Bandres-Ciga S, Baykal-Caglar E, Kelliher C, Greenwood K, O&amp;#039;Grady A, Solle J, Kopil CM, Kuhl MM, Black and African American Connections to Parkinson&amp;#039;s Disease (BLAAC PD) and the Global Parkinson&amp;#039;s Genetics Program (GP2)&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095464&quot;&gt;42095464&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/practical-approaches-inclusive-recruitment-practices-parkinsons-disease-research#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/practical-approaches-inclusive-recruitment-practices-parkinsons-disease-research#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Early cognitive screening for individuals on the dementia continuum: A novel approach amid current trends&quot;.</title>
 <link>https://www.alzforum.org/papers/corrigendum-early-cognitive-screening-individuals-dementia-continuum-novel-approach-amid</link>
 <description>J Alzheimers Dis. 2026 May 7;:13872877261447686.  Epub 2026 May 7&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093610&quot;&gt;42093610&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-early-cognitive-screening-individuals-dementia-continuum-novel-approach-amid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-early-cognitive-screening-individuals-dementia-continuum-novel-approach-amid#comments</comments>
</item>
<item>
 <title>Baseline epidemiological differences between donanemab and lecanemab users in real-world settings: a retrospective cohort study.</title>
 <link>https://www.alzforum.org/papers/baseline-epidemiological-differences-between-donanemab-and-lecanemab-users-real-world</link>
 <description>Neurodegener Dis Manag. 2026 May 7;:1-6.  Epub 2026 May 7&lt;br&gt;Authors: Andreão FF, da Silva RO, Negreli MF, Aguiar-Barros AB, Santos DH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093461&quot;&gt;42093461&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/baseline-epidemiological-differences-between-donanemab-and-lecanemab-users-real-world#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/baseline-epidemiological-differences-between-donanemab-and-lecanemab-users-real-world#comments</comments>
</item>
<item>
 <title>The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/emerging-role-and-therapeutic-targeting-autophagy-lysosome-pathway-pathogenesis-parkinsons</link>
 <description>Transl Neurodegener. 2026 May 7;15(1)&lt;br&gt;Authors: Shimizu T, Isik S, Kamath N, Yue Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093006&quot;&gt;42093006&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emerging-role-and-therapeutic-targeting-autophagy-lysosome-pathway-pathogenesis-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emerging-role-and-therapeutic-targeting-autophagy-lysosome-pathway-pathogenesis-parkinsons#comments</comments>
</item>
<item>
 <title>Mechanistic insights and therapeutic potential of targeting the cGAS-STING pathway in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/mechanistic-insights-and-therapeutic-potential-targeting-cgas-sting-pathway-neurodegenerative</link>
 <description>J Neuroinflammation. 2026 May 7; Epub 2026 May 7&lt;br&gt;Authors: Liu H, Hu C, Liu H, Gong Z, Jiang S, Xie J, Li Y, Liu C, Wang Y, Zou C, Yang G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092970&quot;&gt;42092970&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanistic-insights-and-therapeutic-potential-targeting-cgas-sting-pathway-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanistic-insights-and-therapeutic-potential-targeting-cgas-sting-pathway-neurodegenerative#comments</comments>
</item>
<item>
 <title>When tau stalls the lysosome: decoupling trafficking and degradation in autophagy.</title>
 <link>https://www.alzforum.org/papers/when-tau-stalls-lysosome-decoupling-trafficking-and-degradation-autophagy</link>
 <description>Autophagy. 2026 May 6;:1-3.  Epub 2026 May 6&lt;br&gt;Authors: Karch CM, Mirfakhar FS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093145&quot;&gt;42093145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/when-tau-stalls-lysosome-decoupling-trafficking-and-degradation-autophagy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/when-tau-stalls-lysosome-decoupling-trafficking-and-degradation-autophagy#comments</comments>
</item>
<item>
 <title>Repeated Intra-cisterna Magna Injections with Amyloid-beta Oligomers to Induce Alzheimer&#039;s Disease in Cynomolgus Monkey (Macaca fascicularis): A Pilot Study.</title>
 <link>https://www.alzforum.org/papers/repeated-intra-cisterna-magna-injections-amyloid-beta-oligomers-induce-alzheimers-disease</link>
 <description>Exp Neurobiol. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Cho J, Won J, Kim YG, Jeon CY, Lim KS, Seo J, Seong JB, Yeo HG, Kim K, Kim M, Gwon LW, Jung Y, Nguyen TT, Min J, Moon G, Choi WS, Park SH, Lee HY, Jeong KJ, Bae GS, Jeon E, Cheong DY, Lee G, Kim HC, Baeg E, Yang S, Huh JW, Park J, Lee Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087072&quot;&gt;42087072&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/repeated-intra-cisterna-magna-injections-amyloid-beta-oligomers-induce-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/repeated-intra-cisterna-magna-injections-amyloid-beta-oligomers-induce-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems.</title>
 <link>https://www.alzforum.org/papers/proteasomal-dependent-chk1-degradation-leads-dna-damage-accumulation-als-cellular-model</link>
 <description>Cell Death Dis. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Modafferi S, Silenzi V, Garbelli A, Lazoi G, Scarian E, D&amp;#039;Uva S, Santini T, Riccardi A, Cozzolino M, Pansarasa O, D&amp;#039;Ambrosi N, Sabbioneda S, Morlando M, Francia S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086533&quot;&gt;42086533&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proteasomal-dependent-chk1-degradation-leads-dna-damage-accumulation-als-cellular-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proteasomal-dependent-chk1-degradation-leads-dna-damage-accumulation-als-cellular-model#comments</comments>
</item>
<item>
 <title>Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.</title>
 <link>https://www.alzforum.org/papers/risk-alzheimer-disease-and-other-dementias-patients-parkinson-disease-nationwide-cohort-study</link>
 <description>Alzheimer Dis Assoc Disord. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Bae Y, Kim M, Jeon SR, Lee SW, Jung H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084241&quot;&gt;42084241&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/risk-alzheimer-disease-and-other-dementias-patients-parkinson-disease-nationwide-cohort-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/risk-alzheimer-disease-and-other-dementias-patients-parkinson-disease-nationwide-cohort-study#comments</comments>
</item>
<item>
 <title>Plasma biomarkers for Alzheimer disease: the road from laboratory results to clinical practice.</title>
 <link>https://www.alzforum.org/papers/plasma-biomarkers-alzheimer-disease-road-laboratory-results-clinical-practice</link>
 <description>Nat Rev Neurol. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Teunissen CE, van Harten AC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092056&quot;&gt;42092056&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-biomarkers-alzheimer-disease-road-laboratory-results-clinical-practice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-biomarkers-alzheimer-disease-road-laboratory-results-clinical-practice#comments</comments>
</item>
<item>
 <title>The epitranscriptomic m6A RNA modification modulates the synapse in ageing and in a mouse model of synucleinopathy.</title>
 <link>https://www.alzforum.org/papers/epitranscriptomic-m6a-rna-modification-modulates-synapse-ageing-and-mouse-model</link>
 <description>NPJ Parkinsons Dis. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Chopra A, Xylaki M, Yin F, Castro-Hernández R, Merghani M, Grande V, Mollenhauer B, Fischer A, Outeiro TF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091910&quot;&gt;42091910&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epitranscriptomic-m6a-rna-modification-modulates-synapse-ageing-and-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epitranscriptomic-m6a-rna-modification-modulates-synapse-ageing-and-mouse-model#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-blood-biomarkers-measured-through-remote-capillary-sampling-correlate</link>
 <description>Nat Commun. 2026 May 6;17(1)&lt;br&gt;Authors: Corbett A, Sander-Long M, Ashton NJ, Huber H, Vavra J, Braun-Wohlfahrt LS, Zetterberg H, Montoliu-Gaya L, Cummings J, Bateman F, Davis C, Ballard C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091863&quot;&gt;42091863&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-blood-biomarkers-measured-through-remote-capillary-sampling-correlate#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-blood-biomarkers-measured-through-remote-capillary-sampling-correlate#comments</comments>
</item>
<item>
 <title>Intranasal lipid nanocapsule administration of the new lipophenol quercetin-3-O-DHA-7-O-iPr reduces carbonyl stress and improves behavior in a mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/intranasal-lipid-nanocapsule-administration-new-lipophenol-quercetin-3-o-dha-7-o-ipr-reduces</link>
 <description>Drug Deliv Transl Res. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Otaegui L, Lehoux J, Begu S, Moujellil-Legagneur T, Zussy C, Vitalis M, Mathias M, Beau A, Durand T, Givalois L, Bernoud-Hubac N, Crauste C, Desrumaux C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091792&quot;&gt;42091792&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intranasal-lipid-nanocapsule-administration-new-lipophenol-quercetin-3-o-dha-7-o-ipr-reduces#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intranasal-lipid-nanocapsule-administration-new-lipophenol-quercetin-3-o-dha-7-o-ipr-reduces#comments</comments>
</item>
<item>
 <title>Allergic disease as a risk factor for Parkinson&#039;s disease: a possible role of eosinophil.</title>
 <link>https://www.alzforum.org/papers/allergic-disease-risk-factor-parkinsons-disease-possible-role-eosinophil</link>
 <description>NPJ Parkinsons Dis. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Chang HJ, Ha SH, Lee SH, Lee S, Jeong C, Shin JH, Kim HJ, Park HW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091590&quot;&gt;42091590&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/allergic-disease-risk-factor-parkinsons-disease-possible-role-eosinophil#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/allergic-disease-risk-factor-parkinsons-disease-possible-role-eosinophil#comments</comments>
</item>
<item>
 <title>Clinical GDNF delivery methods for Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/clinical-gdnf-delivery-methods-parkinsons-disease</link>
 <description>J Parkinsons Dis. 2026 May 6;:1877718X261444841.  Epub 2026 May 6&lt;br&gt;Authors: Luz M, Fiandaca MS, Bankiewicz KS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091584&quot;&gt;42091584&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-gdnf-delivery-methods-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-gdnf-delivery-methods-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Interleukin-6 in ALS: metabolic mediator or marker of ventilatory decline?</title>
 <link>https://www.alzforum.org/papers/interleukin-6-als-metabolic-mediator-or-marker-ventilatory-decline</link>
 <description>Amyotroph Lateral Scler Frontotemporal Degener. 2026 May 6;:1-2.  Epub 2026 May 6&lt;br&gt;Authors: Pronto-Laborinho AC, Carvalho M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091241&quot;&gt;42091241&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interleukin-6-als-metabolic-mediator-or-marker-ventilatory-decline#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interleukin-6-als-metabolic-mediator-or-marker-ventilatory-decline#comments</comments>
</item>
<item>
 <title>Determination of Small-Sized α-Synuclein Oligomers Using Solid-State Nanopore Assisted with Circular Single-Stranded DNA Frame.</title>
 <link>https://www.alzforum.org/papers/determination-small-sized-synuclein-oligomers-using-solid-state-nanopore-assisted-circular</link>
 <description>Anal Chem. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Heng S, Tong Y, Xu X, Zhao J, Zhu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091235&quot;&gt;42091235&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/determination-small-sized-synuclein-oligomers-using-solid-state-nanopore-assisted-circular#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/determination-small-sized-synuclein-oligomers-using-solid-state-nanopore-assisted-circular#comments</comments>
</item>
<item>
 <title>Tooth loss and long-term dementia risk: A nationwide population-based cohort study in the Republic of Korea.</title>
 <link>https://www.alzforum.org/papers/tooth-loss-and-long-term-dementia-risk-nationwide-population-based-cohort-study-republic</link>
 <description>Community Dent Health. 2026 May 6;:265539X261450847.  Epub 2026 May 6&lt;br&gt;Authors: Jung ES&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090611&quot;&gt;42090611&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tooth-loss-and-long-term-dementia-risk-nationwide-population-based-cohort-study-republic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tooth-loss-and-long-term-dementia-risk-nationwide-population-based-cohort-study-republic#comments</comments>
</item>
<item>
 <title>Study on the improvement effect and mechanism of resveratrol on cognitive impairment in tau mutant adenovirus-induced alzheimer&#039;s disease model mice.</title>
 <link>https://www.alzforum.org/papers/study-improvement-effect-and-mechanism-resveratrol-cognitive-impairment-tau-mutant-adenovirus</link>
 <description>Psychopharmacology (Berl). 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Chen S, Zhao K, Shi Z, Zhang C, Wu H, Tian M, Sun Y, He L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089987&quot;&gt;42089987&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/study-improvement-effect-and-mechanism-resveratrol-cognitive-impairment-tau-mutant-adenovirus#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/study-improvement-effect-and-mechanism-resveratrol-cognitive-impairment-tau-mutant-adenovirus#comments</comments>
</item>
<item>
 <title>Exploring peripheral immune mechanisms and potential therapeutic drugs for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/exploring-peripheral-immune-mechanisms-and-potential-therapeutic-drugs-alzheimers-disease</link>
 <description>Naunyn Schmiedebergs Arch Pharmacol. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Zhu W, Zhou D, Zhang G, Dai W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089894&quot;&gt;42089894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-peripheral-immune-mechanisms-and-potential-therapeutic-drugs-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-peripheral-immune-mechanisms-and-potential-therapeutic-drugs-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Clinical applicability of the BT2-NPS for assessing neuropsychiatric symptoms across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/clinical-applicability-bt2-nps-assessing-neuropsychiatric-symptoms-across-alzheimers-disease</link>
 <description>Arch Clin Neuropsychol. 2026 May 6;41(4)&lt;br&gt;Authors: Carrión N, Heredia L, Peña-Casanova J, Torrente M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089777&quot;&gt;42089777&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-applicability-bt2-nps-assessing-neuropsychiatric-symptoms-across-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-applicability-bt2-nps-assessing-neuropsychiatric-symptoms-across-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Dynamics of Aβ42 Tetramer by REST2-CHARMM36m Simulations.</title>
 <link>https://www.alzforum.org/papers/dynamics-av42-tetramer-rest2-charmm36m-simulations</link>
 <description>J Phys Chem B. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Nguyen TH, Ngo ST, Derreumaux P, Nguyen PH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089562&quot;&gt;42089562&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dynamics-av42-tetramer-rest2-charmm36m-simulations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dynamics-av42-tetramer-rest2-charmm36m-simulations#comments</comments>
</item>
<item>
 <title>Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson&#039;s Progression Markers Initiative.</title>
 <link>https://www.alzforum.org/papers/biologic-frameworks-synucleinopathies-contributions-parkinsons-progression-markers-initiative</link>
 <description>Ann Neurol. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Chahine LM, Alcalay RN, Brown EG, Chowdhury S, Coffey CS, Foroud T, Frasier M, Galasko D, Merchant KM, Mollenhauer B, Tolosa E, Pavese N, Tropea TF, Marek K, Simuni T, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089472&quot;&gt;42089472&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biologic-frameworks-synucleinopathies-contributions-parkinsons-progression-markers-initiative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biologic-frameworks-synucleinopathies-contributions-parkinsons-progression-markers-initiative#comments</comments>
</item>
<item>
 <title>The role of Annexin A2 in Alzheimer&#039;s disease: From cellular functions to therapeutic potential.</title>
 <link>https://www.alzforum.org/papers/role-annexin-a2-alzheimers-disease-cellular-functions-therapeutic-potential</link>
 <description>FEBS J. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Shu D, Fu C, Liu Z, Li C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089471&quot;&gt;42089471&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-annexin-a2-alzheimers-disease-cellular-functions-therapeutic-potential#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-annexin-a2-alzheimers-disease-cellular-functions-therapeutic-potential#comments</comments>
</item>
<item>
 <title>Electroencephalography-Based Clustering Reveals Robust Neurophysiological Subtypes in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/electroencephalography-based-clustering-reveals-robust-neurophysiological-subtypes-parkinsons</link>
 <description>Mov Disord. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Vered D, Katzir Z, Grosbard ID, Thaler A, Maidan I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089402&quot;&gt;42089402&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/electroencephalography-based-clustering-reveals-robust-neurophysiological-subtypes-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/electroencephalography-based-clustering-reveals-robust-neurophysiological-subtypes-parkinsons#comments</comments>
</item>
<item>
 <title>Arbitrary template docking fails to recapitulate early amyloid fibril oligomers in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/arbitrary-template-docking-fails-recapitulate-early-amyloid-fibril-oligomers</link>
 <description>J Biomol Struct Dyn. 2026 May 6;:1-9.  Epub 2026 May 6&lt;br&gt;Authors: Gillet JN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089289&quot;&gt;42089289&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/arbitrary-template-docking-fails-recapitulate-early-amyloid-fibril-oligomers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/arbitrary-template-docking-fails-recapitulate-early-amyloid-fibril-oligomers#comments</comments>
</item>
<item>
 <title>Hemorrhage Pattern and Amyloid Burden in Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/hemorrhage-pattern-and-amyloid-burden-cerebral-amyloid-angiopathy</link>
 <description>J Am Heart Assoc. 2026 May 6;:e048858.  Epub 2026 May 6&lt;br&gt;Authors: Gokcal E, Becker JA, Horn MJ, Rotschild O, Das AS, Fouks AA, Rosand J, Viswanathan A, Johnson KA, Gurol ME, Greenberg SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089159&quot;&gt;42089159&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hemorrhage-pattern-and-amyloid-burden-cerebral-amyloid-angiopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hemorrhage-pattern-and-amyloid-burden-cerebral-amyloid-angiopathy#comments</comments>
</item>
<item>
 <title>Dynamic Covalent Peptide-Drug Conjugates Address the Heterogeneity in Alzheimer&#039;s Disease Progression.</title>
 <link>https://www.alzforum.org/papers/dynamic-covalent-peptide-drug-conjugates-address-heterogeneity-alzheimers-disease-progression</link>
 <description>Adv Mater. 2026 May 6;:e16343.  Epub 2026 May 6&lt;br&gt;Authors: Yang Y, Wu T, Fan X, Yao Y, Chen C, Kang K, Tang X, Huang T, Xu Y, He Y, Chen Z, Chen Z, Yang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087846&quot;&gt;42087846&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dynamic-covalent-peptide-drug-conjugates-address-heterogeneity-alzheimers-disease-progression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dynamic-covalent-peptide-drug-conjugates-address-heterogeneity-alzheimers-disease-progression#comments</comments>
</item>
<item>
 <title>Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24.</title>
 <link>https://www.alzforum.org/papers/neuroinflammation-and-neurodegeneration-trigger-specific-splice-form-ribosomal-protein-s24</link>
 <description>Brain. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Magadi SS, Jonson M, Lucena PB, Caliandro MF, Almeida B, Bilalli L, Budinger D, Tsoi A, Ntzouni M, Maqdissi JA, Kaczmarczyk L, Zijlstra JJ, Faketija M, Perkins M, Paul G, Hallbeck M, Ingelsson M, Watts JC, Reichenbach N, Petzold GC, Schieweck R, Heneka MT, Jackson WS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087813&quot;&gt;42087813&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroinflammation-and-neurodegeneration-trigger-specific-splice-form-ribosomal-protein-s24#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroinflammation-and-neurodegeneration-trigger-specific-splice-form-ribosomal-protein-s24#comments</comments>
</item>
<item>
 <title>Long-Term Exposure to PM2.5 and Risk of Incident Dementia: A Systematic Review and Meta-Analysis of Cohort Studies.</title>
 <link>https://www.alzforum.org/papers/long-term-exposure-pm25-and-risk-incident-dementia-systematic-review-and-meta-analysis-cohort</link>
 <description>Cardiol Rev. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Rocheeld J, Gluck B, Frishman WH, Aronow WS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087308&quot;&gt;42087308&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/long-term-exposure-pm25-and-risk-incident-dementia-systematic-review-and-meta-analysis-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/long-term-exposure-pm25-and-risk-incident-dementia-systematic-review-and-meta-analysis-cohort#comments</comments>
</item>
<item>
 <title>Hepatic expression of APOE3 Christchurch mitigates APOE4-related Alzheimer&#039;s disease pathologies in mice.</title>
 <link>https://www.alzforum.org/papers/hepatic-expression-apoe3-christchurch-mitigates-apoe4-related-alzheimers-disease-pathologies</link>
 <description>Neuron. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Tang JY, Tan Q, Yu ZY, Yuan ZY, Zeng R, Liu XY, Zhu XY, Zhao Y, Li JH, Bai YD, Zeng GH, Wang C, Wang YJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097136&quot;&gt;42097136&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hepatic-expression-apoe3-christchurch-mitigates-apoe4-related-alzheimers-disease-pathologies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hepatic-expression-apoe3-christchurch-mitigates-apoe4-related-alzheimers-disease-pathologies#comments</comments>
</item>
<item>
 <title>Targeting TLR4 in Parkinson&#039;s disease: mechanisms and therapeutic prospects.</title>
 <link>https://www.alzforum.org/papers/targeting-tlr4-parkinsons-disease-mechanisms-and-therapeutic-prospects</link>
 <description>Int Immunopharmacol. 2026 May 6;182:116780.  Epub 2026 May 6&lt;br&gt;Authors: Dong S, Lu J, Wu L, Wang S, Gong Y, Hu J, Liu Y, Chen X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096963&quot;&gt;42096963&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-tlr4-parkinsons-disease-mechanisms-and-therapeutic-prospects#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-tlr4-parkinsons-disease-mechanisms-and-therapeutic-prospects#comments</comments>
</item>
<item>
 <title>Sleep complaints and genetic risk of Alzheimer&#039;s disease in older women: associations with memory and tau deposition.</title>
 <link>https://www.alzforum.org/papers/sleep-complaints-and-genetic-risk-alzheimers-disease-older-women-associations-memory-and-tau</link>
 <description>J Prev Alzheimers Dis. 2026 May 6;13(7):100581.  Epub 2026 May 6&lt;br&gt;Authors: Lui KK, Wang X, Dratva MA, Lifset ET, Stiver J, Heyworth NC, Shen Q, Thomas M, DeYoung PN, Malhotra A, Sundermann EE, Banks SJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096939&quot;&gt;42096939&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-complaints-and-genetic-risk-alzheimers-disease-older-women-associations-memory-and-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-complaints-and-genetic-risk-alzheimers-disease-older-women-associations-memory-and-tau#comments</comments>
</item>
<item>
 <title>Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers.</title>
 <link>https://www.alzforum.org/papers/clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease-course-modification</link>
 <description>J Prev Alzheimers Dis. 2026 May 6;13(7):100587.  Epub 2026 May 6&lt;br&gt;Authors: Hazan J, Liu KY, Howard R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096938&quot;&gt;42096938&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease-course-modification#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease-course-modification#comments</comments>
</item>
<item>
 <title>Large language models for deductive qualitative content analysis in dementia-focused embedded pragmatic clinical trials: A comparative methodological study.</title>
 <link>https://www.alzforum.org/papers/large-language-models-deductive-qualitative-content-analysis-dementia-focused-embedded</link>
 <description>Implement Sci Commun. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Turner J, Hey SP, Baker ZG, Mor V, Sullivan JL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093066&quot;&gt;42093066&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/large-language-models-deductive-qualitative-content-analysis-dementia-focused-embedded#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/large-language-models-deductive-qualitative-content-analysis-dementia-focused-embedded#comments</comments>
</item>
<item>
 <title>Future Directions: The Parkinson&#039;s Precision Medicine Initiative.</title>
 <link>https://www.alzforum.org/papers/future-directions-parkinsons-precision-medicine-initiative</link>
 <description>Ann Neurol. 2026 May 6; Epub 2026 May 6&lt;br&gt;Authors: Marek K, Tropea TF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092327&quot;&gt;42092327&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/future-directions-parkinsons-precision-medicine-initiative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/future-directions-parkinsons-precision-medicine-initiative#comments</comments>
</item>
<item>
 <title>Dexmedetomidine Exerts Multi-level Effects to Ameliorate Alzheimer&#039;s Disease Pathology in the Adult Zebrafish Brain.</title>
 <link>https://www.alzforum.org/papers/dexmedetomidine-exerts-multi-level-effects-ameliorate-alzheimers-disease-pathology-adult</link>
 <description>Mol Neurobiol. 2026 May 5;63(1)&lt;br&gt;Authors: Nazli D, Poyraz YK, Can K, Ipekgil D, Cakmak N, Turhanlar-Sahin E, Hacoglu S, Erdost HA, Iyilikci L, Ozhan G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082800&quot;&gt;42082800&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dexmedetomidine-exerts-multi-level-effects-ameliorate-alzheimers-disease-pathology-adult#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dexmedetomidine-exerts-multi-level-effects-ameliorate-alzheimers-disease-pathology-adult#comments</comments>
</item>
<item>
 <title>Targeting the integrated stress response or Ataxin-2 alleviates neurodegeneration in PolyGR models of C9orf72 associated frontotemporal dementia and amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/targeting-integrated-stress-response-or-ataxin-2-alleviates-neurodegeneration-polygr-models</link>
 <description>Acta Neuropathol Commun. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Harper NS, Sharpe JL, Speranza J, Gulia R, Chen JX, Allen SP, Atwal MS, Pickering-Brown S, Livesey MR, Bennett CL, Prokop A, La Spada AR, West RJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087256&quot;&gt;42087256&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-integrated-stress-response-or-ataxin-2-alleviates-neurodegeneration-polygr-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-integrated-stress-response-or-ataxin-2-alleviates-neurodegeneration-polygr-models#comments</comments>
</item>
<item>
 <title>Repurposing insulin for Alzheimer&#039;s disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.</title>
 <link>https://www.alzforum.org/papers/repurposing-insulin-alzheimers-disease-treatment-intranasal-delivery-thermoresponsive</link>
 <description>Drug Deliv Transl Res. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Khan TT, Wong CY, Sheikh Z, Fathi A, Maleknia S, Oveissi F, Abrams T, Knox W, van der Hoven J, Antonito A, Murray M, Svolos M, Suman J, Tietz O, Ong HX, Traini D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086977&quot;&gt;42086977&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/repurposing-insulin-alzheimers-disease-treatment-intranasal-delivery-thermoresponsive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/repurposing-insulin-alzheimers-disease-treatment-intranasal-delivery-thermoresponsive#comments</comments>
</item>
<item>
 <title>Correction: The blood lipidome fatty acid profile predicts the disease risk and clinical phenotypes of Alzheimer&#039;s disease: associations from two prospective cohort studies.</title>
 <link>https://www.alzforum.org/papers/correction-blood-lipidome-fatty-acid-profile-predicts-disease-risk-and-clinical-phenotypes</link>
 <description>Transl Psychiatry. 2026 May 5;16(1)&lt;br&gt;Authors: Liu WZ, Huang LY, Chi S, Ma YH, Tan CC, Tan L, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium, Xu W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086543&quot;&gt;42086543&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-blood-lipidome-fatty-acid-profile-predicts-disease-risk-and-clinical-phenotypes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-blood-lipidome-fatty-acid-profile-predicts-disease-risk-and-clinical-phenotypes#comments</comments>
</item>
<item>
 <title>A Novel Combined Audiovisual-Semantic Digital Tool for Early-Stage Cognitive Decline Detection: Development and Validation Study.</title>
 <link>https://www.alzforum.org/papers/novel-combined-audiovisual-semantic-digital-tool-early-stage-cognitive-decline-detection</link>
 <description>JMIR Aging. 2026 May 5;9:e91165. &lt;br&gt;Authors: Wu Q, Zhao B, Zheng Z, Seah B, Zhang X, Shao J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085660&quot;&gt;42085660&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-combined-audiovisual-semantic-digital-tool-early-stage-cognitive-decline-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-combined-audiovisual-semantic-digital-tool-early-stage-cognitive-decline-detection#comments</comments>
</item>
<item>
 <title>Analytical agreement and platform-specific decision thresholds for plasma p-tau217 measured on Lumipulse G600II and Cobas e801 in a paired CSF-plasma cohort.</title>
 <link>https://www.alzforum.org/papers/analytical-agreement-and-platform-specific-decision-thresholds-plasma-p-tau217-measured</link>
 <description>Clin Chem Lab Med. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Martínez-Bujidos M, Menéndez A, Pulido-Gracia JA, Vilas D, Samaniego D, Ispierto L, Morales-Indiano C, Pastor P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085591&quot;&gt;42085591&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/analytical-agreement-and-platform-specific-decision-thresholds-plasma-p-tau217-measured#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/analytical-agreement-and-platform-specific-decision-thresholds-plasma-p-tau217-measured#comments</comments>
</item>
<item>
 <title>A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/new-era-neuropharmacology-assessing-efficacy-and-safety-novel-anti-amyloid-and-non-amyloid</link>
 <description>J Neurol. 2026 May 5;273(5)&lt;br&gt;Authors: Hafez MM, Abbas HA, Shoman NA, Soubh AA, Aly O, Sallam MF, Seliem M, Malaak FA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084750&quot;&gt;42084750&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/new-era-neuropharmacology-assessing-efficacy-and-safety-novel-anti-amyloid-and-non-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/new-era-neuropharmacology-assessing-efficacy-and-safety-novel-anti-amyloid-and-non-amyloid#comments</comments>
</item>
<item>
 <title>Advances in sex-specific single-cell transcriptomic profiling in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/advances-sex-specific-single-cell-transcriptomic-profiling-parkinsons-disease</link>
 <description>J Parkinsons Dis. 2026 May 5;:1877718X261436548.  Epub 2026 May 5&lt;br&gt;Authors: Hoof V, Schulze-Hentrich J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084601&quot;&gt;42084601&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-sex-specific-single-cell-transcriptomic-profiling-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-sex-specific-single-cell-transcriptomic-profiling-parkinsons-disease#comments</comments>
</item>
<item>
 <title>From Food Additives to Neurodegeneration: The Emerging Role of Polyphosphates in Tauopathies.</title>
 <link>https://www.alzforum.org/papers/food-additives-neurodegeneration-emerging-role-polyphosphates-tauopathies</link>
 <description>ACS Chem Neurosci. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Barolo L, Farina MV, Cimaglia G, Gigante Y, Mirone A, Mautone L, Boffi A, Di Angelantonio S, Baiocco P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084231&quot;&gt;42084231&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/food-additives-neurodegeneration-emerging-role-polyphosphates-tauopathies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/food-additives-neurodegeneration-emerging-role-polyphosphates-tauopathies#comments</comments>
</item>
<item>
 <title>The association of adverse childhood experiences and life course relationship quality with late-life cognitive health: Moderation by race/ethnicity and gender.</title>
 <link>https://www.alzforum.org/papers/association-adverse-childhood-experiences-and-life-course-relationship-quality-late-life</link>
 <description>J Alzheimers Dis. 2026 May 5;:13872877251394324.  Epub 2026 May 5&lt;br&gt;Authors: Walters ME, Wong R, Scambray KA, Antonucci TC, Tarraf W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083879&quot;&gt;42083879&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-adverse-childhood-experiences-and-life-course-relationship-quality-late-life#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-adverse-childhood-experiences-and-life-course-relationship-quality-late-life#comments</comments>
</item>
<item>
 <title>Health behavior mechanisms linking childhood socioeconomic status to Alzheimer&#039;s disease and related dementia risk: Exploring gender and racial/ethnic differences.</title>
 <link>https://www.alzforum.org/papers/health-behavior-mechanisms-linking-childhood-socioeconomic-status-alzheimers-disease-and</link>
 <description>J Alzheimers Dis. 2026 May 5;:13872877251394317.  Epub 2026 May 5&lt;br&gt;Authors: Nah S, Chek CJ, Montoya A, Duarte A, Ryan LH, Chopik WJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083876&quot;&gt;42083876&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/health-behavior-mechanisms-linking-childhood-socioeconomic-status-alzheimers-disease-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/health-behavior-mechanisms-linking-childhood-socioeconomic-status-alzheimers-disease-and#comments</comments>
</item>
<item>
 <title>From Parkinson&#039;s Progression Markers Initiative to Parkinson&#039;s Precision Medicine Initiative: Still PPMI.</title>
 <link>https://www.alzforum.org/papers/parkinsons-progression-markers-initiative-parkinsons-precision-medicine-initiative-still-ppmi</link>
 <description>Ann Neurol. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Marek K, Chowdhury S, Tropea TF, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083870&quot;&gt;42083870&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parkinsons-progression-markers-initiative-parkinsons-precision-medicine-initiative-still-ppmi#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parkinsons-progression-markers-initiative-parkinsons-precision-medicine-initiative-still-ppmi#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Dioscin alleviates Alzheimer&#039;s disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation&quot; [Biomed. Pharmacother. 152 (2022) 113248].</title>
 <link>https://www.alzforum.org/papers/corrigendum-dioscin-alleviates-alzheimers-disease-through-regulating-ragenox4-mediated</link>
 <description>Biomed Pharmacother. 2026 May 5;:119454.  Epub 2026 May 5&lt;br&gt;Authors: Guan L, Mao Z, Yang S, Wu G, Chen Y, Yin L, Qi Y, Han L, Xu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42091384&quot;&gt;42091384&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-dioscin-alleviates-alzheimers-disease-through-regulating-ragenox4-mediated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-dioscin-alleviates-alzheimers-disease-through-regulating-ragenox4-mediated#comments</comments>
</item>
<item>
 <title>Adapting the spanish healthcare system for disease-modifying treatments in early-stage alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/adapting-spanish-healthcare-system-disease-modifying-treatments-early-stage-alzheimers</link>
 <description>J Prev Alzheimers Dis. 2026 May 5;13(7):100586.  Epub 2026 May 5&lt;br&gt;Authors: Sánchez Valle R, Lleó Bisa A, Villarejo Galende A, Cuartero Rodríguez E, Escudero-Torrella J, Bargallo Alabart N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090785&quot;&gt;42090785&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adapting-spanish-healthcare-system-disease-modifying-treatments-early-stage-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adapting-spanish-healthcare-system-disease-modifying-treatments-early-stage-alzheimers#comments</comments>
</item>
<item>
 <title>Hazan J; Liu KY; Howard R. Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers. # TJPAD-D-26-00165.</title>
 <link>https://www.alzforum.org/papers/hazan-j-liu-ky-howard-r-clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease</link>
 <description>J Prev Alzheimers Dis. 2026 May 5;13(7):100588.  Epub 2026 May 5&lt;br&gt;Authors: Froelich L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090784&quot;&gt;42090784&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hazan-j-liu-ky-howard-r-clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hazan-j-liu-ky-howard-r-clarity-ad-open-label-extension-data-do-not-robustly-confirm-disease#comments</comments>
</item>
<item>
 <title>Virtual reality-based training in patients with alzheimer&#039;s disease: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/virtual-reality-based-training-patients-alzheimers-disease-systematic-review-and-meta</link>
 <description>J Prev Alzheimers Dis. 2026 May 5;13(7):100590.  Epub 2026 May 5&lt;br&gt;Authors: Wang J, Wu C, Zhu K, Qi X, Chen G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090783&quot;&gt;42090783&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/virtual-reality-based-training-patients-alzheimers-disease-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/virtual-reality-based-training-patients-alzheimers-disease-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Tetanus, diphtheria and pertussis vaccination and risk for incident dementia among adults with down syndrome.</title>
 <link>https://www.alzforum.org/papers/tetanus-diphtheria-and-pertussis-vaccination-and-risk-incident-dementia-among-adults-down</link>
 <description>J Prev Alzheimers Dis. 2026 May 5;13(7):100583.  Epub 2026 May 5&lt;br&gt;Authors: Schiel K, Salas J, Urban A, Hoft DF, Scherrer JF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090782&quot;&gt;42090782&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tetanus-diphtheria-and-pertussis-vaccination-and-risk-incident-dementia-among-adults-down#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tetanus-diphtheria-and-pertussis-vaccination-and-risk-incident-dementia-among-adults-down#comments</comments>
</item>
<item>
 <title>Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer&#039;s disease kindred.</title>
 <link>https://www.alzforum.org/papers/associations-plasma-biomarkers-age-presenilin-1-e280a-autosomal-dominant-alzheimers-disease</link>
 <description>J Prev Alzheimers Dis. 2026 May 5;13(6):100578.  Epub 2026 May 5&lt;br&gt;Authors: Malotaux V, Ku V, Ospina Lopera P, Su Y, Chen Y, Singh A, Ruiz-Triviño J, Hidalgo MJ, Osorio L, Serna L, Giraldo D, Alzate D, He B, Tristão-Pereira C, Ramirez Gomez L, Do Carmo S, Cuello AC, Ashton NJ, Reiman EM, Aguillón D, Quiroz YT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090736&quot;&gt;42090736&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-plasma-biomarkers-age-presenilin-1-e280a-autosomal-dominant-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-plasma-biomarkers-age-presenilin-1-e280a-autosomal-dominant-alzheimers-disease#comments</comments>
</item>
<item>
 <title>ADAM10 and its role in Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/adam10-and-its-role-alzheimer-disease</link>
 <description>Neurologia (Engl Ed). 2026 May 5;:502083.  Epub 2026 May 5&lt;br&gt;Authors: Agüero P, Gómez Tortosa E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097504&quot;&gt;42097504&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adam10-and-its-role-alzheimer-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adam10-and-its-role-alzheimer-disease#comments</comments>
</item>
<item>
 <title>Conjecture for a free radical epimerization process in Alzheimer, Parkinson, Lewy body, amyotrophic lateral sclerosis, progressive Supranuclear Palsy and Creutzfeldt Jakob diseases.</title>
 <link>https://www.alzforum.org/papers/conjecture-free-radical-epimerization-process-alzheimer-parkinson-lewy-body-amyotrophic</link>
 <description>Exp Neurol. 2026 May 5;403:115812.  Epub 2026 May 5&lt;br&gt;Authors: Deloncle R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097486&quot;&gt;42097486&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/conjecture-free-radical-epimerization-process-alzheimer-parkinson-lewy-body-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/conjecture-free-radical-epimerization-process-alzheimer-parkinson-lewy-body-amyotrophic#comments</comments>
</item>
<item>
 <title>ISRIB as a prototype eIF2B activator: Pharmacology, mechanisms, and translational potential in aging-related cognitive disorders.</title>
 <link>https://www.alzforum.org/papers/isrib-prototype-eif2b-activator-pharmacology-mechanisms-and-translational-potential-aging</link>
 <description>Pharmacol Res. 2026 May 5;228:108228.  Epub 2026 May 5&lt;br&gt;Authors: Zhu PF, Lyu Z, Wang Q, Li S, Wang X, Luo A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097410&quot;&gt;42097410&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/isrib-prototype-eif2b-activator-pharmacology-mechanisms-and-translational-potential-aging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/isrib-prototype-eif2b-activator-pharmacology-mechanisms-and-translational-potential-aging#comments</comments>
</item>
<item>
 <title>Synaptic attenuation by human alpha-synuclein depends on two amino acids in its C-terminal tail.</title>
 <link>https://www.alzforum.org/papers/synaptic-attenuation-human-alpha-synuclein-depends-two-amino-acids-its-c-terminal-tail</link>
 <description>Neurobiol Dis. 2026 May 5;225:107437.  Epub 2026 May 5&lt;br&gt;Authors: Riba J, Samuel L, Stavsky A, Adaoui E, Ashkenazy T, Sevilla-Sanchez D, Gitler D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097409&quot;&gt;42097409&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synaptic-attenuation-human-alpha-synuclein-depends-two-amino-acids-its-c-terminal-tail#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synaptic-attenuation-human-alpha-synuclein-depends-two-amino-acids-its-c-terminal-tail#comments</comments>
</item>
<item>
 <title>Reimagining the contribution of iron in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/reimagining-contribution-iron-parkinsons-disease</link>
 <description>Neurobiol Dis. 2026 May 5;225:107434.  Epub 2026 May 5&lt;br&gt;Authors: Serpa RO, Tufano E, Connor JR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097406&quot;&gt;42097406&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reimagining-contribution-iron-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reimagining-contribution-iron-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Abscisic acid ameliorates cognitive deficits in an amyloid-β-induced mouse model of Alzheimer&#039;s disease associated with alterations in markers of neuroplasticity and neuroinflammation.</title>
 <link>https://www.alzforum.org/papers/abscisic-acid-ameliorates-cognitive-deficits-amyloid-v-induced-mouse-model-alzheimers-disease</link>
 <description>Neurosci Lett. 2026 May 5;881:138619.  Epub 2026 May 5&lt;br&gt;Authors: Shahsavari F, Rajizadeh MA, Pirmoradi Z, Sabzalizadeh M, Kohlmeier KA, Soti M, Shabani M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097395&quot;&gt;42097395&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/abscisic-acid-ameliorates-cognitive-deficits-amyloid-v-induced-mouse-model-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/abscisic-acid-ameliorates-cognitive-deficits-amyloid-v-induced-mouse-model-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Prolonged β-adrenergic stimulation reduces β2-adrenergic receptor levels and limits astrocytic responsiveness during early amyloid pathology.</title>
 <link>https://www.alzforum.org/papers/prolonged-v-adrenergic-stimulation-reduces-v2-adrenergic-receptor-levels-and-limits</link>
 <description>Neurosci Lett. 2026 May 5;881:138618.  Epub 2026 May 5&lt;br&gt;Authors: Roy Choudhury R, Kushwaha S, Karunakaran S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097394&quot;&gt;42097394&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prolonged-v-adrenergic-stimulation-reduces-v2-adrenergic-receptor-levels-and-limits#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prolonged-v-adrenergic-stimulation-reduces-v2-adrenergic-receptor-levels-and-limits#comments</comments>
</item>
<item>
 <title>The role of neurogenesis in neurodegenerative diseases: Mechanisms and interventions.</title>
 <link>https://www.alzforum.org/papers/role-neurogenesis-neurodegenerative-diseases-mechanisms-and-interventions</link>
 <description>Ageing Res Rev. 2026 May 5;119:103160.  Epub 2026 May 5&lt;br&gt;Authors: Chen R, Qiu Z, Luo Y, Fu Y, Cui X, Jiang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097313&quot;&gt;42097313&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-neurogenesis-neurodegenerative-diseases-mechanisms-and-interventions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-neurogenesis-neurodegenerative-diseases-mechanisms-and-interventions#comments</comments>
</item>
<item>
 <title>An integrative proteomic approach to reveal altered signaling modules during Alzheimer&#039;s disease progression in PS19 tauopathy mice.</title>
 <link>https://www.alzforum.org/papers/integrative-proteomic-approach-reveal-altered-signaling-modules-during-alzheimers-disease</link>
 <description>Mol Cell Proteomics. 2026 May 5;:101580.  Epub 2026 May 5&lt;br&gt;Authors: Cho E, Lee S, Lee H, Kim J, Kwon YW, Hoe HS, Kim D, Yoon JH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097270&quot;&gt;42097270&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-proteomic-approach-reveal-altered-signaling-modules-during-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-proteomic-approach-reveal-altered-signaling-modules-during-alzheimers-disease#comments</comments>
</item>
<item>
 <title>A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils.</title>
 <link>https://www.alzforum.org/papers/high-content-imaging-workflow-screen-molecules-reduce-cellular-uptake-synuclein-preformed</link>
 <description>Methods. 2026 May 5;252:41-54.  Epub 2026 May 5&lt;br&gt;Authors: Reintsch WE, Krahn AI, Han C, Nguyen-Renou E, Chen CX, Luo W, Shlaifer I, Pfeifer T, Fon EA, Durcan TM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097183&quot;&gt;42097183&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-content-imaging-workflow-screen-molecules-reduce-cellular-uptake-synuclein-preformed#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-content-imaging-workflow-screen-molecules-reduce-cellular-uptake-synuclein-preformed#comments</comments>
</item>
<item>
 <title>Computational investigation of BMS-984923 against Alzheimer&#039;s amyloid-beta (Aβ) structures: insights into their molecular interactions and inhibition of aggregation.</title>
 <link>https://www.alzforum.org/papers/computational-investigation-bms-984923-against-alzheimers-amyloid-beta-av-structures-insights</link>
 <description>Phys Chem Chem Phys. 2026 May 5; Epub 2026 May 5&lt;br&gt;Authors: Patir S, Baruah A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093397&quot;&gt;42093397&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/computational-investigation-bms-984923-against-alzheimers-amyloid-beta-av-structures-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/computational-investigation-bms-984923-against-alzheimers-amyloid-beta-av-structures-insights#comments</comments>
</item>
<item>
 <title>Comment on &quot;effect of extra virgin olive oil on mild cognitive impairment and dementia in older adults: A systematic review and meta-analysis of clinical trials&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-effect-extra-virgin-olive-oil-mild-cognitive-impairment-and-dementia-older-adults</link>
 <description>Clin Nutr ESPEN. 2026 May 5;73:103313.  Epub 2026 May 5&lt;br&gt;Authors: Jaiswal A, Sinnarkar V, Sharma DB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092516&quot;&gt;42092516&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-effect-extra-virgin-olive-oil-mild-cognitive-impairment-and-dementia-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-effect-extra-virgin-olive-oil-mild-cognitive-impairment-and-dementia-older-adults#comments</comments>
</item>
<item>
 <title>TRIM16 attenuates TDP43-mediated oxidative injury by coordinating Nrf2 activation and TFR1 autophagic degradation.</title>
 <link>https://www.alzforum.org/papers/trim16-attenuates-tdp43-mediated-oxidative-injury-coordinating-nrf2-activation-and-tfr1</link>
 <description>Free Radic Biol Med. 2026 May 5;252:132-149.  Epub 2026 May 5&lt;br&gt;Authors: Chen Q, Zhou Y, Peng Y, Lan J, Kang Y, Wu L, Liu J, Tang J, Peng Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092406&quot;&gt;42092406&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trim16-attenuates-tdp43-mediated-oxidative-injury-coordinating-nrf2-activation-and-tfr1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trim16-attenuates-tdp43-mediated-oxidative-injury-coordinating-nrf2-activation-and-tfr1#comments</comments>
</item>
<item>
 <title>The meningeal lymphatic vessel-peripheral immune axis: a novel therapeutic target in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/meningeal-lymphatic-vessel-peripheral-immune-axis-novel-therapeutic-target-neurodegenerative</link>
 <description>J Neuroinflammation. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: He Z, Sun J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071213&quot;&gt;42071213&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/meningeal-lymphatic-vessel-peripheral-immune-axis-novel-therapeutic-target-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/meningeal-lymphatic-vessel-peripheral-immune-axis-novel-therapeutic-target-neurodegenerative#comments</comments>
</item>
<item>
 <title>Viral Mimicry of Alzheimer&#039;s Disease: Innate Sensing of Self-Nucleic Acids as a Driver of Glial Senescence.</title>
 <link>https://www.alzforum.org/papers/viral-mimicry-alzheimers-disease-innate-sensing-self-nucleic-acids-driver-glial-senescence</link>
 <description>J Mol Neurosci. 2026 May 4;76(2)&lt;br&gt;Authors: Abuhassan Q, Saeed TN, Al-Hussainy AF, Roopashree R, Mishra S, Nanda A, Mukherjee G, Rizaev J, Taher SG, Alwan M, Jawad M, Mushtaq H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071158&quot;&gt;42071158&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/viral-mimicry-alzheimers-disease-innate-sensing-self-nucleic-acids-driver-glial-senescence#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/viral-mimicry-alzheimers-disease-innate-sensing-self-nucleic-acids-driver-glial-senescence#comments</comments>
</item>
<item>
 <title>From Cerebrospinal Fluid to Blood Draw: Plasma p-Tau217 as a Non-Invasive Biomarker for Alzheimer&#039;s Disease: A Fagan Nomogram-Based Meta-Analytic Study.</title>
 <link>https://www.alzforum.org/papers/cerebrospinal-fluid-blood-draw-plasma-p-tau217-non-invasive-biomarker-alzheimers-disease</link>
 <description>Mol Neurobiol. 2026 May 4;63(1)&lt;br&gt;Authors: Gebril NM, Elettreby AM, Younis AH, Moawad MH, Hafez AM, Sayed GE, Abdelrahman KM, El-Kot SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071133&quot;&gt;42071133&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebrospinal-fluid-blood-draw-plasma-p-tau217-non-invasive-biomarker-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebrospinal-fluid-blood-draw-plasma-p-tau217-non-invasive-biomarker-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Investigating causal associations among inflammatory proteins, blood metabolites, and Alzheimer&#039;s disease risk.</title>
 <link>https://www.alzforum.org/papers/investigating-causal-associations-among-inflammatory-proteins-blood-metabolites-and</link>
 <description>BMC Psychiatry. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Liu S, Zhu J, Zhong H, Zhou D, Long Q, Zhang Z, Yang X, Wu Q, Cheng C, Wu J, Luu HN, Wang J, Zhao B, Wu C, Deng Y, Wu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082960&quot;&gt;42082960&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-causal-associations-among-inflammatory-proteins-blood-metabolites-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-causal-associations-among-inflammatory-proteins-blood-metabolites-and#comments</comments>
</item>
<item>
 <title>Estimation of Various Physiological Parameters Affecting Amyloid Plaque Distribution of a Novel MRI Contrast Agent in the Brain of Alzheimer&#039;s Disease Transgenic Mice.</title>
 <link>https://www.alzforum.org/papers/estimation-various-physiological-parameters-affecting-amyloid-plaque-distribution-novel-mri</link>
 <description>Mol Pharm. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Salian V, Wang Z, Curran G, Podulso JF, Kandimalla KK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082924&quot;&gt;42082924&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/estimation-various-physiological-parameters-affecting-amyloid-plaque-distribution-novel-mri#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/estimation-various-physiological-parameters-affecting-amyloid-plaque-distribution-novel-mri#comments</comments>
</item>
<item>
 <title>Lamotrigine Improves Spatial Learning and Attenuates AD-Related Pathology in APP/PS1 Mice, with Possible Involvement of the cAMP/PKA/CREB Pathway.</title>
 <link>https://www.alzforum.org/papers/lamotrigine-improves-spatial-learning-and-attenuates-ad-related-pathology-appps1-mice</link>
 <description>Neurochem Res. 2026 May 4;51(3)&lt;br&gt;Authors: Zheng X, Chen P, Li D, Li W, Liao J, Zhang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082835&quot;&gt;42082835&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lamotrigine-improves-spatial-learning-and-attenuates-ad-related-pathology-appps1-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lamotrigine-improves-spatial-learning-and-attenuates-ad-related-pathology-appps1-mice#comments</comments>
</item>
<item>
 <title>Structural MRI in frontotemporal dementia and Alzheimer&#039;s disease: stage-dependent atrophy patterns.</title>
 <link>https://www.alzforum.org/papers/structural-mri-frontotemporal-dementia-and-alzheimers-disease-stage-dependent-atrophy</link>
 <description>J Neural Transm (Vienna). 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Khalili E, Sodaei F, Noroozian M, Sheldrick-Michel TM, Vafaee MS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082780&quot;&gt;42082780&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-mri-frontotemporal-dementia-and-alzheimers-disease-stage-dependent-atrophy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-mri-frontotemporal-dementia-and-alzheimers-disease-stage-dependent-atrophy#comments</comments>
</item>
<item>
 <title>Learning patient-specific spatial biomarker dynamics via operator learning for Alzheimer&#039;s disease progression.</title>
 <link>https://www.alzforum.org/papers/learning-patient-specific-spatial-biomarker-dynamics-operator-learning-alzheimers-disease</link>
 <description>NPJ Syst Biol Appl. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Wang J, Mao Y, Liu X, Hao W, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082519&quot;&gt;42082519&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/learning-patient-specific-spatial-biomarker-dynamics-operator-learning-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/learning-patient-specific-spatial-biomarker-dynamics-operator-learning-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Sex-, gender- and ethnically-sensitive aspects of psychosocial interventions for people living with dementia and BPSD: A protocol for a participatory umbrella review.</title>
 <link>https://www.alzforum.org/papers/sex-gender-and-ethnically-sensitive-aspects-psychosocial-interventions-people-living-dementia</link>
 <description>BMJ Open. 2026 May 4;16(5):e114162. &lt;br&gt;Authors: Yigit G, Michel E, Rommerskirch-Manietta M, Altinok K, Felding SA, Manietta C, Roes M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082231&quot;&gt;42082231&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-gender-and-ethnically-sensitive-aspects-psychosocial-interventions-people-living-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-gender-and-ethnically-sensitive-aspects-psychosocial-interventions-people-living-dementia#comments</comments>
</item>
<item>
 <title>Resting after learning facilitates memory consolidation and reverses spatial reorientation impairments in female 3xTg-AD mice.</title>
 <link>https://www.alzforum.org/papers/resting-after-learning-facilitates-memory-consolidation-and-reverses-spatial-reorientation-0</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261429996.  Epub 2026 May 4&lt;br&gt;Authors: Stimmell AC, Alday LJ, Salvador EM, Marquez Diaz J, Moseley SC, Cushing SD, Zheng Y, Ogg JD, Ragsdale SM, Wilber AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081596&quot;&gt;42081596&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resting-after-learning-facilitates-memory-consolidation-and-reverses-spatial-reorientation-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resting-after-learning-facilitates-memory-consolidation-and-reverses-spatial-reorientation-0#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease subtyping approaches and the role of co-pathologies.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-subtyping-approaches-and-role-co-pathologies</link>
 <description>Brain. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Gawor K, Statz K, Schaeverbeke J, Thal DR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081371&quot;&gt;42081371&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-subtyping-approaches-and-role-co-pathologies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-subtyping-approaches-and-role-co-pathologies#comments</comments>
</item>
<item>
 <title>Choroid plexus volume in Alzheimer&#039;s disease: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/choroid-plexus-volume-alzheimers-disease-systematic-review-and-meta-analysis</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261447404.  Epub 2026 May 4&lt;br&gt;Authors: Mahmoudi F, Yazdan Panah M, Dehghani Firouzabadi D, Vaheb S, Ghoshouni H, Flores Gonzalez R, Shaygannejad V, Mirmosayyeb O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081200&quot;&gt;42081200&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/choroid-plexus-volume-alzheimers-disease-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/choroid-plexus-volume-alzheimers-disease-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Beyond Amyloids: Neuroprotective Potential of Betanin and its Derivatives Against Alpha-Synuclein Aggregates and ROS Overload in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/beyond-amyloids-neuroprotective-potential-betanin-and-its-derivatives-against-alpha-synuclein</link>
 <description>J Mol Neurosci. 2026 May 4;76(2)&lt;br&gt;Authors: Ghahari A, Alikhanian A, Solaei FA, Fattahi A, Hourfar H, Schallmey A, Mohammadi M, Morshedi D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081152&quot;&gt;42081152&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-amyloids-neuroprotective-potential-betanin-and-its-derivatives-against-alpha-synuclein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-amyloids-neuroprotective-potential-betanin-and-its-derivatives-against-alpha-synuclein#comments</comments>
</item>
<item>
 <title>Ketogenic diet enhances cognitive-behavioral function and hippocampal neurogenesis while attenuating amyloid pathology in Tg-SwDI mice.</title>
 <link>https://www.alzforum.org/papers/ketogenic-diet-enhances-cognitive-behavioral-function-and-hippocampal-neurogenesis-while</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261445916.  Epub 2026 May 4&lt;br&gt;Authors: Pulido-Correa VE, Hernandez AV, Wind EJ, Zhu Y, Vogel C, Binu S, Jeneske M, Kuni D, Chiduruppa V, Echeverria B, Rosenberg L, Robison LS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081138&quot;&gt;42081138&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ketogenic-diet-enhances-cognitive-behavioral-function-and-hippocampal-neurogenesis-while#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ketogenic-diet-enhances-cognitive-behavioral-function-and-hippocampal-neurogenesis-while#comments</comments>
</item>
<item>
 <title>Trends in Alzheimer&#039;s disease mortality with metabolic syndrome-related conditions among older adults in the United States, 1999-2020.</title>
 <link>https://www.alzforum.org/papers/trends-alzheimers-disease-mortality-metabolic-syndrome-related-conditions-among-older-adults</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261445035.  Epub 2026 May 4&lt;br&gt;Authors: Alam T, Rajdeep D, Kamal S, Osman Abufatima I, Majid M, Siddiqui S, Waheed SA, Nawaz A, Faheem MS, Burney W, Khatri A, Usman N, Aqeel N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081127&quot;&gt;42081127&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trends-alzheimers-disease-mortality-metabolic-syndrome-related-conditions-among-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trends-alzheimers-disease-mortality-metabolic-syndrome-related-conditions-among-older-adults#comments</comments>
</item>
<item>
 <title>Data-driven detection of lucid episodes in advanced dementia: Application of latent class analysis to observational data.</title>
 <link>https://www.alzforum.org/papers/data-driven-detection-lucid-episodes-advanced-dementia-application-latent-class-analysis</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261445464.  Epub 2026 May 4&lt;br&gt;Authors: Kottler HC, Gilmore-Bykovskyi A, Cochran A, Mueller K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081117&quot;&gt;42081117&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/data-driven-detection-lucid-episodes-advanced-dementia-application-latent-class-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/data-driven-detection-lucid-episodes-advanced-dementia-application-latent-class-analysis#comments</comments>
</item>
<item>
 <title>Projected burden of Alzheimer&#039;s disease and other dementias in the Western Pacific, 2023-2050.</title>
 <link>https://www.alzforum.org/papers/projected-burden-alzheimers-disease-and-other-dementias-western-pacific-2023-2050</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261441774.  Epub 2026 May 4&lt;br&gt;Authors: Marzo RR, Li M, Yang Q, Chen H, Sam R, Farooqui M, Changmai MC, Bibigul Z, Karlygash A, Respati T, Xu D, Zhang H, Sheferaw W, Wolde ZM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081116&quot;&gt;42081116&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/projected-burden-alzheimers-disease-and-other-dementias-western-pacific-2023-2050#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/projected-burden-alzheimers-disease-and-other-dementias-western-pacific-2023-2050#comments</comments>
</item>
<item>
 <title>Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer&#039;s disease dementia.</title>
 <link>https://www.alzforum.org/papers/validation-longitudinal-change-proper-name-recall-ptau217-marker-early-cognitive-decline</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261446477.  Epub 2026 May 4&lt;br&gt;Authors: Basche K, He D, Langhough R, Jonaitis E, Du L, Bruno D, Wilson R, Hermann B, Johnson S, Mueller K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081092&quot;&gt;42081092&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/validation-longitudinal-change-proper-name-recall-ptau217-marker-early-cognitive-decline#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/validation-longitudinal-change-proper-name-recall-ptau217-marker-early-cognitive-decline#comments</comments>
</item>
<item>
 <title>Update on the current state of speech and language testing in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/update-current-state-speech-and-language-testing-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 May 4;:13872877261446637.  Epub 2026 May 4&lt;br&gt;Authors: Dhareshwar S, Kane M, Lewis C, Mineur R, Yao K, Snyder PJ, Alber J, Robb C, Lim YY, Vogel AP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081089&quot;&gt;42081089&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/update-current-state-speech-and-language-testing-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/update-current-state-speech-and-language-testing-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Clinical study on the interaction between iron metabolism and neuroinflammation and iron deposition in the substantia nigra of Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/clinical-study-interaction-between-iron-metabolism-and-neuroinflammation-and-iron-deposition</link>
 <description>Brain Imaging Behav. 2026 May 4;20(3)&lt;br&gt;Authors: Yao Y, Li J, Yan J, Cai Q, Wang Y, Xia H, Feng T, Li P, Yang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080960&quot;&gt;42080960&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-study-interaction-between-iron-metabolism-and-neuroinflammation-and-iron-deposition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-study-interaction-between-iron-metabolism-and-neuroinflammation-and-iron-deposition#comments</comments>
</item>
<item>
 <title>Small Molecule Guided Photocatalytic Proteomics Profiling of Amyloid Deposits in Hippocampal and Cortical Alzheimer&#039;s Disease Tissues.</title>
 <link>https://www.alzforum.org/papers/small-molecule-guided-photocatalytic-proteomics-profiling-amyloid-deposits-hippocampal-and</link>
 <description>Anal Chem. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Yan J, Feng H, Xia Q, Shen D, Jin H, Sun R, Sun J, Tang W, Yu X, Guo F, Guo H, Huang Y, Ge Y, Liu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080913&quot;&gt;42080913&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/small-molecule-guided-photocatalytic-proteomics-profiling-amyloid-deposits-hippocampal-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/small-molecule-guided-photocatalytic-proteomics-profiling-amyloid-deposits-hippocampal-and#comments</comments>
</item>
<item>
 <title>ICAM-1 mediated inhibition of microglial inflammation through ERK/STAT3 signalling pathway improves cognitive functions in 5xFAD mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/icam-1-mediated-inhibition-microglial-inflammation-through-erkstat3-signalling-pathway</link>
 <description>FEBS J. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Goswami S, Gorai N, Biswas SC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080655&quot;&gt;42080655&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/icam-1-mediated-inhibition-microglial-inflammation-through-erkstat3-signalling-pathway#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/icam-1-mediated-inhibition-microglial-inflammation-through-erkstat3-signalling-pathway#comments</comments>
</item>
<item>
 <title>Correction to: Using scores from the 4AT delirium detection tool as an indicator of possible dementia: a study of 75 221 older adult hospital admissions.</title>
 <link>https://www.alzforum.org/papers/correction-using-scores-4at-delirium-detection-tool-indicator-possible-dementia-study-75-221</link>
 <description>Age Ageing. 2026 May 4;55(5)&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080604&quot;&gt;42080604&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-using-scores-4at-delirium-detection-tool-indicator-possible-dementia-study-75-221#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-using-scores-4at-delirium-detection-tool-indicator-possible-dementia-study-75-221#comments</comments>
</item>
<item>
 <title>Impact of Plasma p-tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS.</title>
 <link>https://www.alzforum.org/papers/impact-plasma-p-tau181-cognition-motor-phenotypes-and-disease-course-als</link>
 <description>Ann Clin Transl Neurol. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Kasper E, Lehto A, Nordmann N, Peters O, Hellmann J, Priller J, Spruth EJ, Petzold GC, Vogt I, Weydt P, Bernsen S, Dinter E, Falkenburger B, Günther R, Düzel E, Glanz W, Synofzik M, Beichert L, Spottke A, Wagner M, Brosseron F, Schmid MC, Schneider A, Teipel S, Prudlo J, Hermann A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080410&quot;&gt;42080410&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-plasma-p-tau181-cognition-motor-phenotypes-and-disease-course-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-plasma-p-tau181-cognition-motor-phenotypes-and-disease-course-als#comments</comments>
</item>
<item>
 <title>Impact of Alzheimer&#039;s Disease Co-Pathology on Shunt Outcomes in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/impact-alzheimers-disease-co-pathology-shunt-outcomes-idiopathic-normal-pressure</link>
 <description>Mov Disord. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Patwardhan A, Sharafkhah M, Borrie M, Bhangu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076936&quot;&gt;42076936&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-alzheimers-disease-co-pathology-shunt-outcomes-idiopathic-normal-pressure#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-alzheimers-disease-co-pathology-shunt-outcomes-idiopathic-normal-pressure#comments</comments>
</item>
<item>
 <title>Targeting the NAD+-PARP1-XRCC1 axis in ALS.</title>
 <link>https://www.alzforum.org/papers/targeting-nad-parp1-xrcc1-axis-als</link>
 <description>Trends Mol Med. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Ibrahim M, Hossain MS, Ooi L, Hasan MM, Ahsan S, Salem AK, Piazza GA, Feng X, Ahsan F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086408&quot;&gt;42086408&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-nad-parp1-xrcc1-axis-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-nad-parp1-xrcc1-axis-als#comments</comments>
</item>
<item>
 <title>Comment on &quot;Alzheimer&#039;s disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-alzheimers-disease-diagnosis-update-and-review-biomarkers-positron-emission-0</link>
 <description>J Formos Med Assoc. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Sah NK, Saxena S, Desai D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086387&quot;&gt;42086387&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-alzheimers-disease-diagnosis-update-and-review-biomarkers-positron-emission-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-alzheimers-disease-diagnosis-update-and-review-biomarkers-positron-emission-0#comments</comments>
</item>
<item>
 <title>A Dual-Functional Two-Photon PLIM Probe Based on Ruthenium(II) Complex: Sequence Selectivity and Aβ Aggregation Monitoring.</title>
 <link>https://www.alzforum.org/papers/dual-functional-two-photon-plim-probe-based-rutheniumii-complex-sequence-selectivity-and-av</link>
 <description>Anal Chem. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Mai X, Chen J, Yong K, Chen Y, Wen H, Sun M, Yu H, Xiong K, Yu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083380&quot;&gt;42083380&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dual-functional-two-photon-plim-probe-based-rutheniumii-complex-sequence-selectivity-and-av#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dual-functional-two-photon-plim-probe-based-rutheniumii-complex-sequence-selectivity-and-av#comments</comments>
</item>
<item>
 <title>Pre-Diagnostic Plasma Carotenoids, Tocopherols and Retinol Levels, and Risk of Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/pre-diagnostic-plasma-carotenoids-tocopherols-and-retinol-levels-and-risk-amyotrophic-lateral</link>
 <description>Ann Neurol. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: O&amp;#039;Reilly ÉJ, Bjornevik K, Furtado JD, Patel AV, Wang Y, Kolonel LN, Le Marchand L, Ascherio A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083136&quot;&gt;42083136&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pre-diagnostic-plasma-carotenoids-tocopherols-and-retinol-levels-and-risk-amyotrophic-lateral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pre-diagnostic-plasma-carotenoids-tocopherols-and-retinol-levels-and-risk-amyotrophic-lateral#comments</comments>
</item>
<item>
 <title>Multimorbidity and Associations with Cognition and Alzheimer&#039;s Disease Biomarkers.</title>
 <link>https://www.alzforum.org/papers/multimorbidity-and-associations-cognition-and-alzheimers-disease-biomarkers</link>
 <description>Ann Neurol. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: Jiang X, O&amp;#039;Bryant SE, Rissman RA, Johnson LA, Braskie MN, Yaffe K, HABS‐HD Study Team&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083115&quot;&gt;42083115&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multimorbidity-and-associations-cognition-and-alzheimers-disease-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multimorbidity-and-associations-cognition-and-alzheimers-disease-biomarkers#comments</comments>
</item>
<item>
 <title>Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/sex-dependent-interferon-signaling-contributes-female-biased-vulnerability-alzheimers-disease</link>
 <description>J Neuroinflammation. 2026 May 4; Epub 2026 May 4&lt;br&gt;Authors: López-López V, Iniesta G, Galán-Ganga M, Expósito-Coca A, Durán-Laforet V, Bhojwani-Cabrera AM, Navarrón CM, Guillot-Fernández M, Venero JL, Sánchez-Mut JV, Barco A, Giralt A, López-Atalaya JP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083037&quot;&gt;42083037&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-dependent-interferon-signaling-contributes-female-biased-vulnerability-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-dependent-interferon-signaling-contributes-female-biased-vulnerability-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Factors influencing implementation of an Alzheimer&#039;s disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains framework.</title>
 <link>https://www.alzforum.org/papers/factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age</link>
 <description>Age Ageing. 2026 May 4;55(5)&lt;br&gt;Authors: Jemma H, Mealing M, Lorencatto F, Rapaport P, Keshavan A, Schott JM, Rodda J, Howard R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089739&quot;&gt;42089739&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/factors-influencing-implementation-alzheimers-disease-blood-test-among-uk-old-age#comments</comments>
</item>
<item>
 <title>Hypothalamic microstructure and function are associated with mild cognitive impairment in aging.</title>
 <link>https://www.alzforum.org/papers/hypothalamic-microstructure-and-function-are-associated-mild-cognitive-impairment-aging</link>
 <description>Brain Res Bull. 2026 May 4;240:111921.  Epub 2026 May 4&lt;br&gt;Authors: Sun M, Zhao X, Gao K, Ding G, Yu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092705&quot;&gt;42092705&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hypothalamic-microstructure-and-function-are-associated-mild-cognitive-impairment-aging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hypothalamic-microstructure-and-function-are-associated-mild-cognitive-impairment-aging#comments</comments>
</item>
<item>
 <title>Reproductive history differentially shapes the neural response of middle-aged hAPOEɛ4 female rats to estradiol therapy after a metabolic challenge.</title>
 <link>https://www.alzforum.org/papers/reproductive-history-differentially-shapes-neural-response-middle-aged-hapoee4-female-rats</link>
 <description>Biol Sex Differ. 2026 May 3; Epub 2026 May 3&lt;br&gt;Authors: Richard JE, Mohammad A, Lieblich SE, Go KA, Wang S, Rechlin RK, Splinter TF, Barreto GE, Galea LA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071257&quot;&gt;42071257&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reproductive-history-differentially-shapes-neural-response-middle-aged-hapoee4-female-rats#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reproductive-history-differentially-shapes-neural-response-middle-aged-hapoee4-female-rats#comments</comments>
</item>
<item>
 <title>miRNAs in Amyotrophic Lateral Sclerosis: Tiny Molecules, Tremendous Impact.</title>
 <link>https://www.alzforum.org/papers/mirnas-amyotrophic-lateral-sclerosis-tiny-molecules-tremendous-impact</link>
 <description>Mol Neurobiol. 2026 May 3;63(1)&lt;br&gt;Authors: Abdel Mageed SS, Sayed GA, Mahdy A, El-Dakroury WA, Abdulkader AO, Moustafa HA, Mansour RM, Mohammed OA, Elballal MS, Elesawy AE, Doghish AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070160&quot;&gt;42070160&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mirnas-amyotrophic-lateral-sclerosis-tiny-molecules-tremendous-impact#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mirnas-amyotrophic-lateral-sclerosis-tiny-molecules-tremendous-impact#comments</comments>
</item>
<item>
 <title>Homogenous Cell Transplantation Trials in Parkinson&#039;s Disease: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/homogenous-cell-transplantation-trials-parkinsons-disease-systematic-review-and-meta-analysis</link>
 <description>Mov Disord Clin Pract. 2026 May 3; Epub 2026 May 3&lt;br&gt;Authors: Reinisch N, Mancini A, Elsherbini A, Yuen J, Lozano A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076911&quot;&gt;42076911&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/homogenous-cell-transplantation-trials-parkinsons-disease-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/homogenous-cell-transplantation-trials-parkinsons-disease-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Rethinking Mitochondrial Parkinson&#039;s Disease in the α-Synuclein Seed Amplification Assays Era.</title>
 <link>https://www.alzforum.org/papers/rethinking-mitochondrial-parkinsons-disease-synuclein-seed-amplification-assays-era</link>
 <description>Mov Disord. 2026 May 3; Epub 2026 May 3&lt;br&gt;Authors: Percetti M, Yahya V, Di Fonzo A, Monfrini E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076824&quot;&gt;42076824&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-mitochondrial-parkinsons-disease-synuclein-seed-amplification-assays-era#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-mitochondrial-parkinsons-disease-synuclein-seed-amplification-assays-era#comments</comments>
</item>
<item>
 <title>Phosphorylated Tau at Threonine 181 Is Elevated in Amyotrophic Lateral Sclerosis Plasma.</title>
 <link>https://www.alzforum.org/papers/phosphorylated-tau-threonine-181-elevated-amyotrophic-lateral-sclerosis-plasma</link>
 <description>Muscle Nerve. 2026 May 3; Epub 2026 May 3&lt;br&gt;Authors: Petrozziello T, Mizerak E, Krishnamoorthy A, Donahue RA, Castillo Torres AL, Monsanto RZ, Hammerschlag BL, Webster HA, Fillingham B, Kivisäkk P, Timmons J, Fox K, Arnold SE, Cohen J, Klee J, Paganoni S, Cudkowicz ME, Chibnik LB, Berry JD, Sadri-Vakili G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076823&quot;&gt;42076823&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/phosphorylated-tau-threonine-181-elevated-amyotrophic-lateral-sclerosis-plasma#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/phosphorylated-tau-threonine-181-elevated-amyotrophic-lateral-sclerosis-plasma#comments</comments>
</item>
<item>
 <title>Exploring the differences in efficacy and mechanisms of Schisandra chinensis and its processed products in treating Alzheimer&#039;s disease based on UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation.</title>
 <link>https://www.alzforum.org/papers/exploring-differences-efficacy-and-mechanisms-schisandra-chinensis-and-its-processed-products</link>
 <description>Fitoterapia. 2026 May 3;191:107268.  Epub 2026 May 3&lt;br&gt;Authors: Bai X, Dai J, Wang X, Gao H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086126&quot;&gt;42086126&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-differences-efficacy-and-mechanisms-schisandra-chinensis-and-its-processed-products#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-differences-efficacy-and-mechanisms-schisandra-chinensis-and-its-processed-products#comments</comments>
</item>
<item>
 <title>Microplastics as an emerging environmental pollutant potentially leading to neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/microplastics-emerging-environmental-pollutant-potentially-leading-neurodegenerative-diseases</link>
 <description>Neuroscience. 2026 May 3;607:63-75.  Epub 2026 May 3&lt;br&gt;Authors: Chen M, Huang X, Li Y, Hu L, Lu R, Li L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086102&quot;&gt;42086102&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microplastics-emerging-environmental-pollutant-potentially-leading-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microplastics-emerging-environmental-pollutant-potentially-leading-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study.</title>
 <link>https://www.alzforum.org/papers/aging-alters-vulnerability-pattern-amyloid-beta-oligomers-wild-type-mice-behavioral-and</link>
 <description>Alzheimers Res Ther. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Allouche A, Colin J, Birck C, Schroeder H, Tallandier V, Baldoni M, Muller C, Afrassi M, Violle N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067950&quot;&gt;42067950&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aging-alters-vulnerability-pattern-amyloid-beta-oligomers-wild-type-mice-behavioral-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aging-alters-vulnerability-pattern-amyloid-beta-oligomers-wild-type-mice-behavioral-and#comments</comments>
</item>
<item>
 <title>Biallelic SYNJ1 Variants in a patient with multiple system atrophy mimic syndrome.</title>
 <link>https://www.alzforum.org/papers/biallelic-synj1-variants-patient-multiple-system-atrophy-mimic-syndrome</link>
 <description>Neurol Sci. 2026 May 2;47(5)&lt;br&gt;Authors: Zhang Y, Kang Y, Zheng X, Wang H, Cen Z, Luo W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067721&quot;&gt;42067721&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biallelic-synj1-variants-patient-multiple-system-atrophy-mimic-syndrome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biallelic-synj1-variants-patient-multiple-system-atrophy-mimic-syndrome#comments</comments>
</item>
<item>
 <title>Neuroprotective and antioxidant effects of fermented spent coffee ground fractions against Alzheimer&#039;s-related oxysterol 27-hydroxycholesterol in SH-SY5Y neuronal cells.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-and-antioxidant-effects-fermented-spent-coffee-ground-fractions-against</link>
 <description>Food Chem. 2026 May 2;517:149435.  Epub 2026 May 2&lt;br&gt;Authors: Arancibia-Díaz A, Trujillo-Fernández S, Astudillo-Castro C, Vergara-Castro M, Soto-Maldonado C, Córdova A, Zúñiga-Hansen ME, Vega-Letter AM, Fuentes P, Altamirano C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070356&quot;&gt;42070356&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-and-antioxidant-effects-fermented-spent-coffee-ground-fractions-against#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-and-antioxidant-effects-fermented-spent-coffee-ground-fractions-against#comments</comments>
</item>
<item>
 <title>Association of alzheimer&#039;s disease with prior allergic rhinitis.</title>
 <link>https://www.alzforum.org/papers/association-alzheimers-disease-prior-allergic-rhinitis</link>
 <description>Sci Rep. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Hung SH, Chung SD, Lin HC, Chen CS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069890&quot;&gt;42069890&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-alzheimers-disease-prior-allergic-rhinitis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-alzheimers-disease-prior-allergic-rhinitis#comments</comments>
</item>
<item>
 <title>Idiotypic-susceptible Alzheimer&#039;s disease: a clinically relevant, neurofibrillary tangle subtype.</title>
 <link>https://www.alzforum.org/papers/idiotypic-susceptible-alzheimers-disease-clinically-relevant-neurofibrillary-tangle-subtype</link>
 <description>Acta Neuropathol. 2026 May 2;151(1)&lt;br&gt;Authors: Robinson JL, Cai H, Loh NJ, Vazquez O, Khodakaramimaghsoud Z, Suh E, Van Deerlin VM, Yushkevich PA, Mechanic-Hamilton D, Xie SX, Ohm DT, Wolk DA, Irwin DJ, Phillips JS, Lee EB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069798&quot;&gt;42069798&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/idiotypic-susceptible-alzheimers-disease-clinically-relevant-neurofibrillary-tangle-subtype#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/idiotypic-susceptible-alzheimers-disease-clinically-relevant-neurofibrillary-tangle-subtype#comments</comments>
</item>
<item>
 <title>Methodological adaptations for applying the Harmonised Cognitive Assessment Protocol diagnostic algorithm in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA-HCAP).</title>
 <link>https://www.alzforum.org/papers/methodological-adaptations-applying-harmonised-cognitive-assessment-protocol-diagnostic</link>
 <description>BMC Res Notes. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Ward NA, Marr C, Simoes S, O&amp;#039;Hara L, McAlinden M, Sterling C, Potter C, Kee F, Passmore P, Scott A, Weir DR, McGuinness B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069638&quot;&gt;42069638&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/methodological-adaptations-applying-harmonised-cognitive-assessment-protocol-diagnostic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/methodological-adaptations-applying-harmonised-cognitive-assessment-protocol-diagnostic#comments</comments>
</item>
<item>
 <title>Epigenetic g predicts cognitive function in a diverse, nationally representative sample of older adults.</title>
 <link>https://www.alzforum.org/papers/epigenetic-g-predicts-cognitive-function-diverse-nationally-representative-sample-older</link>
 <description>Clin Epigenetics. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Faul JD, Collins S, Smith T, Klopack ET, Mitchell C, Crimmins EM, Farina MP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069620&quot;&gt;42069620&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epigenetic-g-predicts-cognitive-function-diverse-nationally-representative-sample-older#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epigenetic-g-predicts-cognitive-function-diverse-nationally-representative-sample-older#comments</comments>
</item>
<item>
 <title>ALS-FTD-linked CCNFS621G drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitability.</title>
 <link>https://www.alzforum.org/papers/als-ftd-linked-ccnfs621g-drives-increased-hippocampal-astrocyte-ramification-and</link>
 <description>J Neuroinflammation. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Robinson L, Do-Ha D, Cheng F, Stevens CH, Rosa Porto R, Coles M, Subachandran J, Kalajdzic P, Lui J, Balez R, Sanz Muñoz S, Cabral-da-Silva MC, Berg T, Morsch M, Lisowski L, Tan RH, Burgio G, Karl T, Lee A, Chung RS, Blair I, Ooi L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069601&quot;&gt;42069601&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/als-ftd-linked-ccnfs621g-drives-increased-hippocampal-astrocyte-ramification-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/als-ftd-linked-ccnfs621g-drives-increased-hippocampal-astrocyte-ramification-and#comments</comments>
</item>
<item>
 <title>Structural Characterization of the Interaction of γ-Secretase with GSM-1 Modulator.</title>
 <link>https://www.alzforum.org/papers/structural-characterization-interaction-g-secretase-gsm-1-modulator</link>
 <description>ACS Chem Neurosci. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Santiago Á, Melendez-Martinez D, Aguayo-Ortiz R, Dominguez L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068555&quot;&gt;42068555&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-characterization-interaction-g-secretase-gsm-1-modulator#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-characterization-interaction-g-secretase-gsm-1-modulator#comments</comments>
</item>
<item>
 <title>Stem Cell-Derived Exosomes Regulate Mitochondrial Function: A Novel Strategy for Parkinson&#039;s Disease Therapy.</title>
 <link>https://www.alzforum.org/papers/stem-cell-derived-exosomes-regulate-mitochondrial-function-novel-strategy-parkinsons-disease</link>
 <description>Mol Neurobiol. 2026 May 2;63(1)&lt;br&gt;Authors: Wang J, Wang C, Yuan X, Yan J, Huang H, Li F, You Y, Qi Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068469&quot;&gt;42068469&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stem-cell-derived-exosomes-regulate-mitochondrial-function-novel-strategy-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stem-cell-derived-exosomes-regulate-mitochondrial-function-novel-strategy-parkinsons-disease#comments</comments>
</item>
<item>
 <title>A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer&#039;s Disease?</title>
 <link>https://www.alzforum.org/papers/narrative-review-do-systemic-drugs-used-treatment-psoriatic-disease-affect-alzheimers-disease</link>
 <description>Dermatol Ther (Heidelb). 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Chen JH, Tsai TF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068460&quot;&gt;42068460&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/narrative-review-do-systemic-drugs-used-treatment-psoriatic-disease-affect-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/narrative-review-do-systemic-drugs-used-treatment-psoriatic-disease-affect-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Exploring the role of phase separation in TDP-43 pathogenesis with ArtiTDP43.</title>
 <link>https://www.alzforum.org/papers/exploring-role-phase-separation-tdp-43-pathogenesis-artitdp43</link>
 <description>FEBS J. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Chevet E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068244&quot;&gt;42068244&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-role-phase-separation-tdp-43-pathogenesis-artitdp43#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-role-phase-separation-tdp-43-pathogenesis-artitdp43#comments</comments>
</item>
<item>
 <title>Reduced dementia risk in middle-aged and older atopic dermatitis patients treated with dupilumab: A target trial emulation.</title>
 <link>https://www.alzforum.org/papers/reduced-dementia-risk-middle-aged-and-older-atopic-dermatitis-patients-treated-dupilumab</link>
 <description>Brain Behav Immun. 2026 May 2;136:106796.  Epub 2026 May 2&lt;br&gt;Authors: Fan YH, Fan KS, Lin TL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082123&quot;&gt;42082123&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-dementia-risk-middle-aged-and-older-atopic-dermatitis-patients-treated-dupilumab#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-dementia-risk-middle-aged-and-older-atopic-dermatitis-patients-treated-dupilumab#comments</comments>
</item>
<item>
 <title>Tooth loss is associated with subsequent brain white matter degradation up to over a decade.</title>
 <link>https://www.alzforum.org/papers/tooth-loss-associated-subsequent-brain-white-matter-degradation-over-decade</link>
 <description>J Dent. 2026 May 2;171:106732.  Epub 2026 May 2&lt;br&gt;Authors: Tian Q, Qi X, Greig EE, Landman BA, Davatzikos C, Resnick SM, Wu B, Ferrucci L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082094&quot;&gt;42082094&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tooth-loss-associated-subsequent-brain-white-matter-degradation-over-decade#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tooth-loss-associated-subsequent-brain-white-matter-degradation-over-decade#comments</comments>
</item>
<item>
 <title>Mechanistic insights into the neuroprotective potential of gut microbiota-derived urolithins in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mechanistic-insights-neuroprotective-potential-gut-microbiota-derived-urolithins-alzheimers</link>
 <description>Mech Ageing Dev. 2026 May 2;231:112189.  Epub 2026 May 2&lt;br&gt;Authors: Alami M, Berrougui H, Morvaridzadeh M, Boumezough K, Salih I, Zoubdane N, Oubaouz J, Abboussi O, Sadki K, Fülöp T, Khalil A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42082056&quot;&gt;42082056&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanistic-insights-neuroprotective-potential-gut-microbiota-derived-urolithins-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanistic-insights-neuroprotective-potential-gut-microbiota-derived-urolithins-alzheimers#comments</comments>
</item>
<item>
 <title>Comparing the effects of cognitive and physical training on cognitive function and brain activation in people with mild cognitive impairment and mild dementia: a randomized controlled trial.</title>
 <link>https://www.alzforum.org/papers/comparing-effects-cognitive-and-physical-training-cognitive-function-and-brain-activation</link>
 <description>Arch Phys Med Rehabil. 2026 May 2; Epub 2026 May 2&lt;br&gt;Authors: Weng WH, Yang YR, Wang YH, Yeh NC, Wang RY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081986&quot;&gt;42081986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparing-effects-cognitive-and-physical-training-cognitive-function-and-brain-activation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparing-effects-cognitive-and-physical-training-cognitive-function-and-brain-activation#comments</comments>
</item>
<item>
 <title>uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer&#039;s disease-like pathology.</title>
 <link>https://www.alzforum.org/papers/upar-exhibits-age-and-region-dependent-expression-brains-mice-alzheimers-disease-pathology</link>
 <description>Brain Res. 2026 May 2;1886:150364.  Epub 2026 May 2&lt;br&gt;Authors: Sarko LE, Klaus E, Bondarenko V, Secker C, Mnuk MS, Marino KM, Shippy DC, Ulland TK, Saha K, Emborg ME, Metzger JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081929&quot;&gt;42081929&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/upar-exhibits-age-and-region-dependent-expression-brains-mice-alzheimers-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/upar-exhibits-age-and-region-dependent-expression-brains-mice-alzheimers-disease-pathology#comments</comments>
</item>
<item>
 <title>Cognitive Reserve in rural and urban populations: Insights from two aging cohorts in southern India.</title>
 <link>https://www.alzforum.org/papers/cognitive-reserve-rural-and-urban-populations-insights-two-aging-cohorts-southern-india</link>
 <description>Alzheimers Res Ther. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Burra R, Malo PK, Pradhan H, Prasad R, Rai P, Issac TG, Sundarakumar JS, Athreya S, Sundaresan R, CBR-SANSCOG Study Team, CBR-TLSA Study Team&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067901&quot;&gt;42067901&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-reserve-rural-and-urban-populations-insights-two-aging-cohorts-southern-india#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-reserve-rural-and-urban-populations-insights-two-aging-cohorts-southern-india#comments</comments>
</item>
<item>
 <title>Blood biomarkers to improve dementia diagnostic accuracy: a cross-sectional analysis.</title>
 <link>https://www.alzforum.org/papers/blood-biomarkers-improve-dementia-diagnostic-accuracy-cross-sectional-analysis</link>
 <description>BMC Geriatr. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Kwon J, Chang MK, Gordon-Boyle A, Creavin S, Hughes L, Raymont V, Bhui K, Tsiachristas A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067818&quot;&gt;42067818&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-biomarkers-improve-dementia-diagnostic-accuracy-cross-sectional-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-biomarkers-improve-dementia-diagnostic-accuracy-cross-sectional-analysis#comments</comments>
</item>
<item>
 <title>Membrane Proteome Remodeling in Female APP/PS1 Mice Following M1 Muscarinic Receptor Modulation Revealed by Peptidisc-Enabled DIA-MS.</title>
 <link>https://www.alzforum.org/papers/membrane-proteome-remodeling-female-appps1-mice-following-m1-muscarinic-receptor-modulation</link>
 <description>J Proteome Res. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Bhattacharya A, Antony F, Aoki H, Babu M, Ferguson SS, Abd-Elrahman KS, Duong van Hoa F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067398&quot;&gt;42067398&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/membrane-proteome-remodeling-female-appps1-mice-following-m1-muscarinic-receptor-modulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/membrane-proteome-remodeling-female-appps1-mice-following-m1-muscarinic-receptor-modulation#comments</comments>
</item>
<item>
 <title>Homocysteine Is Associated With Cognitive Impairment and Sarcopenia in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/homocysteine-associated-cognitive-impairment-and-sarcopenia-alzheimers-disease</link>
 <description>Psychogeriatrics. 2026 May;26(3):e70172. &lt;br&gt;Authors: Li FB, Ma XT, Yao LL, Liu SW, Weng XF, Liu CF, Hu H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42065338&quot;&gt;42065338&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/homocysteine-associated-cognitive-impairment-and-sarcopenia-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/homocysteine-associated-cognitive-impairment-and-sarcopenia-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Corrigendum to CRISPR/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA.</title>
 <link>https://www.alzforum.org/papers/corrigendum-crisprcas13d-targeting-suppresses-repeat-associated-non-aug-translation-c9orf72</link>
 <description>J Clin Invest. 2026 May 1;136(9) Epub 2026 May 1&lt;br&gt;Authors: Liu H, Zhao XF, Lu YN, Hayes LR, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42065251&quot;&gt;42065251&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-crisprcas13d-targeting-suppresses-repeat-associated-non-aug-translation-c9orf72#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-crisprcas13d-targeting-suppresses-repeat-associated-non-aug-translation-c9orf72#comments</comments>
</item>
<item>
 <title>Integrative Role of Orexigenic Peptides in Neuroprotection and Neurodegenerative Disease Modulation.</title>
 <link>https://www.alzforum.org/papers/integrative-role-orexigenic-peptides-neuroprotection-and-neurodegenerative-disease-modulation</link>
 <description>Biosci Rep. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Sopko Z, Pačesová A, Železná B, Maletinska L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063365&quot;&gt;42063365&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-role-orexigenic-peptides-neuroprotection-and-neurodegenerative-disease-modulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-role-orexigenic-peptides-neuroprotection-and-neurodegenerative-disease-modulation#comments</comments>
</item>
<item>
 <title>Predictors of cognitive resilience in the old-old: An observational study using real-world electronic health record data.</title>
 <link>https://www.alzforum.org/papers/predictors-cognitive-resilience-old-old-observational-study-using-real-world-electronic</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71443. &lt;br&gt;Authors: Skolariki K, Rosenberg PB, Oh ES, Leoutsakos J, Lyketsos CG, Adams R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063315&quot;&gt;42063315&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predictors-cognitive-resilience-old-old-observational-study-using-real-world-electronic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predictors-cognitive-resilience-old-old-observational-study-using-real-world-electronic#comments</comments>
</item>
<item>
 <title>Aberrant Brain Entropy in Alzheimer&#039;s Disease: Evidence From a Resting-State fMRI Study.</title>
 <link>https://www.alzforum.org/papers/aberrant-brain-entropy-alzheimers-disease-evidence-resting-state-fmri-study</link>
 <description>Brain Behav. 2026 May;16(5):e71454. &lt;br&gt;Authors: Zhang X, Wen M, Zhang S, Rao C, Gu T, Zha Z, He C, Song Y, Niu S, Zhu L, Yu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063237&quot;&gt;42063237&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aberrant-brain-entropy-alzheimers-disease-evidence-resting-state-fmri-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aberrant-brain-entropy-alzheimers-disease-evidence-resting-state-fmri-study#comments</comments>
</item>
<item>
 <title>Incidence of primary progressive aphasia in Salento, Italy: a population-based study.</title>
 <link>https://www.alzforum.org/papers/incidence-primary-progressive-aphasia-salento-italy-population-based-study</link>
 <description>Alzheimers Res Ther. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Urso D, Vitulli A, Giannoni-Luza S, Gnoni V, Giugno A, Rollo E, Vilella D, Zecca C, Ray N, Logroscino G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063156&quot;&gt;42063156&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/incidence-primary-progressive-aphasia-salento-italy-population-based-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/incidence-primary-progressive-aphasia-salento-italy-population-based-study#comments</comments>
</item>
<item>
 <title>A Brainstem Radiomics Framework to Distinguish Progressive Supranuclear Palsy from Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/brainstem-radiomics-framework-distinguish-progressive-supranuclear-palsy-parkinsons-disease</link>
 <description>Mov Disord. 2026 May 1; Epub 2026 May 1&lt;br&gt;Authors: Camastra C, Buonocore J, Augimeri A, Calomino C, Bianco MG, Sarica A, Arcuri PP, Quattrone A, Quattrone A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068059&quot;&gt;42068059&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brainstem-radiomics-framework-distinguish-progressive-supranuclear-palsy-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brainstem-radiomics-framework-distinguish-progressive-supranuclear-palsy-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Cognitive reserve and longitudinal changes in brain and cognition in semantic variant primary progressive aphasia.</title>
 <link>https://www.alzforum.org/papers/cognitive-reserve-and-longitudinal-changes-brain-and-cognition-semantic-variant-primary</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71440. &lt;br&gt;Authors: Grebe LA, Morin BT, Pillai J, Baquirin DP, Ratnasiri B, Bogley R, Ezzes Z, Wauters LD, Mandelli ML, Miller ZA, Tee BL, de Leon J, Casaletto KB, Rosen HJ, Gorno Tempini ML, Galletta EE, Goral M, Vonk JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071171&quot;&gt;42071171&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-reserve-and-longitudinal-changes-brain-and-cognition-semantic-variant-primary#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-reserve-and-longitudinal-changes-brain-and-cognition-semantic-variant-primary#comments</comments>
</item>
<item>
 <title>Reply to: Beyond AUC: Advancing clinical interpretability of depression-MRI-machine learning analyses in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/reply-beyond-auc-advancing-clinical-interpretability-depression-mri-machine-learning-analyses</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71439. &lt;br&gt;Authors: Tang C, Yang J, Lei X, He D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071170&quot;&gt;42071170&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reply-beyond-auc-advancing-clinical-interpretability-depression-mri-machine-learning-analyses#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reply-beyond-auc-advancing-clinical-interpretability-depression-mri-machine-learning-analyses#comments</comments>
</item>
<item>
 <title>Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging.</title>
 <link>https://www.alzforum.org/papers/effects-synuclein-pathology-synaptic-dysfunction-and-clinical-outcomes-normal-aging</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71455. &lt;br&gt;Authors: Winer JR, Plastini MJ, Romero A, Vossler H, Sai I, Channappa D, Abdelnour C, Shahid-Besanti M, Wilson EN, Oh HS, Young CB, Trelle A, Yutsis M, Sha SJ, Ramirez V, Taylor R, Younes K, Wyss-Coray T, Greicius MD, Henderson VW, Wagner AD, Poston KL, Mormino EC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071168&quot;&gt;42071168&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-synuclein-pathology-synaptic-dysfunction-and-clinical-outcomes-normal-aging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-synuclein-pathology-synaptic-dysfunction-and-clinical-outcomes-normal-aging#comments</comments>
</item>
<item>
 <title>Organelle-orchestrated cGAS-STING signaling and its role in neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/organelle-orchestrated-cgas-sting-signaling-and-its-role-neurodegeneration</link>
 <description>Pharmacol Res. 2026 May 1;228:108216.  Epub 2026 May 1&lt;br&gt;Authors: Liu JY, Liu SY, Ran LX, Qiao WH, Zhang F, Zhang KS, Liang XX, Liu MY, Yu ZH, Wei MJ, Zhong X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070757&quot;&gt;42070757&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/organelle-orchestrated-cgas-sting-signaling-and-its-role-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/organelle-orchestrated-cgas-sting-signaling-and-its-role-neurodegeneration#comments</comments>
</item>
<item>
 <title>Descriptive analysis of mortality due to Parkinson&#039;s disease and Alzheimer disease in Argentina.</title>
 <link>https://www.alzforum.org/papers/descriptive-analysis-mortality-due-parkinsons-disease-and-alzheimer-disease-argentina</link>
 <description>Neurologia (Engl Ed). 2026 May 1;:502084.  Epub 2026 May 1&lt;br&gt;Authors: Molinatti F, De Gracia L, Oliva A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070656&quot;&gt;42070656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/descriptive-analysis-mortality-due-parkinsons-disease-and-alzheimer-disease-argentina#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/descriptive-analysis-mortality-due-parkinsons-disease-and-alzheimer-disease-argentina#comments</comments>
</item>
<item>
 <title>Glyceraldehyde-induced metabolic defects in cortical astrocytes: implication for Alzheimer&#039;s disease pathogenesis and therapy.</title>
 <link>https://www.alzforum.org/papers/glyceraldehyde-induced-metabolic-defects-cortical-astrocytes-implication-alzheimers-disease</link>
 <description>Biomed Pharmacother. 2026 May 1;199:119473.  Epub 2026 May 1&lt;br&gt;Authors: Piccirillo S, Preziuso A, Serfilippi T, Terenzi V, Castaldo P, Lariccia V, Secondo A, Magi S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068817&quot;&gt;42068817&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glyceraldehyde-induced-metabolic-defects-cortical-astrocytes-implication-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glyceraldehyde-induced-metabolic-defects-cortical-astrocytes-implication-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Integrating polygenic and transcriptional risk scores for detecting Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/integrating-polygenic-and-transcriptional-risk-scores-detecting-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71408. &lt;br&gt;Authors: Hwang J, Pyun JM, Lee JY, Park JS, Bice PJ, Saykin AJ, Sung J, Kim S, Park YH, Nho K, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080296&quot;&gt;42080296&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-polygenic-and-transcriptional-risk-scores-detecting-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-polygenic-and-transcriptional-risk-scores-detecting-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Usage and positivity rates of Alzheimer&#039;s disease biomarkers in a memory clinic.</title>
 <link>https://www.alzforum.org/papers/usage-and-positivity-rates-alzheimers-disease-biomarkers-memory-clinic</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71442. &lt;br&gt;Authors: Hofmann A, Saef B, Powell WJ, Paczynski M, Ponisio MR, Vila-Castelar C, Posey Z, Oh IY, Hofford MR, Aldinger M, Bateman RJ, Raji CA, Benzinger TL, Cruchaga C, Dow A, Buckley R, Xiong C, Morris JC, Snider BJ, Gupta A, Schindler SE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080249&quot;&gt;42080249&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/usage-and-positivity-rates-alzheimers-disease-biomarkers-memory-clinic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/usage-and-positivity-rates-alzheimers-disease-biomarkers-memory-clinic#comments</comments>
</item>
<item>
 <title>circPDE4B downregulation triggers GEMIN5‑dependent translational stress response and autophagy to reduce MAPT pathology.</title>
 <link>https://www.alzforum.org/papers/circpde4b-downregulation-triggers-gemin5-dependent-translational-stress-response-and</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71436. &lt;br&gt;Authors: Puri S, van der Spek SJ, Lin M, Wang Z, Porter J, Hu J, Hu L, Rondón-Ortiz AN, Knyshov A, Libera JL, Counts SE, Lahiri DK, T C W J, Emili A, Zhang X, Wolozin B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080242&quot;&gt;42080242&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circpde4b-downregulation-triggers-gemin5-dependent-translational-stress-response-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circpde4b-downregulation-triggers-gemin5-dependent-translational-stress-response-and#comments</comments>
</item>
<item>
 <title>Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup.</title>
 <link>https://www.alzforum.org/papers/pre-analytical-guidelines-blood-and-csf-biomarkers-2025-recommendations-nacc-adrc-biofluid</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71252. &lt;br&gt;Authors: Van Meter TE, Wilson EN, Elahi F, Rissman RA, Lago AL, Faber K, Gauthreaux K, Osorio R, Perkins M, Gray N, Morris J, Liu A, Stockwell H, Kukull W, Wilson R, Wingo TS, Kanaan NM, Russ K, Wilcock D, Biber SA, Bekris LM, Karikari TK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080228&quot;&gt;42080228&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pre-analytical-guidelines-blood-and-csf-biomarkers-2025-recommendations-nacc-adrc-biofluid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pre-analytical-guidelines-blood-and-csf-biomarkers-2025-recommendations-nacc-adrc-biofluid#comments</comments>
</item>
<item>
 <title>Centella asiatica ameliorates scopolamine-induced cognitive impairment via acetylcholinesterase modulation and oxidative stress reduction.</title>
 <link>https://www.alzforum.org/papers/centella-asiatica-ameliorates-scopolamine-induced-cognitive-impairment-acetylcholinesterase</link>
 <description>Food Sci Biotechnol. 2026 May;35(6):1611-1623.  Epub 2026 Mar 25&lt;br&gt;Authors: Kim YJ, Kang YM, Pak ME, Eom HJ, Kim KY, Hur N, Seo Y, Oh TK, Bae J, Lee JK, Kim K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42077787&quot;&gt;42077787&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/centella-asiatica-ameliorates-scopolamine-induced-cognitive-impairment-acetylcholinesterase#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/centella-asiatica-ameliorates-scopolamine-induced-cognitive-impairment-acetylcholinesterase#comments</comments>
</item>
<item>
 <title>Oral administration of evening primrose leaf extract improves cognitive impairment in 5xFAD transgenic mice.</title>
 <link>https://www.alzforum.org/papers/oral-administration-evening-primrose-leaf-extract-improves-cognitive-impairment-5xfad</link>
 <description>Food Sci Biotechnol. 2026 May;35(6):1601-1610.  Epub 2026 Apr 15&lt;br&gt;Authors: Kim Y, Cho M, Woo Y, Park J, Lim JS, Lee JS, Oh J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42077786&quot;&gt;42077786&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oral-administration-evening-primrose-leaf-extract-improves-cognitive-impairment-5xfad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oral-administration-evening-primrose-leaf-extract-improves-cognitive-impairment-5xfad#comments</comments>
</item>
<item>
 <title>Copper Overload Affects α-Synuclein Clearance Mechanisms in a Parkinson&#039;s Disease In Vitro Model.</title>
 <link>https://www.alzforum.org/papers/copper-overload-affects-synuclein-clearance-mechanisms-parkinsons-disease-vitro-model</link>
 <description>Adv Biol (Weinh). 2026 May;10(5):e00274. &lt;br&gt;Authors: Musarò D, Damato M, Coppola C, Greco M, Maffia M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076898&quot;&gt;42076898&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/copper-overload-affects-synuclein-clearance-mechanisms-parkinsons-disease-vitro-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/copper-overload-affects-synuclein-clearance-mechanisms-parkinsons-disease-vitro-model#comments</comments>
</item>
<item>
 <title>Investigation of the Therapeutic Effects of Transcorneal Electrical Stimulation on Alzheimer&#039;s Disease Using Optical Coherence Tomography.</title>
 <link>https://www.alzforum.org/papers/investigation-therapeutic-effects-transcorneal-electrical-stimulation-alzheimers-disease</link>
 <description>J Biophotonics. 2026 May;19(5):e70274. &lt;br&gt;Authors: Si P, He N, Liu J, Wang Q, Lin J, Dai C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42086074&quot;&gt;42086074&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigation-therapeutic-effects-transcorneal-electrical-stimulation-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigation-therapeutic-effects-transcorneal-electrical-stimulation-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Novel Cellular Signalling Axes in Neurodegenerative Diseases: From NLRP3 Inflammasome to Wnt/β-Catenin and Hippo-YAP Pathways.</title>
 <link>https://www.alzforum.org/papers/novel-cellular-signalling-axes-neurodegenerative-diseases-nlrp3-inflammasome-wntv-catenin-and</link>
 <description>J Biochem Mol Toxicol. 2026 May;40(5):e70880. &lt;br&gt;Authors: Singh K, Ahmad I, Jain D, Mim TJ, Noman AA, Shihab MP, Kondaveeti SB, Gupta JK, Wal P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085565&quot;&gt;42085565&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-cellular-signalling-axes-neurodegenerative-diseases-nlrp3-inflammasome-wntv-catenin-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-cellular-signalling-axes-neurodegenerative-diseases-nlrp3-inflammasome-wntv-catenin-and#comments</comments>
</item>
<item>
 <title>Non-Invasive Temporal Interference Electrical Stimulation Modulates Neurotransmitter Release and Improves Aberrant Neural Oscillations in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/non-invasive-temporal-interference-electrical-stimulation-modulates-neurotransmitter-release</link>
 <description>CNS Neurosci Ther. 2026 May;32(5):e70848. &lt;br&gt;Authors: Wu L, Li S, Huang L, Li L, Zhou P, Lu Z, Liu T, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084363&quot;&gt;42084363&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/non-invasive-temporal-interference-electrical-stimulation-modulates-neurotransmitter-release#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/non-invasive-temporal-interference-electrical-stimulation-modulates-neurotransmitter-release#comments</comments>
</item>
<item>
 <title>Digital seed amplification assay for TDP-43 aggregate quantification in CSF.</title>
 <link>https://www.alzforum.org/papers/digital-seed-amplification-assay-tdp-43-aggregate-quantification-csf-0</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71272. &lt;br&gt;Authors: Borberg E, Swank Z, Gilboa T, Shearer LA, Melkonian AV, Rolando JC, Walt DR, Stern AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084118&quot;&gt;42084118&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/digital-seed-amplification-assay-tdp-43-aggregate-quantification-csf-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/digital-seed-amplification-assay-tdp-43-aggregate-quantification-csf-0#comments</comments>
</item>
<item>
 <title>The impact of learning about financial compensation on enrollment in Alzheimer&#039;s disease longitudinal research.</title>
 <link>https://www.alzforum.org/papers/impact-learning-about-financial-compensation-enrollment-alzheimers-disease-longitudinal</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71356. &lt;br&gt;Authors: Gabel M, Goswami S, Bekena S, Solomon ED, Moulder KL, Morris JC, Mozersky J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084109&quot;&gt;42084109&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-learning-about-financial-compensation-enrollment-alzheimers-disease-longitudinal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-learning-about-financial-compensation-enrollment-alzheimers-disease-longitudinal#comments</comments>
</item>
<item>
 <title>Association of plasma biomarkers with amyloid and tau PET in pre-dementia stages.</title>
 <link>https://www.alzforum.org/papers/association-plasma-biomarkers-amyloid-and-tau-pet-pre-dementia-stages</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71441. &lt;br&gt;Authors: Boutajangout A, Masurkar AV, Osorio R, Debure L, Ghuman M, Ahmed W, Vedvyas A, Pirraglia E, Links J, Bokacheva L, Vega B, Bernard MA, Marsh K, Bubu OM, Shao Y, Chodosh J, Rusinek H, Wisniewski T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42084083&quot;&gt;42084083&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-plasma-biomarkers-amyloid-and-tau-pet-pre-dementia-stages#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-plasma-biomarkers-amyloid-and-tau-pet-pre-dementia-stages#comments</comments>
</item>
<item>
 <title>Current Landscape of Indole Hybrids in the Design and Development of Anti-Alzheimer Agents: Structural Insights, Therapeutic Potential and In Silico Studies.</title>
 <link>https://www.alzforum.org/papers/current-landscape-indole-hybrids-design-and-development-anti-alzheimer-agents-structural</link>
 <description>Arch Pharm (Weinheim). 2026 May;359(5):e70248. &lt;br&gt;Authors: Bagul AD, Irfan M, Jaitak A, Asati V, Goyal K, Monga V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42089694&quot;&gt;42089694&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/current-landscape-indole-hybrids-design-and-development-anti-alzheimer-agents-structural#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/current-landscape-indole-hybrids-design-and-development-anti-alzheimer-agents-structural#comments</comments>
</item>
<item>
 <title>Biomarkers, Cognitive Function, and Mortality in Centenarians.</title>
 <link>https://www.alzforum.org/papers/biomarkers-cognitive-function-and-mortality-centenarians</link>
 <description>JAMA Netw Open. 2026 May 1;9(5):e2611335. &lt;br&gt;Authors: Shikimoto R, Sasaki T, Abe Y, Tai K, Hirose N, Okano H, Arai Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096201&quot;&gt;42096201&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biomarkers-cognitive-function-and-mortality-centenarians#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biomarkers-cognitive-function-and-mortality-centenarians#comments</comments>
</item>
<item>
 <title>Abi3S212F Alzheimer&#039;s disease variant alters plaque structure and disrupts microglia.</title>
 <link>https://www.alzforum.org/papers/abi3s212f-alzheimers-disease-variant-alters-plaque-structure-and-disrupts-microglia</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71452. &lt;br&gt;Authors: Butler CA, Gee MS, O&amp;#039;Gara K, Milinkeviciute G, Da Cunha C, Kawauchi S, Lu YH, Kwang N, Tsourmas KI, Prekopa C, Shi Z, Liang HY, Collins SD, Pashkutz ZA, Sanchez JA, Shi KX, Walker AD, Wang S, Wong ML, Genaro K, Neumann J, Gomez-Arboledas A, Duong DM, Seyfried NT, Tenner AJ, LaFerla FM, Mortazavi A, Swarup V, MacGregor GR, Green KN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092345&quot;&gt;42092345&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/abi3s212f-alzheimers-disease-variant-alters-plaque-structure-and-disrupts-microglia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/abi3s212f-alzheimers-disease-variant-alters-plaque-structure-and-disrupts-microglia#comments</comments>
</item>
<item>
 <title>Abnormal amyloid PET usually represents intermediate/high Alzheimer&#039;s disease neuropathologic change.</title>
 <link>https://www.alzforum.org/papers/abnormal-amyloid-pet-usually-represents-intermediatehigh-alzheimers-disease-neuropathologic</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71449. &lt;br&gt;Authors: Burkett BJ, Wiste HJ, Johnson DR, Boeve BF, Kantarci K, Petersen RC, Knopman DS, Vemuri P, Graff-Radford J, Lowe V, Cogswell PM, Pillai J, Schwarz CG, Nguyen AT, Murray ME, Dickson DW, Jack CR Jr&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092343&quot;&gt;42092343&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/abnormal-amyloid-pet-usually-represents-intermediatehigh-alzheimers-disease-neuropathologic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/abnormal-amyloid-pet-usually-represents-intermediatehigh-alzheimers-disease-neuropathologic#comments</comments>
</item>
<item>
 <title>Associations of blood biomarkers of glial cell dysfunction and neuronal injury with future cognitive decline and incident dementia.</title>
 <link>https://www.alzforum.org/papers/associations-blood-biomarkers-glial-cell-dysfunction-and-neuronal-injury-future-cognitive</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71422. &lt;br&gt;Authors: Shrestha S, Zhu X, Windham BG, Sullivan KJ, Palta P, Gottesman RF, Tracy RP, Jack CR Jr, Cogswell PM, Vemuri P, Seshadri S, Mosley TH Jr, Griswold ME, Fornage M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092335&quot;&gt;42092335&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-blood-biomarkers-glial-cell-dysfunction-and-neuronal-injury-future-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-blood-biomarkers-glial-cell-dysfunction-and-neuronal-injury-future-cognitive#comments</comments>
</item>
<item>
 <title>Unraveling the role of non-coding RNAs in Parkinson&#039;s disease: Molecular mechanisms and therapeutic insights.</title>
 <link>https://www.alzforum.org/papers/unraveling-role-non-coding-rnas-parkinsons-disease-molecular-mechanisms-and-therapeutic</link>
 <description>Int J Biochem Cell Biol. 2026 Apr 30;197-198:106963.  Epub 2026 Apr 30&lt;br&gt;Authors: Tang P, Jing Z, Tong Z, Peng X, Tong J, Peng Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067182&quot;&gt;42067182&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unraveling-role-non-coding-rnas-parkinsons-disease-molecular-mechanisms-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unraveling-role-non-coding-rnas-parkinsons-disease-molecular-mechanisms-and-therapeutic#comments</comments>
</item>
<item>
 <title>The glymphatic system and meningeal lymphatic vessels: from physiology to pathophysiology, with insights into visualization.</title>
 <link>https://www.alzforum.org/papers/glymphatic-system-and-meningeal-lymphatic-vessels-physiology-pathophysiology-insights</link>
 <description>Neuroscience. 2026 Apr 30;607:22-38.  Epub 2026 Apr 30&lt;br&gt;Authors: Li Z, Wang S, Yang J, Hu H, Zheng Y, Li C, Ding Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066888&quot;&gt;42066888&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glymphatic-system-and-meningeal-lymphatic-vessels-physiology-pathophysiology-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glymphatic-system-and-meningeal-lymphatic-vessels-physiology-pathophysiology-insights#comments</comments>
</item>
<item>
 <title>Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/multi-ancestry-transcriptome-wide-association-study-reveals-shared-and-population-specific-0</link>
 <description>Am J Hum Genet. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Sun X, Mews M, Wheeler NR, Benchek P, Gu T, Gomez L, Ray N, Reitz C, Naj AC, Below JE, Tosto G, Cornejo-Olivas M, Byrd GS, Feliciano-Astacio BE, Celis K, Rajabli F, Kunkle BW, Pericak-Vance MA, Haines JL, Griswold AJ, Bush WS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066773&quot;&gt;42066773&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-ancestry-transcriptome-wide-association-study-reveals-shared-and-population-specific-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-ancestry-transcriptome-wide-association-study-reveals-shared-and-population-specific-0#comments</comments>
</item>
<item>
 <title>Escherichia coli Nissle 1917 alleviates Alzheimer&#039;s disease in mice through OmpA-containing outer membrane vesicles.</title>
 <link>https://www.alzforum.org/papers/escherichia-coli-nissle-1917-alleviates-alzheimers-disease-mice-through-ompa-containing-outer</link>
 <description>Cell Rep Med. 2026 Apr 30;:102781.  Epub 2026 Apr 30&lt;br&gt;Authors: Xie J, Dai XJ, Li Q, Zhang W, Nie X, Ji H, Chen X, Wang Y, Feng J, Li Z, Liu Q, Ye J, Zhang G, Nie S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066770&quot;&gt;42066770&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/escherichia-coli-nissle-1917-alleviates-alzheimers-disease-mice-through-ompa-containing-outer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/escherichia-coli-nissle-1917-alleviates-alzheimers-disease-mice-through-ompa-containing-outer#comments</comments>
</item>
<item>
 <title>Taurine inhibits apolipoprotein E4 aggregation.</title>
 <link>https://www.alzforum.org/papers/taurine-inhibits-apolipoprotein-e4-aggregation</link>
 <description>Biomed Pharmacother. 2026 Apr 30;199:119395.  Epub 2026 Apr 30&lt;br&gt;Authors: Legrand A, Amruz Cerna K, Marques SM, Verma N, Kopko J, Vanova T, Subramanian M, Kursit A, Bendl J, Henek T, Vanacek P, Kucera J, Planas-Iglesias J, Sedmik J, Pospisilova V, Kouba P, Vaskova A, Nezvedova M, Sedlar J, Damborsky J, Mazurenko S, Marek M, Sivic J, Hernychova L, Bednar D, Bohaciakova D, Prokop Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066671&quot;&gt;42066671&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/taurine-inhibits-apolipoprotein-e4-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/taurine-inhibits-apolipoprotein-e4-aggregation#comments</comments>
</item>
<item>
 <title>Interpretable Deep Survival Analysis of Alzheimer&#039;s Disease via Metabolic Genetic Variants.</title>
 <link>https://www.alzforum.org/papers/interpretable-deep-survival-analysis-alzheimers-disease-metabolic-genetic-variants</link>
 <description>Bioinformatics. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Goo S, Lee S, Chae JW, Jung S, Yun HY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063212&quot;&gt;42063212&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-deep-survival-analysis-alzheimers-disease-metabolic-genetic-variants#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-deep-survival-analysis-alzheimers-disease-metabolic-genetic-variants#comments</comments>
</item>
<item>
 <title>Discovering non-linear dynamics of miRNAs in Alzheimer&#039;s disease-related cognitive impairment: a cross-species approach with explainable machine learning.</title>
 <link>https://www.alzforum.org/papers/discovering-non-linear-dynamics-mirnas-alzheimers-disease-related-cognitive-impairment-cross</link>
 <description>Biol Direct. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Lee SH, Kim S, Lee SB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063169&quot;&gt;42063169&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/discovering-non-linear-dynamics-mirnas-alzheimers-disease-related-cognitive-impairment-cross#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/discovering-non-linear-dynamics-mirnas-alzheimers-disease-related-cognitive-impairment-cross#comments</comments>
</item>
<item>
 <title>Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson&#039;s disease severity.</title>
 <link>https://www.alzforum.org/papers/machine-learning-based-multi-omics-analysis-reveals-key-molecular-determinants-parkinsons</link>
 <description>Neurobiol Dis. 2026 Apr 30;225:107424.  Epub 2026 Apr 30&lt;br&gt;Authors: Jin H, Meng L, Yulug B, Altay O, Li X, Cankaya S, Hanoglu L, Ji B, Coskun E, Idil E, Nogaylar R, Oktem EO, Sayman D, Karaca R, Ozsimsek A, Shoaie S, Turkez H, Nielsen J, Borén J, Zhang C, Uhlén M, Mardinoglu A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069091&quot;&gt;42069091&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/machine-learning-based-multi-omics-analysis-reveals-key-molecular-determinants-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/machine-learning-based-multi-omics-analysis-reveals-key-molecular-determinants-parkinsons#comments</comments>
</item>
<item>
 <title>Elevated plasma sTREM2 reflects microglial activation but lacks diagnostic and clinical relevance in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/elevated-plasma-strem2-reflects-microglial-activation-lacks-diagnostic-and-clinical-relevance</link>
 <description>Neurobiol Dis. 2026 Apr 30;224:107430.  Epub 2026 Apr 30&lt;br&gt;Authors: Senerchia G, Iuzzolino VV, Spisto M, Panico F, Polito C, Aruta L, Fiorenza M, Sirica R, Terracciano D, Dubbioso R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069088&quot;&gt;42069088&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/elevated-plasma-strem2-reflects-microglial-activation-lacks-diagnostic-and-clinical-relevance#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/elevated-plasma-strem2-reflects-microglial-activation-lacks-diagnostic-and-clinical-relevance#comments</comments>
</item>
<item>
 <title>Neurofilament light and GFAP predict survival in frontotemporal dementia spectrum: A population-based study.</title>
 <link>https://www.alzforum.org/papers/neurofilament-light-and-gfap-predict-survival-frontotemporal-dementia-spectrum-population</link>
 <description>Neurobiol Dis. 2026 Apr 30;225:107421.  Epub 2026 Apr 30&lt;br&gt;Authors: Zecca C, Urso D, Dell&amp;#039;Abate MT, Borlizzi F, Rollo E, Logroscino G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069087&quot;&gt;42069087&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neurofilament-light-and-gfap-predict-survival-frontotemporal-dementia-spectrum-population#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neurofilament-light-and-gfap-predict-survival-frontotemporal-dementia-spectrum-population#comments</comments>
</item>
<item>
 <title>Multimodal deep learning neuroimaging approach to enhance CT-based diagnosis of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/multimodal-deep-learning-neuroimaging-approach-enhance-ct-based-diagnosis-alzheimers-disease</link>
 <description>Psychiatry Res Neuroimaging. 2026 Apr 30;361:112234.  Epub 2026 Apr 30&lt;br&gt;Authors: Abbas A, Tsai HC, Hsu YL, Kenneth MJ, Hussain B, Lai LM, Hsu BM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085916&quot;&gt;42085916&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multimodal-deep-learning-neuroimaging-approach-enhance-ct-based-diagnosis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multimodal-deep-learning-neuroimaging-approach-enhance-ct-based-diagnosis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Therapeutic efficacy of computerized cognitive remediation therapy on cognitive function, inflammatory biomarkers, and brain structure in patients with amnestic mild cognitive impairment and Alzheimer&#039;s disease: A randomized controlled trial.</title>
 <link>https://www.alzforum.org/papers/therapeutic-efficacy-computerized-cognitive-remediation-therapy-cognitive-function</link>
 <description>J Psychiatr Res. 2026 Apr 30;199:252-258.  Epub 2026 Apr 30&lt;br&gt;Authors: Huang X, Sun H, Zhong J, Niu T, Geng X, Zeng Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096995&quot;&gt;42096995&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-efficacy-computerized-cognitive-remediation-therapy-cognitive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-efficacy-computerized-cognitive-remediation-therapy-cognitive-function#comments</comments>
</item>
<item>
 <title>Metformin attenuates neurodegeneration in ICV-STZ-induced Alzheimer&#039;s model via antioxidant and anti-inflammatory mechanisms: implications for disease-modifying therapy.</title>
 <link>https://www.alzforum.org/papers/metformin-attenuates-neurodegeneration-icv-stz-induced-alzheimers-model-antioxidant-and-anti</link>
 <description>Neurosci Lett. 2026 Apr 29;880:138617.  Epub 2026 Apr 29&lt;br&gt;Authors: Darzi M, Golchoobian R, Varzi HN, Shanehbandpour Tabari F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067052&quot;&gt;42067052&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metformin-attenuates-neurodegeneration-icv-stz-induced-alzheimers-model-antioxidant-and-anti#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metformin-attenuates-neurodegeneration-icv-stz-induced-alzheimers-model-antioxidant-and-anti#comments</comments>
</item>
<item>
 <title>From pathology to precision therapy: Contemporary and emerging strategies in Alzheimer&#039;s disease treatment.</title>
 <link>https://www.alzforum.org/papers/pathology-precision-therapy-contemporary-and-emerging-strategies-alzheimers-disease-treatment</link>
 <description>Eur J Pharmacol. 2026 Apr 29;1025:178913.  Epub 2026 Apr 29&lt;br&gt;Authors: Belavadi S, Kadiri SK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42067018&quot;&gt;42067018&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pathology-precision-therapy-contemporary-and-emerging-strategies-alzheimers-disease-treatment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pathology-precision-therapy-contemporary-and-emerging-strategies-alzheimers-disease-treatment#comments</comments>
</item>
<item>
 <title>From stability to pathology: protein degradation pathways underlying synaptic proteins in neurological diseases.</title>
 <link>https://www.alzforum.org/papers/stability-pathology-protein-degradation-pathways-underlying-synaptic-proteins-neurological</link>
 <description>Neuroscience. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Li Y, Hou XY, Tao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066889&quot;&gt;42066889&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stability-pathology-protein-degradation-pathways-underlying-synaptic-proteins-neurological#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stability-pathology-protein-degradation-pathways-underlying-synaptic-proteins-neurological#comments</comments>
</item>
<item>
 <title>The chaperone DNAJB6b halts amyloid formation through association with transient Aβ oligomers.</title>
 <link>https://www.alzforum.org/papers/chaperone-dnajb6b-halts-amyloid-formation-through-association-transient-av-oligomers</link>
 <description>Phys Chem Chem Phys. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Getachew J, Carlsson A, Axell E, Thacker D, Olsson U, Linse S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42065441&quot;&gt;42065441&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chaperone-dnajb6b-halts-amyloid-formation-through-association-transient-av-oligomers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chaperone-dnajb6b-halts-amyloid-formation-through-association-transient-av-oligomers#comments</comments>
</item>
<item>
 <title>Microfluidic compartmentalization reveals that ferrostatin-1 restores directional mitochondrial transport in Aβ-challenged neurons.</title>
 <link>https://www.alzforum.org/papers/microfluidic-compartmentalization-reveals-ferrostatin-1-restores-directional-mitochondrial</link>
 <description>Lab Chip. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Majerníková N, Corci B, Zhang Y, Chen T, van Koeveringe M, Mensinga D, Mulder PP, Verpoorte E, Mattarei A, Pendin D, Mammucari C, Åberg C, den Dunnen W, Dolga AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42065434&quot;&gt;42065434&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microfluidic-compartmentalization-reveals-ferrostatin-1-restores-directional-mitochondrial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microfluidic-compartmentalization-reveals-ferrostatin-1-restores-directional-mitochondrial#comments</comments>
</item>
<item>
 <title>Aging, neurodegenerative diseases and geriatrics.</title>
 <link>https://www.alzforum.org/papers/aging-neurodegenerative-diseases-and-geriatrics</link>
 <description>Maturitas. 2026 Apr 29;:108962.  Epub 2026 Apr 29&lt;br&gt;Authors: Zhu S, Gharti S, Chhetri JK, Chan P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42069449&quot;&gt;42069449&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aging-neurodegenerative-diseases-and-geriatrics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aging-neurodegenerative-diseases-and-geriatrics#comments</comments>
</item>
<item>
 <title>Advances in Microneedle Technology for Targeted Therapy in Alzheimer&#039;s and Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/advances-microneedle-technology-targeted-therapy-alzheimers-and-parkinsons-disease</link>
 <description>Curr Drug Deliv. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Kanojia N, Deswal G, Grewal AS, Kumar J, Thapa K, Sharma A, Sharma A, Dheer D, Puri V, Rani L, Saini V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083963&quot;&gt;42083963&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-microneedle-technology-targeted-therapy-alzheimers-and-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-microneedle-technology-targeted-therapy-alzheimers-and-parkinsons-disease#comments</comments>
</item>
<item>
 <title>The Gut-Brain Connection: Exploring the Connection Between the Gastrointestinal System and Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/gut-brain-connection-exploring-connection-between-gastrointestinal-system-and-parkinsons</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: YuXuan G, Iqbal MK, Khan B, Khan H, Ud Din Shah SS, Al-Hussain F, Kiyani MM, Bashir S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083540&quot;&gt;42083540&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-brain-connection-exploring-connection-between-gastrointestinal-system-and-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-brain-connection-exploring-connection-between-gastrointestinal-system-and-parkinsons#comments</comments>
</item>
<item>
 <title>Methodological considerations in the study of peripheral blood immune cells and Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/methodological-considerations-study-peripheral-blood-immune-cells-and-parkinsons-disease</link>
 <description>J Neurol Sci. 2026 Apr 27;486:125961.  Epub 2026 Apr 27&lt;br&gt;Authors: Aijaz M, Khan A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42066586&quot;&gt;42066586&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/methodological-considerations-study-peripheral-blood-immune-cells-and-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/methodological-considerations-study-peripheral-blood-immune-cells-and-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Nanopore Fingerprinting of Neurodegenerative Proteins and Phosphoproteins within a Minute.</title>
 <link>https://www.alzforum.org/papers/nanopore-fingerprinting-neurodegenerative-proteins-and-phosphoproteins-within-minute</link>
 <description>JACS Au. 2026 Apr 27;6(4):2516-2522.  Epub 2026 Apr 6&lt;br&gt;Authors: Xin KL, Zhang LL, Li MY, Liu SC, She HQ, Ying YL, Long YT, Hu ZL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063816&quot;&gt;42063816&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nanopore-fingerprinting-neurodegenerative-proteins-and-phosphoproteins-within-minute#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nanopore-fingerprinting-neurodegenerative-proteins-and-phosphoproteins-within-minute#comments</comments>
</item>
<item>
 <title>Lipid Composition Drastically Alters Tau-Membrane Interaction: Implications for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/lipid-composition-drastically-alters-tau-membrane-interaction-implications-alzheimers-disease</link>
 <description>JACS Au. 2026 Apr 27;6(4):2264-2273.  Epub 2026 Mar 25&lt;br&gt;Authors: Wu A, Kandel N, Li S, Enoki TA, Hewes K, Palumbo J, Buttaci M, Jones K, Xia K, Zhao J, Dick RA, Belfort G, Chen J, Forth S, Wang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063815&quot;&gt;42063815&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipid-composition-drastically-alters-tau-membrane-interaction-implications-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipid-composition-drastically-alters-tau-membrane-interaction-implications-alzheimers-disease#comments</comments>
</item>
<item>
 <title>A lightweight vision transformer with context-aware convolution and uniformity normalization for Alzheimer&#039;s Disease diagnosis.</title>
 <link>https://www.alzforum.org/papers/lightweight-vision-transformer-context-aware-convolution-and-uniformity-normalization</link>
 <description>Comput Methods Programs Biomed. 2026 Apr 27;282:109413.  Epub 2026 Apr 27&lt;br&gt;Authors: Lu SY, Zhu Z, Zhang B, Zhang YD, Yao YD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070480&quot;&gt;42070480&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lightweight-vision-transformer-context-aware-convolution-and-uniformity-normalization#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lightweight-vision-transformer-context-aware-convolution-and-uniformity-normalization#comments</comments>
</item>
<item>
 <title>Reconsidering peripheral immune markers in Parkinson&#039;s disease: Methodological reflections on recent findings.</title>
 <link>https://www.alzforum.org/papers/reconsidering-peripheral-immune-markers-parkinsons-disease-methodological-reflections-recent</link>
 <description>J Neurol Sci. 2026 Apr 27;486:125960.  Epub 2026 Apr 27&lt;br&gt;Authors: Sahin A, Ismah, Herawati AA, Mubarak MA, Pautina AR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070469&quot;&gt;42070469&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reconsidering-peripheral-immune-markers-parkinsons-disease-methodological-reflections-recent#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reconsidering-peripheral-immune-markers-parkinsons-disease-methodological-reflections-recent#comments</comments>
</item>
<item>
 <title>Donepezil-derived multi-target-directed ligands: design, synthesis, and anti-Alzheimer&#039;s evaluation.</title>
 <link>https://www.alzforum.org/papers/donepezil-derived-multi-target-directed-ligands-design-synthesis-and-anti-alzheimers</link>
 <description>Bioorg Chem. 2026 Apr 27;178:109924.  Epub 2026 Apr 27&lt;br&gt;Authors: Bassiouny MS, Shahin MI, Jaballah MY, Ahmed TE, Henary M, Samir N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090829&quot;&gt;42090829&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/donepezil-derived-multi-target-directed-ligands-design-synthesis-and-anti-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/donepezil-derived-multi-target-directed-ligands-design-synthesis-and-anti-alzheimers#comments</comments>
</item>
<item>
 <title>40 Hz light flicker stimulation for neurodegenerative diseases: Mechanisms and clinical perspectives.</title>
 <link>https://www.alzforum.org/papers/40-hz-light-flicker-stimulation-neurodegenerative-diseases-mechanisms-and-clinical</link>
 <description>Biochem Biophys Res Commun. 2026 Apr 27;821:153858.  Epub 2026 Apr 27&lt;br&gt;Authors: Shu Y, Ding ZH, Chen XQ, Liu F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42097044&quot;&gt;42097044&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/40-hz-light-flicker-stimulation-neurodegenerative-diseases-mechanisms-and-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/40-hz-light-flicker-stimulation-neurodegenerative-diseases-mechanisms-and-clinical#comments</comments>
</item>
<item>
 <title>Comment on &quot;A systematic review: Brain age gap as a promising early diagnostic biomarker for Alzheimer&#039;s disease&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-systematic-review-brain-age-gap-promising-early-diagnostic-biomarker-alzheimers</link>
 <description>J Neurol Sci. 2026 Apr 27;487:125954.  Epub 2026 Apr 27&lt;br&gt;Authors: Banu AS, Hazra S, Banu MR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42096792&quot;&gt;42096792&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-systematic-review-brain-age-gap-promising-early-diagnostic-biomarker-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-systematic-review-brain-age-gap-promising-early-diagnostic-biomarker-alzheimers#comments</comments>
</item>
<item>
 <title>Characterization of proteoforms within α-synuclein complexes in living cells by cleavable cross-linking combined with top-down mass spectrometry.</title>
 <link>https://www.alzforum.org/papers/characterization-proteoforms-within-synuclein-complexes-living-cells-cleavable-cross-linking</link>
 <description>Talanta. 2026 Apr 27;307:129914.  Epub 2026 Apr 27&lt;br&gt;Authors: Yang X, Zhong B, Chen J, Sun Y, Zhao B, Zhao Q, Liang Z, Zhang Y, Liang Y, Zhang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42092374&quot;&gt;42092374&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterization-proteoforms-within-synuclein-complexes-living-cells-cleavable-cross-linking#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterization-proteoforms-within-synuclein-complexes-living-cells-cleavable-cross-linking#comments</comments>
</item>
<item>
 <title>Probiotics combat sarcopenia by restoring gut integrity in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/probiotics-combat-sarcopenia-restoring-gut-integrity-alzheimers-disease</link>
 <description>Explore (NY). 2026 Apr 24;22(4):103428.  Epub 2026 Apr 24&lt;br&gt;Authors: Qaisar R, Iqbal MS, Ahmad F, Karim A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42068795&quot;&gt;42068795&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/probiotics-combat-sarcopenia-restoring-gut-integrity-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/probiotics-combat-sarcopenia-restoring-gut-integrity-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Causality relationship between 91 inflammatory factors and Alzheimer disease: A bidirectional Mendelian randomization study.</title>
 <link>https://www.alzforum.org/papers/causality-relationship-between-91-inflammatory-factors-and-alzheimer-disease-bidirectional</link>
 <description>Medicine (Baltimore). 2026 Apr 24;105(17):e48136. &lt;br&gt;Authors: Li Q, Jing S, Li N, Yuan X, Wang T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071824&quot;&gt;42071824&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/causality-relationship-between-91-inflammatory-factors-and-alzheimer-disease-bidirectional#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/causality-relationship-between-91-inflammatory-factors-and-alzheimer-disease-bidirectional#comments</comments>
</item>
<item>
 <title>Association between food insecurity and Parkinson&#039;s disease: A cross-sectional analysis of nationally representative data.</title>
 <link>https://www.alzforum.org/papers/association-between-food-insecurity-and-parkinsons-disease-cross-sectional-analysis</link>
 <description>Medicine (Baltimore). 2026 Apr 24;105(17):e48488. &lt;br&gt;Authors: He R, Lu L, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42071793&quot;&gt;42071793&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-food-insecurity-and-parkinsons-disease-cross-sectional-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-food-insecurity-and-parkinsons-disease-cross-sectional-analysis#comments</comments>
</item>
<item>
 <title>Exosomes as Advanced Nanocarriers: Overcoming the Blood-Brain Barrier for Targeted Therapeutic Delivery in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/exosomes-advanced-nanocarriers-overcoming-blood-brain-barrier-targeted-therapeutic-delivery</link>
 <description>Curr Drug Deliv. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Aliakbari F, Rahmani M, Marzookian K, Boroujeni NN, Alikhanian A, Ghasemi F, Otzen DE, Morshedi D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083346&quot;&gt;42083346&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exosomes-advanced-nanocarriers-overcoming-blood-brain-barrier-targeted-therapeutic-delivery#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exosomes-advanced-nanocarriers-overcoming-blood-brain-barrier-targeted-therapeutic-delivery#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease with progression analysis using a novel dilated convolutional attention based long short term memory model.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-progression-analysis-using-novel-dilated-convolutional-attention-based</link>
 <description>Psychiatry Res Neuroimaging. 2026 Apr 24;361:112232.  Epub 2026 Apr 24&lt;br&gt;Authors: Rudraraju A, Lakshmi SV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42090937&quot;&gt;42090937&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-progression-analysis-using-novel-dilated-convolutional-attention-based#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-progression-analysis-using-novel-dilated-convolutional-attention-based#comments</comments>
</item>
<item>
 <title>An Inverse Association Between the Composite Dietary Antioxidant Index and Alzheimer&#039;s Disease: Evidence from an NHANES-Based Cross-Sectional Study.</title>
 <link>https://www.alzforum.org/papers/inverse-association-between-composite-dietary-antioxidant-index-and-alzheimers-disease</link>
 <description>Curr Alzheimer Res. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Zhang Y, Tong S, Chen Y, Li C, Yao Y, Tang S, Shang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083373&quot;&gt;42083373&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/inverse-association-between-composite-dietary-antioxidant-index-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/inverse-association-between-composite-dietary-antioxidant-index-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Sodium-to-Potassium Ratio and Alzheimer&#039;s Disease: A Mendelian Randomization Study.</title>
 <link>https://www.alzforum.org/papers/sodium-potassium-ratio-and-alzheimers-disease-mendelian-randomization-study</link>
 <description>Curr Alzheimer Res. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Yoshida H, Inoue T, Suzuki S, Tomata Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083372&quot;&gt;42083372&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sodium-potassium-ratio-and-alzheimers-disease-mendelian-randomization-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sodium-potassium-ratio-and-alzheimers-disease-mendelian-randomization-study#comments</comments>
</item>
<item>
 <title>Nanomedicine for Alzheimer&#039;s Disease: Diagnostic and Therapeutic Progress.</title>
 <link>https://www.alzforum.org/papers/nanomedicine-alzheimers-disease-diagnostic-and-therapeutic-progress</link>
 <description>Microrna. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Pandey H, Kaur A, Khan J, Sharma A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083360&quot;&gt;42083360&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nanomedicine-alzheimers-disease-diagnostic-and-therapeutic-progress#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nanomedicine-alzheimers-disease-diagnostic-and-therapeutic-progress#comments</comments>
</item>
<item>
 <title>Predicting progression from subjective cognitive decline to dementia using different neuropsychological criteria: A longitudinal study.</title>
 <link>https://www.alzforum.org/papers/predicting-progression-subjective-cognitive-decline-dementia-using-different</link>
 <description>Arch Gerontol Geriatr. 2026 Apr 22;148:106269.  Epub 2026 Apr 22&lt;br&gt;Authors: Pestana PC, Cardoso S, Guerreiro M, Jessen F, Simões do Couto F, Marôco J, de Mendonça A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42070416&quot;&gt;42070416&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predicting-progression-subjective-cognitive-decline-dementia-using-different#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predicting-progression-subjective-cognitive-decline-dementia-using-different#comments</comments>
</item>
<item>
 <title>E2AD: Enhanced and explainable Alzheimer&#039;s disease detection framework via anatomy- and relation-aware cross-modal knowledge distillation.</title>
 <link>https://www.alzforum.org/papers/e2ad-enhanced-and-explainable-alzheimers-disease-detection-framework-anatomy-and-relation</link>
 <description>Med Image Anal. 2026 Apr 22;112:104099.  Epub 2026 Apr 22&lt;br&gt;Authors: Wang C, Piao S, Chen Z, Chen T, Li Z, Zhang T, Li Y, Zhao XM, Shan H, Alzheimer’s Disease Neuroimaging Initiative, Australian Imaging Biomarkers and Lifestyle flagship study of aging&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42085921&quot;&gt;42085921&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/e2ad-enhanced-and-explainable-alzheimers-disease-detection-framework-anatomy-and-relation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/e2ad-enhanced-and-explainable-alzheimers-disease-detection-framework-anatomy-and-relation#comments</comments>
</item>
<item>
 <title>Cerebrospinal Fluid Sediments as a Novel Tool for Potential Biomarkers of Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/cerebrospinal-fluid-sediments-novel-tool-potential-biomarkers-neurodegenerative-diseases</link>
 <description>Int J Mol Sci. 2026 Apr 21;27(8)&lt;br&gt;Authors: Alsina R, Riba M, Sartorio M, Romera C, Vilaplana B, Prats E, Molina-Porcel L, Del Valle J, Pelegrí C, Vilaplana J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074330&quot;&gt;42074330&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebrospinal-fluid-sediments-novel-tool-potential-biomarkers-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebrospinal-fluid-sediments-novel-tool-potential-biomarkers-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to Interventions.</title>
 <link>https://www.alzforum.org/papers/loss-proteostasis-and-early-onset-neurodegeneration-down-syndrome-mechanisms-interventions</link>
 <description>Antioxidants (Basel). 2026 Apr 21;15(4)&lt;br&gt;Authors: Tramutola A, Lanzillotta C, Di Domenico F, Barone E, Perluigi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072161&quot;&gt;42072161&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/loss-proteostasis-and-early-onset-neurodegeneration-down-syndrome-mechanisms-interventions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/loss-proteostasis-and-early-onset-neurodegeneration-down-syndrome-mechanisms-interventions#comments</comments>
</item>
<item>
 <title>Potential Protection Against Parkinson&#039;s Disease by Ergothioneine-Nature&#039;s Multifactorial Neuroprotectant.</title>
 <link>https://www.alzforum.org/papers/potential-protection-against-parkinsons-disease-ergothioneine-natures-multifactorial</link>
 <description>Antioxidants (Basel). 2026 Apr 21;15(4)&lt;br&gt;Authors: Tng TJ, Cheah IK, Halliwell B, Lim KL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072160&quot;&gt;42072160&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/potential-protection-against-parkinsons-disease-ergothioneine-natures-multifactorial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/potential-protection-against-parkinsons-disease-ergothioneine-natures-multifactorial#comments</comments>
</item>
<item>
 <title>ScFv T1 Protects Against Mitochondrial Damage of SH-SY5Y Cells Caused by Extracellular Tau Aggregates.</title>
 <link>https://www.alzforum.org/papers/scfv-t1-protects-against-mitochondrial-damage-sh-sy5y-cells-caused-extracellular-tau</link>
 <description>Antioxidants (Basel). 2026 Apr 21;15(4)&lt;br&gt;Authors: Wang Z, Jiang X, Lin J, An R, He Y, Li S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072156&quot;&gt;42072156&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/scfv-t1-protects-against-mitochondrial-damage-sh-sy5y-cells-caused-extracellular-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/scfv-t1-protects-against-mitochondrial-damage-sh-sy5y-cells-caused-extracellular-tau#comments</comments>
</item>
<item>
 <title>The Relationship between Ergothioneine, Allantoin and Neocortical Amyloid Load.</title>
 <link>https://www.alzforum.org/papers/relationship-between-ergothioneine-allantoin-and-neocortical-amyloid-load</link>
 <description>Aging Dis. 2026 Apr 20; Epub 2026 Apr 20&lt;br&gt;Authors: Eslick S, Kee-Mun IC, Chatterjee P, Jerome S, Halliwell B, Martins R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42065921&quot;&gt;42065921&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/relationship-between-ergothioneine-allantoin-and-neocortical-amyloid-load#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/relationship-between-ergothioneine-allantoin-and-neocortical-amyloid-load#comments</comments>
</item>
<item>
 <title>Amyloid-β, Tau Protein, α-Synuclein, TDP-43, and FUS in Mixed Pathology: And Intrinsic Disorder to Rule Them All.</title>
 <link>https://www.alzforum.org/papers/amyloid-v-tau-protein-synuclein-tdp-43-and-fus-mixed-pathology-and-intrinsic-disorder-rule</link>
 <description>Int J Mol Sci. 2026 Apr 20;27(8)&lt;br&gt;Authors: Siebner AS, Uversky VN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074305&quot;&gt;42074305&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-v-tau-protein-synuclein-tdp-43-and-fus-mixed-pathology-and-intrinsic-disorder-rule#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-v-tau-protein-synuclein-tdp-43-and-fus-mixed-pathology-and-intrinsic-disorder-rule#comments</comments>
</item>
<item>
 <title>Research on Threshold Optimization and Variability-Based Digital Biomarker Approaches Through MMSE-Lifelog Multimodal Integrated Analysis from a Clinical Screening Perspective.</title>
 <link>https://www.alzforum.org/papers/research-threshold-optimization-and-variability-based-digital-biomarker-approaches-through</link>
 <description>Healthcare (Basel). 2026 Apr 20;14(8)&lt;br&gt;Authors: Park Y, Jeong JH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073000&quot;&gt;42073000&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-threshold-optimization-and-variability-based-digital-biomarker-approaches-through#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-threshold-optimization-and-variability-based-digital-biomarker-approaches-through#comments</comments>
</item>
<item>
 <title>A Degradable Nanosystem Based on Small Gold Nanoparticles and Albumin for Amyloid Aggregation Inhibition.</title>
 <link>https://www.alzforum.org/papers/degradable-nanosystem-based-small-gold-nanoparticles-and-albumin-amyloid-aggregation</link>
 <description>Pharmaceutics. 2026 Apr 19;18(4)&lt;br&gt;Authors: Levio M, Rossel Carrera F, Sánchez Hoyos F, Huerta M, Alamos C, Vásquez-Contreras R, Kogan MJ, Fuentes EA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076154&quot;&gt;42076154&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/degradable-nanosystem-based-small-gold-nanoparticles-and-albumin-amyloid-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/degradable-nanosystem-based-small-gold-nanoparticles-and-albumin-amyloid-aggregation#comments</comments>
</item>
<item>
 <title>Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/emerging-roles-rivastigmine-derivatives-bearing-antioxidant-motifs-multi-target-agents</link>
 <description>Int J Mol Sci. 2026 Apr 19;27(8)&lt;br&gt;Authors: Dias I, Guerreiro-Oliveira C, Melo-Marques I, Cardoso SM, Guedes RC, Carvalho I, Rocha T, Chavarria D, Chaves S, Santos MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074275&quot;&gt;42074275&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emerging-roles-rivastigmine-derivatives-bearing-antioxidant-motifs-multi-target-agents#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emerging-roles-rivastigmine-derivatives-bearing-antioxidant-motifs-multi-target-agents#comments</comments>
</item>
<item>
 <title>Motor-Derived Digital Biomarkers for Identifying Low-MoCA Status in People with Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/motor-derived-digital-biomarkers-identifying-low-moca-status-people-parkinsons-disease</link>
 <description>Sensors (Basel). 2026 Apr 18;26(8)&lt;br&gt;Authors: Kim B, Youm C, Cheon SM, Park H, Choi H, Hwang J, Kim M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42076613&quot;&gt;42076613&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/motor-derived-digital-biomarkers-identifying-low-moca-status-people-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/motor-derived-digital-biomarkers-identifying-low-moca-status-people-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Synergistic Effects of Multi-Kinase Inhibition on LRRK2-G2019S and Alpha-Synuclein Pathologies in Models of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/synergistic-effects-multi-kinase-inhibition-lrrk2-g2019s-and-alpha-synuclein-pathologies</link>
 <description>Biomedicines. 2026 Apr 18;14(4)&lt;br&gt;Authors: Liu X, Baxely S, Hebron ML, Moussa C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072468&quot;&gt;42072468&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synergistic-effects-multi-kinase-inhibition-lrrk2-g2019s-and-alpha-synuclein-pathologies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synergistic-effects-multi-kinase-inhibition-lrrk2-g2019s-and-alpha-synuclein-pathologies#comments</comments>
</item>
<item>
 <title>The Microbiota-Gut-Brain Axis Across the Lifespan: From Neurodevelopment to Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/microbiota-gut-brain-axis-across-lifespan-neurodevelopment-neurodegeneration</link>
 <description>J Clin Med. 2026 Apr 17;15(8)&lt;br&gt;Authors: Carnazzo SM, Fanos V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074869&quot;&gt;42074869&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microbiota-gut-brain-axis-across-lifespan-neurodevelopment-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microbiota-gut-brain-axis-across-lifespan-neurodevelopment-neurodegeneration#comments</comments>
</item>
<item>
 <title>Enrichment of Rare Variants in Nuclear-Encoded Mitochondrial Metabolism Genes in Patients with Early-Onset or Familial Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/enrichment-rare-variants-nuclear-encoded-mitochondrial-metabolism-genes-patients-early-onset</link>
 <description>Genes (Basel). 2026 Apr 17;17(4)&lt;br&gt;Authors: Bergant G, van Midden VM, Tsygankova P, Laslo D, Rački V, Georgiev D, Papić E, Branković M, Janković M, Svetel M, Teran N, Misković ND, Petrović I, Maver A, Novaković I, Pirtošek Z, Rakuša M, Vuletić V, Peterlin B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074590&quot;&gt;42074590&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/enrichment-rare-variants-nuclear-encoded-mitochondrial-metabolism-genes-patients-early-onset#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/enrichment-rare-variants-nuclear-encoded-mitochondrial-metabolism-genes-patients-early-onset#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Spinal Pathology: Neuronal, Glial, and Cholesterol Metabolic Changes in Female and Male 5xFAD Mice.</title>
 <link>https://www.alzforum.org/papers/alzheimers-spinal-pathology-neuronal-glial-and-cholesterol-metabolic-changes-female-and-male</link>
 <description>Int J Mol Sci. 2026 Apr 17;27(8)&lt;br&gt;Authors: Wang X, Harnett W, Shu X, Jiang HR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074231&quot;&gt;42074231&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-spinal-pathology-neuronal-glial-and-cholesterol-metabolic-changes-female-and-male#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-spinal-pathology-neuronal-glial-and-cholesterol-metabolic-changes-female-and-male#comments</comments>
</item>
<item>
 <title>&quot;Polyradiculoneuritis&quot; as an Atypical Clinical Presentation of Creutzfeldt-Jakob Disease: A Case Report and Review of Literature.</title>
 <link>https://www.alzforum.org/papers/polyradiculoneuritis-atypical-clinical-presentation-creutzfeldt-jakob-disease-case-report-and</link>
 <description>Life (Basel). 2026 Apr 17;16(4)&lt;br&gt;Authors: Colaizzo E, Ladogana A, Tiple D, Vaianella L, Bufano G, Moda F, Merlo D, Longo E, Perna A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073492&quot;&gt;42073492&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polyradiculoneuritis-atypical-clinical-presentation-creutzfeldt-jakob-disease-case-report-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polyradiculoneuritis-atypical-clinical-presentation-creutzfeldt-jakob-disease-case-report-and#comments</comments>
</item>
<item>
 <title>Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/tau-and-v-amyloid-relevant-pathology-central-therapeutic-target-alzheimers-disease</link>
 <description>Biomolecules. 2026 Apr 17;16(4)&lt;br&gt;Authors: Strużyńska L, Adamiak K, Sidoryk-Węgrzynowicz M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072716&quot;&gt;42072716&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tau-and-v-amyloid-relevant-pathology-central-therapeutic-target-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tau-and-v-amyloid-relevant-pathology-central-therapeutic-target-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Ferroptosis in Neuropsychiatric and Neurodegenerative Disorders: Shared Mechanisms and Disease-Specific Signatures.</title>
 <link>https://www.alzforum.org/papers/ferroptosis-neuropsychiatric-and-neurodegenerative-disorders-shared-mechanisms-and-disease</link>
 <description>Pharmaceuticals (Basel). 2026 Apr 16;19(4)&lt;br&gt;Authors: Liu M, Zeng C, Si Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075884&quot;&gt;42075884&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ferroptosis-neuropsychiatric-and-neurodegenerative-disorders-shared-mechanisms-and-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ferroptosis-neuropsychiatric-and-neurodegenerative-disorders-shared-mechanisms-and-disease#comments</comments>
</item>
<item>
 <title>Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/interactions-between-blood-nutritional-biomarkers-and-apolipoprotein-e-e4-progression-mild</link>
 <description>Nutrients. 2026 Apr 16;18(8)&lt;br&gt;Authors: Lawal R, Kumar S, Chigevenga R, Coe S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075076&quot;&gt;42075076&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interactions-between-blood-nutritional-biomarkers-and-apolipoprotein-e-e4-progression-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interactions-between-blood-nutritional-biomarkers-and-apolipoprotein-e-e4-progression-mild#comments</comments>
</item>
<item>
 <title>Theranostic Nanoplatforms for Alzheimer&#039;s Disease: A Critical Analysis of Conceptual Contradictions.</title>
 <link>https://www.alzforum.org/papers/theranostic-nanoplatforms-alzheimers-disease-critical-analysis-conceptual-contradictions</link>
 <description>Int J Mol Sci. 2026 Apr 16;27(8)&lt;br&gt;Authors: Zorkina Y, Abramova O, Zubkov E, Gurina O, Ushakova V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074200&quot;&gt;42074200&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/theranostic-nanoplatforms-alzheimers-disease-critical-analysis-conceptual-contradictions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/theranostic-nanoplatforms-alzheimers-disease-critical-analysis-conceptual-contradictions#comments</comments>
</item>
<item>
 <title>Correction: Urbano et al. Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment. Diagnostics 2024, 14, 2408.</title>
 <link>https://www.alzforum.org/papers/correction-urbano-et-al-comparison-serum-and-cerebrospinal-fluid-neurofilament-light-chain</link>
 <description>Diagnostics (Basel). 2026 Apr 16;16(8)&lt;br&gt;Authors: Urbano T, Maramotti R, Tondelli M, Gallingani C, Carbone C, Iacovino N, Vinceti G, Zamboni G, Chiari A, Bedin R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072874&quot;&gt;42072874&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-urbano-et-al-comparison-serum-and-cerebrospinal-fluid-neurofilament-light-chain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-urbano-et-al-comparison-serum-and-cerebrospinal-fluid-neurofilament-light-chain#comments</comments>
</item>
<item>
 <title>Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[h]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity.</title>
 <link>https://www.alzforum.org/papers/synthesis-and-biological-profiling-new-1234-tetrahydrobenzohnaphthyridine-based-hybrids-dual</link>
 <description>Biomolecules. 2026 Apr 16;16(4)&lt;br&gt;Authors: Verano AB, Sampietro A, Mallo-Abreu A, Spagnuolo R, Pérez B, Bartolini M, Loza MI, Brea J, Juárez-Jiménez J, Sabate R, Galdeano C, Muñoz-Torrero D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072714&quot;&gt;42072714&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synthesis-and-biological-profiling-new-1234-tetrahydrobenzohnaphthyridine-based-hybrids-dual#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synthesis-and-biological-profiling-new-1234-tetrahydrobenzohnaphthyridine-based-hybrids-dual#comments</comments>
</item>
<item>
 <title>Targeting Pain and Depression in Alzheimer&#039;s Disease: Translational Insights and Emerging Treatments.</title>
 <link>https://www.alzforum.org/papers/targeting-pain-and-depression-alzheimers-disease-translational-insights-and-emerging</link>
 <description>Pharmaceuticals (Basel). 2026 Apr 15;19(4)&lt;br&gt;Authors: Costachescu I, Stanciu GD, Gogu RM, Tamba BI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075881&quot;&gt;42075881&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-pain-and-depression-alzheimers-disease-translational-insights-and-emerging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-pain-and-depression-alzheimers-disease-translational-insights-and-emerging#comments</comments>
</item>
<item>
 <title>Associations of Circadian Rhythms with Cognitive Performance in Patients with Amnestic Mild Cognitive Impairment (aMCI).</title>
 <link>https://www.alzforum.org/papers/associations-circadian-rhythms-cognitive-performance-patients-amnestic-mild-cognitive</link>
 <description>J Clin Med. 2026 Apr 15;15(8)&lt;br&gt;Authors: Kim SJ, Lee JH, Jang JW, Choi M, Suh IB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074823&quot;&gt;42074823&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-circadian-rhythms-cognitive-performance-patients-amnestic-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-circadian-rhythms-cognitive-performance-patients-amnestic-mild-cognitive#comments</comments>
</item>
<item>
 <title>Gut-Brain Signaling in Parkinson&#039;s Disease: A Narrative Review.</title>
 <link>https://www.alzforum.org/papers/gut-brain-signaling-parkinsons-disease-narrative-review</link>
 <description>Int J Mol Sci. 2026 Apr 15;27(8)&lt;br&gt;Authors: Ratajczyk K, Kaczorowska E, Wyka K, Tarasiuk-Zawadzka A, Fichna J, Gajos A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074174&quot;&gt;42074174&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-brain-signaling-parkinsons-disease-narrative-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-brain-signaling-parkinsons-disease-narrative-review#comments</comments>
</item>
<item>
 <title>Features of Cross-Seeding of Wild-Type Alpha-Synuclein and Its Mutant Form A53T Potentially Useful for the Development of Test Systems.</title>
 <link>https://www.alzforum.org/papers/features-cross-seeding-wild-type-alpha-synuclein-and-its-mutant-form-a53t-potentially-useful</link>
 <description>Life (Basel). 2026 Apr 15;16(4)&lt;br&gt;Authors: Barinova K, Kudryavtseva S, Kurochkina L, Golyshev S, Kolotyeva N, Illarioshkin S, Piradov M, Muronetz V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073483&quot;&gt;42073483&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/features-cross-seeding-wild-type-alpha-synuclein-and-its-mutant-form-a53t-potentially-useful#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/features-cross-seeding-wild-type-alpha-synuclein-and-its-mutant-form-a53t-potentially-useful#comments</comments>
</item>
<item>
 <title>Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic-Neuroinflammatory Crosstalk.</title>
 <link>https://www.alzforum.org/papers/leucine-rich-repeat-kinase-2-lrrk2-glucose-metabolism-and-metabolic-neuroinflammatory</link>
 <description>Biomolecules. 2026 Apr 15;16(4)&lt;br&gt;Authors: Kawakami F, Imai M, Ogata M, Habata T, Tamaki S, Kawashima R, Kurosaki Y, Miyai S, Chatatikun M, Kyaw MP, Ohba K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072709&quot;&gt;42072709&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/leucine-rich-repeat-kinase-2-lrrk2-glucose-metabolism-and-metabolic-neuroinflammatory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/leucine-rich-repeat-kinase-2-lrrk2-glucose-metabolism-and-metabolic-neuroinflammatory#comments</comments>
</item>
<item>
 <title>The myth of digital biomarkers in Alzheimer&#039;s disease: how to make them a reality.</title>
 <link>https://www.alzforum.org/papers/myth-digital-biomarkers-alzheimers-disease-how-make-them-reality</link>
 <description>Curr Opin Psychiatry. 2026 Apr 15; Epub 2026 Apr 15&lt;br&gt;Authors: Au R, Gifford KA, Paschalidis IC, Wighton P, Levin M, Imam F, Bose N, Pratap A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083983&quot;&gt;42083983&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/myth-digital-biomarkers-alzheimers-disease-how-make-them-reality#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/myth-digital-biomarkers-alzheimers-disease-how-make-them-reality#comments</comments>
</item>
<item>
 <title>Astragaloside IV Improves Cognitive Impairment in Alzheimer&#039;s Mice by Alleviating Neuron PANoptosis.</title>
 <link>https://www.alzforum.org/papers/astragaloside-iv-improves-cognitive-impairment-alzheimers-mice-alleviating-neuron-panoptosis</link>
 <description>Int J Mol Sci. 2026 Apr 14;27(8)&lt;br&gt;Authors: Wang W, Zhao Y, Li Z, Lv Y, Xu Z, Qi B, Yin J, Wang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074152&quot;&gt;42074152&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astragaloside-iv-improves-cognitive-impairment-alzheimers-mice-alleviating-neuron-panoptosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astragaloside-iv-improves-cognitive-impairment-alzheimers-mice-alleviating-neuron-panoptosis#comments</comments>
</item>
<item>
 <title>Synphilin-1 Is Essential for Cytoskeletal Integrity of Brain Ventricular Cilia and Mitochondrial Proteostasis.</title>
 <link>https://www.alzforum.org/papers/synphilin-1-essential-cytoskeletal-integrity-brain-ventricular-cilia-and-mitochondrial</link>
 <description>Int J Mol Sci. 2026 Apr 14;27(8)&lt;br&gt;Authors: Farhoud M, Shah AK, Pavoncello N, Hamza H, Abd Elghani F, Shani V, Toren-Hershkoviz M, Zaer S, Saar G, Shaulov L, Vitic Z, Brodski C, Maoz I, Zubedat S, Avital A, Safory H, Engelender S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074141&quot;&gt;42074141&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synphilin-1-essential-cytoskeletal-integrity-brain-ventricular-cilia-and-mitochondrial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synphilin-1-essential-cytoskeletal-integrity-brain-ventricular-cilia-and-mitochondrial#comments</comments>
</item>
<item>
 <title>Pridopidine Protects ALS Patient-Derived Neural Progenitor Cells via Sigma-1 Receptor Activation.</title>
 <link>https://www.alzforum.org/papers/pridopidine-protects-als-patient-derived-neural-progenitor-cells-sigma-1-receptor-activation</link>
 <description>Int J Mol Sci. 2026 Apr 14;27(8)&lt;br&gt;Authors: Meltzer M, Zamir MS, Tzuri N, Tan AM, Geva M, Hayden MR, Lichtenstein RG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074133&quot;&gt;42074133&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pridopidine-protects-als-patient-derived-neural-progenitor-cells-sigma-1-receptor-activation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pridopidine-protects-als-patient-derived-neural-progenitor-cells-sigma-1-receptor-activation#comments</comments>
</item>
<item>
 <title>Evaluation of Low-Dose Radiation Treatment Effects Using Conductivity, Diffusivity, and Brain Tissue Volumes Treated in Patients with Mild Alzheimer&#039;s Disease: Exploratory Investigation.</title>
 <link>https://www.alzforum.org/papers/evaluation-low-dose-radiation-treatment-effects-using-conductivity-diffusivity-and-brain</link>
 <description>Diagnostics (Basel). 2026 Apr 14;16(8)&lt;br&gt;Authors: Chung WK, Kim HM, Lee MB, Kim K, Kwon OI, Yoo YJ, Rhee HY, Jahng GH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072789&quot;&gt;42072789&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluation-low-dose-radiation-treatment-effects-using-conductivity-diffusivity-and-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluation-low-dose-radiation-treatment-effects-using-conductivity-diffusivity-and-brain#comments</comments>
</item>
<item>
 <title>Genetic Associations of Parkinson&#039;s Disease Clinical, Pathological, and Data-Driven Subtypes.</title>
 <link>https://www.alzforum.org/papers/genetic-associations-parkinsons-disease-clinical-pathological-and-data-driven-subtypes</link>
 <description>Genes (Basel). 2026 Apr 13;17(4)&lt;br&gt;Authors: Negida A, Abouelmagd ME, Hamed BM, Hawas Y, Dziri A, Negida Y, Berman BD, Barrett MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074567&quot;&gt;42074567&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-associations-parkinsons-disease-clinical-pathological-and-data-driven-subtypes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-associations-parkinsons-disease-clinical-pathological-and-data-driven-subtypes#comments</comments>
</item>
<item>
 <title>LRRK2 I1371V Mutation Drives Astrocytic Glucose Metabolism Failure and Induces Integrated ER-Mitochondria-Lysosome Dysfunction in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/lrrk2-i1371v-mutation-drives-astrocytic-glucose-metabolism-failure-and-induces-integrated-er</link>
 <description>Int J Mol Sci. 2026 Apr 12;27(8)&lt;br&gt;Authors: Banerjee R, Santhoshkumar R, Holla V, Kamble N, Yadav R, Pal PK, Datta I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074107&quot;&gt;42074107&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lrrk2-i1371v-mutation-drives-astrocytic-glucose-metabolism-failure-and-induces-integrated-er#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lrrk2-i1371v-mutation-drives-astrocytic-glucose-metabolism-failure-and-induces-integrated-er#comments</comments>
</item>
<item>
 <title>Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived Talaromyces sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway.</title>
 <link>https://www.alzforum.org/papers/variecolactone-natural-pde4-inhibitor-marine-derived-talaromyces-sp-zsd-1-alleviates-amyloid</link>
 <description>Biomolecules. 2026 Apr 12;16(4)&lt;br&gt;Authors: Fu T, Shi Y, Yang Z, Zhou J, Huang L, Fu Y, Xiong W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072691&quot;&gt;42072691&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/variecolactone-natural-pde4-inhibitor-marine-derived-talaromyces-sp-zsd-1-alleviates-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/variecolactone-natural-pde4-inhibitor-marine-derived-talaromyces-sp-zsd-1-alleviates-amyloid#comments</comments>
</item>
<item>
 <title>Prion Diseases-When Proteins Turn Lethal: Creutzfeldt-Jakob Disease (CJD) and the Quest for Classification, Diagnosis, Therapeutic Approaches, and Emerging Research.</title>
 <link>https://www.alzforum.org/papers/prion-diseases-when-proteins-turn-lethal-creutzfeldt-jakob-disease-cjd-and-quest</link>
 <description>Molecules. 2026 Apr 11;31(8)&lt;br&gt;Authors: Ramesh TS, Bartusik-Aebisher D, Dynarowicz K, Aebisher D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075943&quot;&gt;42075943&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prion-diseases-when-proteins-turn-lethal-creutzfeldt-jakob-disease-cjd-and-quest#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prion-diseases-when-proteins-turn-lethal-creutzfeldt-jakob-disease-cjd-and-quest#comments</comments>
</item>
<item>
 <title>Metatranscriptomic Reanalysis of Alzheimer&#039;s Brains Identifies Low-Biomass Microbial Signals Including Enrichment of Acinetobacter radioresistens.</title>
 <link>https://www.alzforum.org/papers/metatranscriptomic-reanalysis-alzheimers-brains-identifies-low-biomass-microbial-signals</link>
 <description>Int J Mol Sci. 2026 Apr 11;27(8)&lt;br&gt;Authors: Guix FX&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074073&quot;&gt;42074073&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metatranscriptomic-reanalysis-alzheimers-brains-identifies-low-biomass-microbial-signals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metatranscriptomic-reanalysis-alzheimers-brains-identifies-low-biomass-microbial-signals#comments</comments>
</item>
<item>
 <title>Blood-Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/blood-brain-network-based-polygenic-risk-scores-reveal-biomarker-signatures-and-progression</link>
 <description>J Clin Med. 2026 Apr 10;15(8)&lt;br&gt;Authors: Goldstein D, Sahelijo N, Priyadarshi D, Panitch R, Nho K, Farrer LA, Stein TD, Jun GR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074686&quot;&gt;42074686&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-brain-network-based-polygenic-risk-scores-reveal-biomarker-signatures-and-progression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-brain-network-based-polygenic-risk-scores-reveal-biomarker-signatures-and-progression#comments</comments>
</item>
<item>
 <title>Molecular Modulation of the Crosstalk Between TDP-43 and SOD1.</title>
 <link>https://www.alzforum.org/papers/molecular-modulation-crosstalk-between-tdp-43-and-sod1</link>
 <description>Int J Mol Sci. 2026 Apr 10;27(8)&lt;br&gt;Authors: Ribeiro GD, Queiroz DD, Monteiro-Neto JR, Gerhardt E, de Souza GF, Albino PC, Paranhos LH, Outeiro TF, Eleutherio EC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074053&quot;&gt;42074053&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-modulation-crosstalk-between-tdp-43-and-sod1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-modulation-crosstalk-between-tdp-43-and-sod1#comments</comments>
</item>
<item>
 <title>Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model.</title>
 <link>https://www.alzforum.org/papers/transcriptomic-analysis-reveals-beneficial-effects-spermidine-als-mouse-model</link>
 <description>Biomolecules. 2026 Apr 10;16(4)&lt;br&gt;Authors: Fiorucci C, Rossi MN, Santo RD, Salvatori I, Scaricamazza S, Giuliani S, Carletta O, Filomena E, Laurenti D, Mattioli R, Mosca L, Valle C, Ferri A, D&amp;#039;Erchia AM, Cervelli M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072687&quot;&gt;42072687&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/transcriptomic-analysis-reveals-beneficial-effects-spermidine-als-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/transcriptomic-analysis-reveals-beneficial-effects-spermidine-als-mouse-model#comments</comments>
</item>
<item>
 <title>Condensate State as Determinant of Amyloid Pathology in Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/condensate-state-determinant-amyloid-pathology-neurodegeneration</link>
 <description>Biomolecules. 2026 Apr 10;16(4)&lt;br&gt;Authors: Lucas L, Ferreon JC, Ferreon AC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072681&quot;&gt;42072681&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/condensate-state-determinant-amyloid-pathology-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/condensate-state-determinant-amyloid-pathology-neurodegeneration#comments</comments>
</item>
<item>
 <title>CRISPR Applications in Alzheimer&#039;s Disease: From High-Throughput Genetic Screening to Precision Editing and CNS Delivery.</title>
 <link>https://www.alzforum.org/papers/crispr-applications-alzheimers-disease-high-throughput-genetic-screening-precision-editing</link>
 <description>Int J Mol Sci. 2026 Apr 9;27(8)&lt;br&gt;Authors: Li Y, Ma S, Fei T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074014&quot;&gt;42074014&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/crispr-applications-alzheimers-disease-high-throughput-genetic-screening-precision-editing#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/crispr-applications-alzheimers-disease-high-throughput-genetic-screening-precision-editing#comments</comments>
</item>
<item>
 <title>Insights into the Impact of Low-Dose Ionizing Radiation on Neurodegenerative Disease Progression in In Vivo Models.</title>
 <link>https://www.alzforum.org/papers/insights-impact-low-dose-ionizing-radiation-neurodegenerative-disease-progression-vivo-models</link>
 <description>Int J Mol Sci. 2026 Apr 9;27(8)&lt;br&gt;Authors: Goloborshcheva VV, Kostikova YS, Kucheryanu VG, Morozov SG, Kokhan VS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074010&quot;&gt;42074010&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/insights-impact-low-dose-ionizing-radiation-neurodegenerative-disease-progression-vivo-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/insights-impact-low-dose-ionizing-radiation-neurodegenerative-disease-progression-vivo-models#comments</comments>
</item>
<item>
 <title>Microbiota-Gut-Brain Axis in Alzheimer&#039;s Disease: Linking Oxidative Stress, Mitochondrial Dysfunction and Amyloid Pathology-A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/microbiota-gut-brain-axis-alzheimers-disease-linking-oxidative-stress-mitochondrial</link>
 <description>Biomedicines. 2026 Apr 9;14(4)&lt;br&gt;Authors: Shajahan SR, Hamid N, Okunsai B, Shari N, Ramli MD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072403&quot;&gt;42072403&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microbiota-gut-brain-axis-alzheimers-disease-linking-oxidative-stress-mitochondrial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microbiota-gut-brain-axis-alzheimers-disease-linking-oxidative-stress-mitochondrial#comments</comments>
</item>
<item>
 <title>The T Allele of the HNMT C314T Polymorphism Is Associated with a Reduced Risk of Idiopathic Parkinson&#039;s Disease in Mexican Patients.</title>
 <link>https://www.alzforum.org/papers/t-allele-hnmt-c314t-polymorphism-associated-reduced-risk-idiopathic-parkinsons-disease</link>
 <description>Biomedicines. 2026 Apr 9;14(4)&lt;br&gt;Authors: Bueno-Nava A, Díaz-Hernández DK, Paniagua-Pérez R, Carrillo-Mora P, Martínez-Cortez JA, Hernández-Arenas C, León-Hernández SR, Olmos-Hernández A, Verduzco-Mendoza A, Avila-Luna A, Gálvez-Rosas A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072401&quot;&gt;42072401&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/t-allele-hnmt-c314t-polymorphism-associated-reduced-risk-idiopathic-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/t-allele-hnmt-c314t-polymorphism-associated-reduced-risk-idiopathic-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Impact of Oxidative Stress-Driven Ferroptosis in Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/impact-oxidative-stress-driven-ferroptosis-neurodegeneration</link>
 <description>Int J Mol Sci. 2026 Apr 8;27(8)&lt;br&gt;Authors: Rafique A, Junaid A, Bakovic M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073997&quot;&gt;42073997&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-oxidative-stress-driven-ferroptosis-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-oxidative-stress-driven-ferroptosis-neurodegeneration#comments</comments>
</item>
<item>
 <title>Effects of UMP, Choline, and Fish Oil on Synaptic Integrity and Motor Coordination in an Alzheimer&#039;s Disease Mouse Model.</title>
 <link>https://www.alzforum.org/papers/effects-ump-choline-and-fish-oil-synaptic-integrity-and-motor-coordination-alzheimers-disease</link>
 <description>Int J Mol Sci. 2026 Apr 8;27(8)&lt;br&gt;Authors: Keskinoz EN, Footohi G, Celik M, Acar D, Ozgun G, Elmas MA, Yavuz İ, Ada E, Sari E, Ay B, Unal MC, Ulus İH, Arbak S, Suyen G, Oz-Arslan D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073986&quot;&gt;42073986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-ump-choline-and-fish-oil-synaptic-integrity-and-motor-coordination-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-ump-choline-and-fish-oil-synaptic-integrity-and-motor-coordination-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Correction: Quansah et al. The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer&#039;s Disease: A Systematic Review. Healthcare 2025, 13, 74.</title>
 <link>https://www.alzforum.org/papers/correction-quansah-et-al-beneficial-effects-lactobacillus-strains-gut-microbiome-alzheimers</link>
 <description>Healthcare (Basel). 2026 Apr 8;14(8)&lt;br&gt;Authors: Quansah M, David MA, Martins R, El-Omar E, Aliberti SM, Capunzo M, Jensen SO, Tayebi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073016&quot;&gt;42073016&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-quansah-et-al-beneficial-effects-lactobacillus-strains-gut-microbiome-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-quansah-et-al-beneficial-effects-lactobacillus-strains-gut-microbiome-alzheimers#comments</comments>
</item>
<item>
 <title>IL-10-STAT3-Dependent Transcriptional Regulation in Microglia: Alzheimer&#039;s Disease and Neuroinflammation.</title>
 <link>https://www.alzforum.org/papers/il-10-stat3-dependent-transcriptional-regulation-microglia-alzheimers-disease-and</link>
 <description>Biomedicines. 2026 Apr 5;14(4)&lt;br&gt;Authors: Kim ME, Lee JS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072370&quot;&gt;42072370&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/il-10-stat3-dependent-transcriptional-regulation-microglia-alzheimers-disease-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/il-10-stat3-dependent-transcriptional-regulation-microglia-alzheimers-disease-and#comments</comments>
</item>
<item>
 <title>Beneficial Effects of Olive Oil and the Mediterranean Diet on Alzheimer&#039;s Disease and Vascular Dementia: A Review.</title>
 <link>https://www.alzforum.org/papers/beneficial-effects-olive-oil-and-mediterranean-diet-alzheimers-disease-and-vascular-dementia</link>
 <description>Medicina (Kaunas). 2026 Apr 4;62(4)&lt;br&gt;Authors: González-Cidad A, García-Moncó JC, Román GC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075568&quot;&gt;42075568&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beneficial-effects-olive-oil-and-mediterranean-diet-alzheimers-disease-and-vascular-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beneficial-effects-olive-oil-and-mediterranean-diet-alzheimers-disease-and-vascular-dementia#comments</comments>
</item>
<item>
 <title>Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment.</title>
 <link>https://www.alzforum.org/papers/drug-induced-amyloid-related-imaging-abnormalities-neurovascular-perspective-risk-assessment</link>
 <description>Pharmaceuticals (Basel). 2026 Apr 3;19(4)&lt;br&gt;Authors: Zedde M, Losa M, Donniaquio A, Gandoglia I, Sette MD, Roccatagliata L, Piazza F, Pardini M, Pascarella R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075835&quot;&gt;42075835&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/drug-induced-amyloid-related-imaging-abnormalities-neurovascular-perspective-risk-assessment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/drug-induced-amyloid-related-imaging-abnormalities-neurovascular-perspective-risk-assessment#comments</comments>
</item>
<item>
 <title>Biomarkers in the Early Detection of Dementia: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/biomarkers-early-detection-dementia-systematic-review</link>
 <description>Cureus. 2026 Apr;18(4):e106323.  Epub 2026 Apr 2&lt;br&gt;Authors: Putnam E, Katsoulos S, Ownby RL, Kesselman MM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078262&quot;&gt;42078262&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biomarkers-early-detection-dementia-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biomarkers-early-detection-dementia-systematic-review#comments</comments>
</item>
<item>
 <title>Gene Targeted Therapies for Neurodegenerative Disorders: Strategies and Implications in ALS and SMA.</title>
 <link>https://www.alzforum.org/papers/gene-targeted-therapies-neurodegenerative-disorders-strategies-and-implications-als-and-sma</link>
 <description>Genes (Basel). 2026 Apr 1;17(4)&lt;br&gt;Authors: Yesbek Kaymaz A, Bora-Akoğlu G, Erdem Yurter H, Grunseich C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074537&quot;&gt;42074537&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gene-targeted-therapies-neurodegenerative-disorders-strategies-and-implications-als-and-sma#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gene-targeted-therapies-neurodegenerative-disorders-strategies-and-implications-als-and-sma#comments</comments>
</item>
<item>
 <title>In Silico Analyses Suggest That Exercise-Induced Irisin-Mediated Neuroprotection Supports Non-Pharmacological Preventive Strategies for Alzheimer&#039;s Disease in Public Health.</title>
 <link>https://www.alzforum.org/papers/silico-analyses-suggest-exercise-induced-irisin-mediated-neuroprotection-supports-non</link>
 <description>Int J Environ Res Public Health. 2026 Apr 1;23(4)&lt;br&gt;Authors: Manias M, Vieira JV, Cremonesi AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42074388&quot;&gt;42074388&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/silico-analyses-suggest-exercise-induced-irisin-mediated-neuroprotection-supports-non#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/silico-analyses-suggest-exercise-induced-irisin-mediated-neuroprotection-supports-non#comments</comments>
</item>
<item>
 <title>Integrating Weighted Gene Co-Expression Network and Differential Expression Analyses to Unveil the Role of RNA m6A Methylation Regulators in Idiopathic Parkinson&#039;s Disease in Latin America.</title>
 <link>https://www.alzforum.org/papers/integrating-weighted-gene-co-expression-network-and-differential-expression-analyses-unveil</link>
 <description>Life (Basel). 2026 Apr 1;16(4)&lt;br&gt;Authors: Leiva F, Constandil L, Chana-Cuevas P, Vidal RL, Morales B, Vidal R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073402&quot;&gt;42073402&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-weighted-gene-co-expression-network-and-differential-expression-analyses-unveil#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-weighted-gene-co-expression-network-and-differential-expression-analyses-unveil#comments</comments>
</item>
<item>
 <title>Mapping the Polar Neuro-Interactome of Garcinia mangostana Against the AD-PD-ALS Nexus.</title>
 <link>https://www.alzforum.org/papers/mapping-polar-neuro-interactome-garcinia-mangostana-against-ad-pd-als-nexus</link>
 <description>Life (Basel). 2026 Apr 1;16(4)&lt;br&gt;Authors: Hossain R, Surinkaew S, Sompol P, Bastaki NK, Jafrin R, Sekeroglu N, Tangpong J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42073390&quot;&gt;42073390&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-polar-neuro-interactome-garcinia-mangostana-against-ad-pd-als-nexus#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-polar-neuro-interactome-garcinia-mangostana-against-ad-pd-als-nexus#comments</comments>
</item>
<item>
 <title>Effects of Sarcopenia and Frailty on Cognitive Function, Brain Volume, and Dementia Risk: A Prospective Cohort Study Based on UK Biobank.</title>
 <link>https://www.alzforum.org/papers/effects-sarcopenia-and-frailty-cognitive-function-brain-volume-and-dementia-risk-prospective</link>
 <description>Dement Neurocogn Disord. 2026 Apr;25(2):115-129.  Epub 2026 Apr 15&lt;br&gt;Authors: Heo SJ, Chun MY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088088&quot;&gt;42088088&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-sarcopenia-and-frailty-cognitive-function-brain-volume-and-dementia-risk-prospective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-sarcopenia-and-frailty-cognitive-function-brain-volume-and-dementia-risk-prospective#comments</comments>
</item>
<item>
 <title>Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea.</title>
 <link>https://www.alzforum.org/papers/demographic-social-and-clinical-profiles-patients-initiating-lecanemab-clinical-practice</link>
 <description>Dement Neurocogn Disord. 2026 Apr;25(2):134-136.  Epub 2026 Apr 15&lt;br&gt;Authors: Lee J, Kim H, Park HK, Kim S, Lee KB, Kang H, Shin D, Kim JP, Lee BH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088087&quot;&gt;42088087&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/demographic-social-and-clinical-profiles-patients-initiating-lecanemab-clinical-practice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/demographic-social-and-clinical-profiles-patients-initiating-lecanemab-clinical-practice#comments</comments>
</item>
<item>
 <title>Stage-Specific Efficacy of Lecanemab and Donanemab in Early Alzheimer&#039;s Disease: An Indirect, Comparative Interpretation of Phase 3 Trials.</title>
 <link>https://www.alzforum.org/papers/stage-specific-efficacy-lecanemab-and-donanemab-early-alzheimers-disease-indirect-comparative</link>
 <description>Dement Neurocogn Disord. 2026 Apr;25(2):130-133.  Epub 2026 Mar 25&lt;br&gt;Authors: Shim Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088086&quot;&gt;42088086&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stage-specific-efficacy-lecanemab-and-donanemab-early-alzheimers-disease-indirect-comparative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stage-specific-efficacy-lecanemab-and-donanemab-early-alzheimers-disease-indirect-comparative#comments</comments>
</item>
<item>
 <title>Baseline Clinical and Neuropsychological Characteristics of Amyloid PET-Confirmed Alzheimer&#039;s Disease Treated With Lecanemab: Early Experience at a Tertiary Hospital in Korea.</title>
 <link>https://www.alzforum.org/papers/baseline-clinical-and-neuropsychological-characteristics-amyloid-pet-confirmed-alzheimers</link>
 <description>Dement Neurocogn Disord. 2026 Apr;25(2):137-139.  Epub 2026 Apr 20&lt;br&gt;Authors: Kim H, Lee J, Park HK, Lee KB, Kim JP, Lee BH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088084&quot;&gt;42088084&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/baseline-clinical-and-neuropsychological-characteristics-amyloid-pet-confirmed-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/baseline-clinical-and-neuropsychological-characteristics-amyloid-pet-confirmed-alzheimers#comments</comments>
</item>
<item>
 <title>AI-Based Dementia Prediction From Low-Dose Brain CT in Mild Cognitive Impairments.</title>
 <link>https://www.alzforum.org/papers/ai-based-dementia-prediction-low-dose-brain-ct-mild-cognitive-impairments</link>
 <description>Dement Neurocogn Disord. 2026 Apr;25(2):91-102.  Epub 2026 Apr 16&lt;br&gt;Authors: Park S, Ahn J, Na DL, Kwak K, Kim JP, K-ROAD study&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088083&quot;&gt;42088083&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-based-dementia-prediction-low-dose-brain-ct-mild-cognitive-impairments#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-based-dementia-prediction-low-dose-brain-ct-mild-cognitive-impairments#comments</comments>
</item>
<item>
 <title>Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/plasma-autoantibodies-against-neurodegeneration-related-antigens-dementia-and-elevated-chi3li</link>
 <description>Biomolecules. 2026 Mar 31;16(4)&lt;br&gt;Authors: Kocurova G, Svabenska Z, Klaschka J, Bartos A, Ricny J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072639&quot;&gt;42072639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-autoantibodies-against-neurodegeneration-related-antigens-dementia-and-elevated-chi3li#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-autoantibodies-against-neurodegeneration-related-antigens-dementia-and-elevated-chi3li#comments</comments>
</item>
<item>
 <title>Intranasal Formaldehyde Exposure Induces RAGE-Mediated Alteration of the ADAM10/BACE1 Expression Balance and Amyloid Deposition.</title>
 <link>https://www.alzforum.org/papers/intranasal-formaldehyde-exposure-induces-rage-mediated-alteration-adam10bace1-expression</link>
 <description>Biomedicines. 2026 Mar 30;14(4)&lt;br&gt;Authors: Mikhailov IG, Mikhailova MS, Baklashov AD, Ponamareva PS, Shumilova SN, Shuvaev AN, Belozor OS, Shuvaev AN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072320&quot;&gt;42072320&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intranasal-formaldehyde-exposure-induces-rage-mediated-alteration-adam10bace1-expression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intranasal-formaldehyde-exposure-induces-rage-mediated-alteration-adam10bace1-expression#comments</comments>
</item>
<item>
 <title>Isoflurane Preconditioning Enhances Neuronal Tolerance to Amyloid-β Toxicity in HT-22 Cells via Mild Oxidative Signaling and Akt-Nrf2 Activation.</title>
 <link>https://www.alzforum.org/papers/isoflurane-preconditioning-enhances-neuronal-tolerance-amyloid-v-toxicity-ht-22-cells-mild</link>
 <description>Antioxidants (Basel). 2026 Mar 30;15(4)&lt;br&gt;Authors: Chen SH, Tsou SH, Weng SH, Huang SH, Chen WJ, Huang CN, Chang CC, Lin CL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072074&quot;&gt;42072074&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/isoflurane-preconditioning-enhances-neuronal-tolerance-amyloid-v-toxicity-ht-22-cells-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/isoflurane-preconditioning-enhances-neuronal-tolerance-amyloid-v-toxicity-ht-22-cells-mild#comments</comments>
</item>
<item>
 <title>Olive Components (Biophenols or Polyphenols) in Neurodegenerative Disease Models and Clinical Studies: A Systematic Review of Evidence and Translational Barriers.</title>
 <link>https://www.alzforum.org/papers/olive-components-biophenols-or-polyphenols-neurodegenerative-disease-models-and-clinical</link>
 <description>Biomedicines. 2026 Mar 26;14(4)&lt;br&gt;Authors: Omar SH, Ghani MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072302&quot;&gt;42072302&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/olive-components-biophenols-or-polyphenols-neurodegenerative-disease-models-and-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/olive-components-biophenols-or-polyphenols-neurodegenerative-disease-models-and-clinical#comments</comments>
</item>
<item>
 <title>Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities.</title>
 <link>https://www.alzforum.org/papers/cellular-senescence-neurodegeneration-cell-types-therapeutic-opportunities</link>
 <description>Biomedicines. 2026 Mar 26;14(4)&lt;br&gt;Authors: Zawadzka M, Rydzek J, Lizon J, Krupa Z, Wrona J, Woźniak S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42072300&quot;&gt;42072300&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-senescence-neurodegeneration-cell-types-therapeutic-opportunities#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-senescence-neurodegeneration-cell-types-therapeutic-opportunities#comments</comments>
</item>
<item>
 <title>Quantitative and Qualitative MRI Assessment of Perivascular Spaces in Parkinson&#039;s Disease Patients.</title>
 <link>https://www.alzforum.org/papers/quantitative-and-qualitative-mri-assessment-perivascular-spaces-parkinsons-disease-patients</link>
 <description>Medicina (Kaunas). 2026 Mar 24;62(4)&lt;br&gt;Authors: Stagisa E, Silovs A, Skuburs GK, Zdanovskis N, Sevcenko A, Mednieks J, Naudins E, Bartusevica S, Umbrasko S, Zarina L, Zelge L, Pastare AA, Smilga J, Skilters J, Pinna B, Platkajis A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42075485&quot;&gt;42075485&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quantitative-and-qualitative-mri-assessment-perivascular-spaces-parkinsons-disease-patients#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quantitative-and-qualitative-mri-assessment-perivascular-spaces-parkinsons-disease-patients#comments</comments>
</item>
<item>
 <title>WZB117-Induced Glucose Hypometabolism Triggers Mitochondrial Dysfunction and Amyloidogenic Processing in an In Vitro Primary Forebrain Neuron Model.</title>
 <link>https://www.alzforum.org/papers/wzb117-induced-glucose-hypometabolism-triggers-mitochondrial-dysfunction-and-amyloidogenic</link>
 <description>Cureus. 2026 Mar;18(3):e106239.  Epub 2026 Mar 31&lt;br&gt;Authors: Saiyad SS, Rajput JP, Horo SM, Kumari K, Chatterjee Biswas P, Ekambaram G, Chouhan A, Ranga S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42077725&quot;&gt;42077725&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/wzb117-induced-glucose-hypometabolism-triggers-mitochondrial-dysfunction-and-amyloidogenic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/wzb117-induced-glucose-hypometabolism-triggers-mitochondrial-dysfunction-and-amyloidogenic#comments</comments>
</item>
<item>
 <title>Identifying Alzheimer&#039;s Disease Progression Subphenotypes Via a Graph-based Framework Using Electronic Health Records.</title>
 <link>https://www.alzforum.org/papers/identifying-alzheimers-disease-progression-subphenotypes-graph-based-framework-using-0</link>
 <description>J Healthc Inform Res. 2026 Feb 11;10(2):317-39.  Epub 2026 Feb 11&lt;br&gt;Authors: Huang Y, Xu J, Fan Z, Hu Y, He X, Chen A, Liu Y, Yin R, Guo J, DeKosky ST, Jaffee M, Zhou M, Su C, Wang F, Guo Y, Bian J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063485&quot;&gt;42063485&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identifying-alzheimers-disease-progression-subphenotypes-graph-based-framework-using-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identifying-alzheimers-disease-progression-subphenotypes-graph-based-framework-using-0#comments</comments>
</item>
<item>
 <title>The impact of antidiabetic drugs on dementia risk: a Bayesian network meta-analysis.</title>
 <link>https://www.alzforum.org/papers/impact-antidiabetic-drugs-dementia-risk-bayesian-network-meta-analysis</link>
 <description>Front Endocrinol (Lausanne). 2026;17:1780676.  Epub 2026 Apr 15&lt;br&gt;Authors: Yu Y, Peng X, Su C, Bai Y, Hou D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42064764&quot;&gt;42064764&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-antidiabetic-drugs-dementia-risk-bayesian-network-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-antidiabetic-drugs-dementia-risk-bayesian-network-meta-analysis#comments</comments>
</item>
<item>
 <title>The complement system in Alzheimer&#039;s disease: mechanisms, biomarkers, and therapeutic implications.</title>
 <link>https://www.alzforum.org/papers/complement-system-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-implications</link>
 <description>Front Immunol. 2026;17:1798288.  Epub 2026 Apr 15&lt;br&gt;Authors: Liu G, Deng B, Han X, Zhao Y, Zeng S, Yu S, Wang L, Wang S, Wu Y, Cai L, Wu Y, Yang H, Chen J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42064068&quot;&gt;42064068&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/complement-system-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-implications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/complement-system-alzheimers-disease-mechanisms-biomarkers-and-therapeutic-implications#comments</comments>
</item>
<item>
 <title>Oleic acid improves pathological changes in Aβ1-42-induced astrocytes and Alzheimer&#039;s disease mouse models through PKA/ACACB/CPT1A.</title>
 <link>https://www.alzforum.org/papers/oleic-acid-improves-pathological-changes-av1-42-induced-astrocytes-and-alzheimers-disease</link>
 <description>Front Neurosci. 2026;20:1771310.  Epub 2026 Apr 15&lt;br&gt;Authors: Xie Y, Tian J, Li H, Peng Y, Li M, Wu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063966&quot;&gt;42063966&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oleic-acid-improves-pathological-changes-av1-42-induced-astrocytes-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oleic-acid-improves-pathological-changes-av1-42-induced-astrocytes-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Mediterranean, MIND, and ketogenic diets in Alzheimer&#039;s disease: mechanistic coherence and clinical uncertainty.</title>
 <link>https://www.alzforum.org/papers/mediterranean-mind-and-ketogenic-diets-alzheimers-disease-mechanistic-coherence-and-clinical</link>
 <description>Front Nutr. 2026;13:1819499.  Epub 2026 Apr 15&lt;br&gt;Authors: Christimann GM, Sattler JA, Fabi JP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063949&quot;&gt;42063949&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mediterranean-mind-and-ketogenic-diets-alzheimers-disease-mechanistic-coherence-and-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mediterranean-mind-and-ketogenic-diets-alzheimers-disease-mechanistic-coherence-and-clinical#comments</comments>
</item>
<item>
 <title>High-efficacy serum biomarkers PCSK9 and LCAT predict cognitive impairment in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/high-efficacy-serum-biomarkers-pcsk9-and-lcat-predict-cognitive-impairment-parkinsons-disease</link>
 <description>Front Psychol. 2026;17:1789929.  Epub 2026 Apr 15&lt;br&gt;Authors: Su M, Yang T, Fan X, Qiang X, Liao Z, Gu H, Gao L, Chen R, Tang C, Mu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063887&quot;&gt;42063887&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-efficacy-serum-biomarkers-pcsk9-and-lcat-predict-cognitive-impairment-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-efficacy-serum-biomarkers-pcsk9-and-lcat-predict-cognitive-impairment-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts.</title>
 <link>https://www.alzforum.org/papers/amyloid-beta-pathology-induces-astrocytic-ptdp-43-mislocalization-and-disrupts-tdp-43</link>
 <description>Front Aging Neurosci. 2026;18:1766448.  Epub 2026 Apr 15&lt;br&gt;Authors: Rafiee Z, Santiago J, Andersson E, Hansson O, Wennström M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063624&quot;&gt;42063624&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-beta-pathology-induces-astrocytic-ptdp-43-mislocalization-and-disrupts-tdp-43#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-beta-pathology-induces-astrocytic-ptdp-43-mislocalization-and-disrupts-tdp-43#comments</comments>
</item>
<item>
 <title>Exercise-based modulation of the gut-brain axis: a new direction for neurorehabilitation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/exercise-based-modulation-gut-brain-axis-new-direction-neurorehabilitation-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1765016.  Epub 2026 Apr 15&lt;br&gt;Authors: Yu Z, Yao R, Li Y, Li H, Shen F, Wang Y, Wang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063622&quot;&gt;42063622&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exercise-based-modulation-gut-brain-axis-new-direction-neurorehabilitation-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exercise-based-modulation-gut-brain-axis-new-direction-neurorehabilitation-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Reducing annotation burden in medical imaging with ADGNET: A semi-supervised deep learning strategy.</title>
 <link>https://www.alzforum.org/papers/reducing-annotation-burden-medical-imaging-adgnet-semi-supervised-deep-learning-strategy</link>
 <description>PLoS One. 2026;21(5):e0348596.  Epub 2026 May 4&lt;br&gt;Authors: Yang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42081490&quot;&gt;42081490&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reducing-annotation-burden-medical-imaging-adgnet-semi-supervised-deep-learning-strategy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reducing-annotation-burden-medical-imaging-adgnet-semi-supervised-deep-learning-strategy#comments</comments>
</item>
<item>
 <title>Impact of Lewy body and limbic-predominant TDP-43 neuropathology on cognitive and neuropsychiatric trajectory in Alzheimer&#039;s disease: a retrospective neuropathological study.</title>
 <link>https://www.alzforum.org/papers/impact-lewy-body-and-limbic-predominant-tdp-43-neuropathology-cognitive-and-neuropsychiatric</link>
 <description>Front Aging Neurosci. 2026;18:1724274.  Epub 2026 Apr 17&lt;br&gt;Authors: Koo J, Lee H, Choi Y, Baik K, Park M, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080118&quot;&gt;42080118&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-lewy-body-and-limbic-predominant-tdp-43-neuropathology-cognitive-and-neuropsychiatric#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-lewy-body-and-limbic-predominant-tdp-43-neuropathology-cognitive-and-neuropsychiatric#comments</comments>
</item>
<item>
 <title>New integrated three-interface conceptual model for clearance and immune surveillance in the human CNS.</title>
 <link>https://www.alzforum.org/papers/new-integrated-three-interface-conceptual-model-clearance-and-immune-surveillance-human-cns</link>
 <description>Front Cell Dev Biol. 2026;14:1785072.  Epub 2026 Apr 16&lt;br&gt;Authors: García-Cosamalón J, Marchena M, Villar-Suárez V, Ley L, de Castro F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42080090&quot;&gt;42080090&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/new-integrated-three-interface-conceptual-model-clearance-and-immune-surveillance-human-cns#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/new-integrated-three-interface-conceptual-model-clearance-and-immune-surveillance-human-cns#comments</comments>
</item>
<item>
 <title>Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/blood-dna-methylation-signature-cognitive-reserve-moderates-association-between-csf-tau</link>
 <description>Alzheimers Dement (N Y). 2026;12:e70257.  Epub 2026 May 1&lt;br&gt;Authors: Lukacsovich D, Young JI, Gomez L, Kunkle BW, Mao Z, Zhang W, Chen XS, O&amp;#039;Shea DM, Rundek T, Martin ER, Wang L, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079999&quot;&gt;42079999&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-dna-methylation-signature-cognitive-reserve-moderates-association-between-csf-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-dna-methylation-signature-cognitive-reserve-moderates-association-between-csf-tau#comments</comments>
</item>
<item>
 <title>Impaired event-related theta spectral coherence in emotional facial expression processing in neurodegenerative disorders.</title>
 <link>https://www.alzforum.org/papers/impaired-event-related-theta-spectral-coherence-emotional-facial-expression-processing</link>
 <description>Front Hum Neurosci. 2026;20:1708832.  Epub 2026 Apr 16&lt;br&gt;Authors: Uzunlar H, Duygun R, Kıyı-Atilla İ, Aktürk T, Yıldırım E, Helvacı Yılmaz N, Hanoğlu L, Sequeira H, Papo D, Zanin M, Babiloni C, Yener G, Güntekin B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079986&quot;&gt;42079986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impaired-event-related-theta-spectral-coherence-emotional-facial-expression-processing#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impaired-event-related-theta-spectral-coherence-emotional-facial-expression-processing#comments</comments>
</item>
<item>
 <title>Impaired pathways of detoxification and risk of Alzheimer&#039;s disease: Differential gene expression studies via gene set expression analysis.</title>
 <link>https://www.alzforum.org/papers/impaired-pathways-detoxification-and-risk-alzheimers-disease-differential-gene-expression</link>
 <description>J Alzheimers Dis Rep. 2026;10:25424823261419382.  Epub 2026 Jan 27&lt;br&gt;Authors: McCaulley ME&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079451&quot;&gt;42079451&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impaired-pathways-detoxification-and-risk-alzheimers-disease-differential-gene-expression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impaired-pathways-detoxification-and-risk-alzheimers-disease-differential-gene-expression#comments</comments>
</item>
<item>
 <title>The association between major depressive disorder, plasma biomarkers of Alzheimer&#039;s disease, and mild behavioral impairment among older adults.</title>
 <link>https://www.alzforum.org/papers/association-between-major-depressive-disorder-plasma-biomarkers-alzheimers-disease-and-mild</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70337.  Epub 2026 Apr 29&lt;br&gt;Authors: Zhu Y, Trani JF, Singh RK, Bekena S, Williams J, Lenze EJ, Babulal GM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079383&quot;&gt;42079383&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-major-depressive-disorder-plasma-biomarkers-alzheimers-disease-and-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-major-depressive-disorder-plasma-biomarkers-alzheimers-disease-and-mild#comments</comments>
</item>
<item>
 <title>Correction to &quot;Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer&#039;s disease&quot;.</title>
 <link>https://www.alzforum.org/papers/correction-associations-plasma-phosphorylated-tau217-cognitive-impairment-and-brain</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70359.  Epub 2026 Apr 29&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079382&quot;&gt;42079382&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-associations-plasma-phosphorylated-tau217-cognitive-impairment-and-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-associations-plasma-phosphorylated-tau217-cognitive-impairment-and-brain#comments</comments>
</item>
<item>
 <title>The Subjective Memory Complaints Questionnaire: a systematic review of psychometric properties, clinical applications, and neurobiological correlates.</title>
 <link>https://www.alzforum.org/papers/subjective-memory-complaints-questionnaire-systematic-review-psychometric-properties-clinical</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70339.  Epub 2026 Apr 30&lt;br&gt;Authors: Han JW, Choi YJ, Kim KW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42079381&quot;&gt;42079381&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subjective-memory-complaints-questionnaire-systematic-review-psychometric-properties-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subjective-memory-complaints-questionnaire-systematic-review-psychometric-properties-clinical#comments</comments>
</item>
<item>
 <title>Serum GDF-15 Levels Correlate With Motor and Nonmotor Symptom Domains and Overall Disease Severity in Patients With Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/serum-gdf-15-levels-correlate-motor-and-nonmotor-symptom-domains-and-overall-disease-severity</link>
 <description>Parkinsons Dis. 2026;2026:9949931.  Epub 2026 Apr 29&lt;br&gt;Authors: Miyaue N, Yabe H, Yasugi M, Nagai M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078944&quot;&gt;42078944&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/serum-gdf-15-levels-correlate-motor-and-nonmotor-symptom-domains-and-overall-disease-severity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/serum-gdf-15-levels-correlate-motor-and-nonmotor-symptom-domains-and-overall-disease-severity#comments</comments>
</item>
<item>
 <title>Dexmedetomidine attenuates Alzheimer&#039;s pathogenesis by targeting the ROS-mediated XIAP-MDM2-p53 signaling axis.</title>
 <link>https://www.alzforum.org/papers/dexmedetomidine-attenuates-alzheimers-pathogenesis-targeting-ros-mediated-xiap-mdm2-p53</link>
 <description>Front Pharmacol. 2026;17:1811373.  Epub 2026 Apr 17&lt;br&gt;Authors: Wu W, Wang H, Zhang L, Li D, Chen Y, Lin B, Jiang H, Meng T, Zhu Z, He L, Zhang H, Liu H, Zhang R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078936&quot;&gt;42078936&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dexmedetomidine-attenuates-alzheimers-pathogenesis-targeting-ros-mediated-xiap-mdm2-p53#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dexmedetomidine-attenuates-alzheimers-pathogenesis-targeting-ros-mediated-xiap-mdm2-p53#comments</comments>
</item>
<item>
 <title>Neuroprotective effect of standardized Vitex pubescens Vahl bark extract and its n-butanol fraction against scopolamine-induced cognitive impairment in Sprague-Dawley rats in relationship to its isolated phytochemicals.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-effect-standardized-vitex-pubescens-vahl-bark-extract-and-its-n-butanol</link>
 <description>Front Pharmacol. 2026;17:1775571.  Epub 2026 Apr 17&lt;br&gt;Authors: Abdelbaset S, Ayoub IM, Tawfiq RA, Majrashi TA, El Hassab MA, Eldehna W, El-Kersh DM, Eldahshan OA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078934&quot;&gt;42078934&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-effect-standardized-vitex-pubescens-vahl-bark-extract-and-its-n-butanol#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-effect-standardized-vitex-pubescens-vahl-bark-extract-and-its-n-butanol#comments</comments>
</item>
<item>
 <title>Mass spectrometry imaging-based explainable machine learning reveals the biochemical landscapes of the mouse brain.</title>
 <link>https://www.alzforum.org/papers/mass-spectrometry-imaging-based-explainable-machine-learning-reveals-biochemical-landscapes</link>
 <description>Free Neuropathol. 2026;7:9.  Epub 2026 Apr 28&lt;br&gt;Authors: Gildenblat J, Stamnas J, Pahnke J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078793&quot;&gt;42078793&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mass-spectrometry-imaging-based-explainable-machine-learning-reveals-biochemical-landscapes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mass-spectrometry-imaging-based-explainable-machine-learning-reveals-biochemical-landscapes#comments</comments>
</item>
<item>
 <title>Common pathogenic mechanisms in the hippocampus across neurodegenerative dementias: Alzheimer&#039;s disease, Down syndrome, and Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/common-pathogenic-mechanisms-hippocampus-across-neurodegenerative-dementias-alzheimers</link>
 <description>NPJ Dement. 2026;2(1):32.  Epub 2026 Apr 29&lt;br&gt;Authors: Crans RA, Fructuoso M, Bascón-Cardozo K, Recaioglu H, Sotelo-Fonseca J, Vermeiren Y, Strydom A, Van Dam D, De Deyn PP, Rodríguez-Martín B, Potier MC, Dierssen M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078116&quot;&gt;42078116&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/common-pathogenic-mechanisms-hippocampus-across-neurodegenerative-dementias-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/common-pathogenic-mechanisms-hippocampus-across-neurodegenerative-dementias-alzheimers#comments</comments>
</item>
<item>
 <title>&quot;Micro-managing&quot; immune activation and protein turnover: microglial lysosomes in the context of health and disease.</title>
 <link>https://www.alzforum.org/papers/micro-managing-immune-activation-and-protein-turnover-microglial-lysosomes-context-health-and</link>
 <description>NPJ Dement. 2026;2(1):35.  Epub 2026 Apr 29&lt;br&gt;Authors: Somodji EA, Gowrishankar S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42078115&quot;&gt;42078115&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/micro-managing-immune-activation-and-protein-turnover-microglial-lysosomes-context-health-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/micro-managing-immune-activation-and-protein-turnover-microglial-lysosomes-context-health-and#comments</comments>
</item>
<item>
 <title>The Gut-Brain Axis in Alzheimer&#039;s: From Microbiota Genetics to Stigmasterol&#039;s Neuroprotection Mechanism.</title>
 <link>https://www.alzforum.org/papers/gut-brain-axis-alzheimers-microbiota-genetics-stigmasterols-neuroprotection-mechanism</link>
 <description>Degener Neurol Neuromuscul Dis. 2026;16:580890.  Epub 2026 Apr 27&lt;br&gt;Authors: Ding T, Chen J, Xiang Y, Zhou X, Zheng H, Bai Y, Wang W, Fu Q, Chen Y, Fu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42077232&quot;&gt;42077232&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-brain-axis-alzheimers-microbiota-genetics-stigmasterols-neuroprotection-mechanism#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-brain-axis-alzheimers-microbiota-genetics-stigmasterols-neuroprotection-mechanism#comments</comments>
</item>
<item>
 <title>Reduced Expression of Immune Response Genes in Neural Cells with Mutations in the PARK2 Gene in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/reduced-expression-immune-response-genes-neural-cells-mutations-park2-gene-parkinsons-disease</link>
 <description>Acta Naturae. 2026;18(1):104-113. &lt;br&gt;Authors: Fedoseyeva VB, Novosadova EV, Nenasheva VV, Novosadova LV, Grivennikov IA, Tarantul VZ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083593&quot;&gt;42083593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-expression-immune-response-genes-neural-cells-mutations-park2-gene-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-expression-immune-response-genes-neural-cells-mutations-park2-gene-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Rodents&#039; episodic-like memory: concepts, ageing, neurodegeneration, future.</title>
 <link>https://www.alzforum.org/papers/rodents-episodic-memory-concepts-ageing-neurodegeneration-future</link>
 <description>Transl Neurosci. 2026 Jan;17(1):20250392.  Epub 2026 May 4&lt;br&gt;Authors: Soliani AG, Muratori BG, Baptista JS, Cerutti SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42083556&quot;&gt;42083556&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rodents-episodic-memory-concepts-ageing-neurodegeneration-future#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rodents-episodic-memory-concepts-ageing-neurodegeneration-future#comments</comments>
</item>
<item>
 <title>Risk genes in progressive supranuclear palsy (PSP) affect integrity and function of microtubules.</title>
 <link>https://www.alzforum.org/papers/risk-genes-progressive-supranuclear-palsy-psp-affect-integrity-and-function-microtubules</link>
 <description>Front Aging. 2026;7:1769377.  Epub 2026 Apr 20&lt;br&gt;Authors: Donlon TA, Müller U&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088849&quot;&gt;42088849&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/risk-genes-progressive-supranuclear-palsy-psp-affect-integrity-and-function-microtubules#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/risk-genes-progressive-supranuclear-palsy-psp-affect-integrity-and-function-microtubules#comments</comments>
</item>
<item>
 <title>Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer&#039;s disease: Initial findings from LEADS.</title>
 <link>https://www.alzforum.org/papers/criterion-and-convergent-validity-plasma-biomarkers-early-onset-alzheimers-disease-initial</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70342.  Epub 2026 May 3&lt;br&gt;Authors: Hammers DB, Polsinelli A, Eloyan A, Taurone A, Thangarajah M, Foroud T, Gao S, Beckett L, La Joie R, Touroutoglou A, Vemuri P, Zetterberg H, Blennow K, Nemes S, Kostadinova R, Aisen P, Nudelman KN, Kirby K, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Grant I, Honig LS, Johnson EC, Jones DT, Masdeu JC, Mendez MF, Parand L, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Rabinovici GD, Dickerson BC, Dage JL, Apostolova LG, LEADS Consortium&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088846&quot;&gt;42088846&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/criterion-and-convergent-validity-plasma-biomarkers-early-onset-alzheimers-disease-initial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/criterion-and-convergent-validity-plasma-biomarkers-early-onset-alzheimers-disease-initial#comments</comments>
</item>
<item>
 <title>Targeting microglia microtubules: cytoskeletal remodeling as a druggable hub in neuroinflammation and neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/targeting-microglia-microtubules-cytoskeletal-remodeling-druggable-hub-neuroinflammation-and</link>
 <description>Front Neurosci. 2026;20:1812417.  Epub 2026 Apr 20&lt;br&gt;Authors: Sanchini C, Rosito M, Bartolini F, Di Angelantonio S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088827&quot;&gt;42088827&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-microglia-microtubules-cytoskeletal-remodeling-druggable-hub-neuroinflammation-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-microglia-microtubules-cytoskeletal-remodeling-druggable-hub-neuroinflammation-and#comments</comments>
</item>
<item>
 <title>Editorial: Genetic underpinnings of Alzheimer&#039;s and Parkinson&#039;s: insights and innovations.</title>
 <link>https://www.alzforum.org/papers/editorial-genetic-underpinnings-alzheimers-and-parkinsons-insights-and-innovations</link>
 <description>Front Genet. 2026;17:1846361.  Epub 2026 Apr 21&lt;br&gt;Authors: Marongiu R, Cordato D, Reiss AB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088780&quot;&gt;42088780&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/editorial-genetic-underpinnings-alzheimers-and-parkinsons-insights-and-innovations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/editorial-genetic-underpinnings-alzheimers-and-parkinsons-insights-and-innovations#comments</comments>
</item>
<item>
 <title>Angiotensin-converting enzyme overexpression in mouse neutrophils prevents Alzheimer&#039;s-like cognitive decline.</title>
 <link>https://www.alzforum.org/papers/angiotensin-converting-enzyme-overexpression-mouse-neutrophils-prevents-alzheimers-cognitive</link>
 <description>Front Immunol. 2026;17:1674330.  Epub 2026 Apr 20&lt;br&gt;Authors: Shibata T, Bhat SA, Cao D, Saito S, Bernstein EA, Okwan-Duodu D, Tourtellotte WG, Bernstein KE, Khan Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088504&quot;&gt;42088504&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/angiotensin-converting-enzyme-overexpression-mouse-neutrophils-prevents-alzheimers-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/angiotensin-converting-enzyme-overexpression-mouse-neutrophils-prevents-alzheimers-cognitive#comments</comments>
</item>
<item>
 <title>Mindfulness-based stress reduction combined with reminiscence therapy: a non-pharmacological approach for older adults with mild cognitive impairment or mild dementia due to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mindfulness-based-stress-reduction-combined-reminiscence-therapy-non-pharmacological-approach</link>
 <description>Front Aging Neurosci. 2026;18:1772932.  Epub 2026 Apr 20&lt;br&gt;Authors: Zhang F, Wang Y, Lv D, Cai L, Zhou F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088298&quot;&gt;42088298&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mindfulness-based-stress-reduction-combined-reminiscence-therapy-non-pharmacological-approach#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mindfulness-based-stress-reduction-combined-reminiscence-therapy-non-pharmacological-approach#comments</comments>
</item>
<item>
 <title>Different stages of Alzheimer&#039;s disease with periodontitis: clinical features and potential mechanisms involving gingipains, neuropathological biomarkers and neurological damage.</title>
 <link>https://www.alzforum.org/papers/different-stages-alzheimers-disease-periodontitis-clinical-features-and-potential-mechanisms</link>
 <description>Front Aging Neurosci. 2026;18:1737524.  Epub 2026 Apr 20&lt;br&gt;Authors: Li JH, Lian TH, Guo P, Li J, Qi J, He MY, Luo DM, Zhang YN, Liu GF, Huang Y, Zhang WJ, Zheng ZJ, Yue H, Guan HY, Liu Z, Zhang F, Meng Y, Zhang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088293&quot;&gt;42088293&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/different-stages-alzheimers-disease-periodontitis-clinical-features-and-potential-mechanisms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/different-stages-alzheimers-disease-periodontitis-clinical-features-and-potential-mechanisms#comments</comments>
</item>
<item>
 <title>Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.</title>
 <link>https://www.alzforum.org/papers/agreement-and-comparative-performance-cognitive-testing-visual-mri-rating-and-automated-brain</link>
 <description>Degener Neurol Neuromuscul Dis. 2026;16:590989.  Epub 2026 Apr 30&lt;br&gt;Authors: Nassanga R, Kaddumukasa M, Jones SE, Sajatovic M, Nemani A, Basiimwa RC, Kawooya MG, Tumwine JK, Lwere K, Gumikiriza-Onoria JL, Mubuuke AG, Nakasujja N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088091&quot;&gt;42088091&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/agreement-and-comparative-performance-cognitive-testing-visual-mri-rating-and-automated-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/agreement-and-comparative-performance-cognitive-testing-visual-mri-rating-and-automated-brain#comments</comments>
</item>
<item>
 <title>E3 ubiquitin ligases in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/e3-ubiquitin-ligases-neurodegenerative-diseases</link>
 <description>Mil Med Res. 2026;13(1):100032.  Epub 2026 Apr 27&lt;br&gt;Authors: Hou DL, Ho J, Guan T, Dong XX, Zeng L, Sanders LH, Wu YC, Tan EK, Zhou ZD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42088060&quot;&gt;42088060&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/e3-ubiquitin-ligases-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/e3-ubiquitin-ligases-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Association between dentition defects and Alzheimer&#039;s disease risk: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/association-between-dentition-defects-and-alzheimers-disease-risk-systematic-review-and-meta</link>
 <description>Front Dent Med. 2026;7:1783171.  Epub 2026 Apr 20&lt;br&gt;Authors: Wang Q, Zhou K, Zhang M, Dong Y, Zhao M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42087981&quot;&gt;42087981&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-dentition-defects-and-alzheimers-disease-risk-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-dentition-defects-and-alzheimers-disease-risk-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease drug development pipeline: 2026.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-drug-development-pipeline-2026</link>
 <description>Alzheimers Dement (N Y). 2026;12:e70251.  Epub 2026 May 5&lt;br&gt;Authors: Cummings JL, Zhou Y, Yang Y, Zhong K, Fonseca J, Osse AL, Cheng F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095064&quot;&gt;42095064&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-drug-development-pipeline-2026#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-drug-development-pipeline-2026#comments</comments>
</item>
<item>
 <title>Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in C9ORF72-related neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/systematic-proteomics-reveals-plasma-nefl-robust-predictor-and-pathological-associate-c9orf72</link>
 <description>Front Aging Neurosci. 2026;18:1792887.  Epub 2026 Apr 21&lt;br&gt;Authors: Hu Z, Wan JJ, Yan QQ, Fan Y, Liu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095061&quot;&gt;42095061&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/systematic-proteomics-reveals-plasma-nefl-robust-predictor-and-pathological-associate-c9orf72#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/systematic-proteomics-reveals-plasma-nefl-robust-predictor-and-pathological-associate-c9orf72#comments</comments>
</item>
<item>
 <title>Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer&#039;s disease pathology in a Brazilian admixed cohort.</title>
 <link>https://www.alzforum.org/papers/plasma-av42p-tau217-ratio-and-p-tau217-independently-predict-csf-defined-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1773606.  Epub 2026 Apr 21&lt;br&gt;Authors: Rizzi L, Ribeiro IC, da Rocha Silva MC, Aventurato ÍK, Santos LE, Dos Santos Silva AM, Pinheiro TL, Fernandes GB, De Felice FG, Balthazar ML&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42095059&quot;&gt;42095059&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-av42p-tau217-ratio-and-p-tau217-independently-predict-csf-defined-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-av42p-tau217-ratio-and-p-tau217-independently-predict-csf-defined-alzheimers-disease#comments</comments>
</item>
<item>
 <title>LRRK2 regulates ArfGAP1 membrane localization, activity and neuronal integrity via phosphorylation within its lipid-sensing ALPS2 motif.</title>
 <link>https://www.alzforum.org/papers/lrrk2-regulates-arfgap1-membrane-localization-activity-and-neuronal-integrity-phosphorylation</link>
 <description>Front Mol Neurosci. 2026;19:1786336.  Epub 2026 Apr 21&lt;br&gt;Authors: Islam MS, Cóppola-Segovia V, Musso A, Moore DJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42094986&quot;&gt;42094986&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lrrk2-regulates-arfgap1-membrane-localization-activity-and-neuronal-integrity-phosphorylation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lrrk2-regulates-arfgap1-membrane-localization-activity-and-neuronal-integrity-phosphorylation#comments</comments>
</item>
<item>
 <title>Iron dyshomeostasis in neuropsychiatric disorders.</title>
 <link>https://www.alzforum.org/papers/iron-dyshomeostasis-neuropsychiatric-disorders</link>
 <description>Front Psychiatry. 2026;17:1771423.  Epub 2026 Apr 21&lt;br&gt;Authors: Cheng M, Ma J, Yang Y, Cao M, Zhang E, Feng B, Wang Q, Du Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42094831&quot;&gt;42094831&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/iron-dyshomeostasis-neuropsychiatric-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/iron-dyshomeostasis-neuropsychiatric-disorders#comments</comments>
</item>
<item>
 <title>Mechanistic role of APOE lipidation in Alzheimer&#039;s disease pathogenesis.</title>
 <link>https://www.alzforum.org/papers/mechanistic-role-apoe-lipidation-alzheimers-disease-pathogenesis</link>
 <description>Theranostics. 2026;16(11):5926-5950.  Epub 2026 Apr 8&lt;br&gt;Authors: Zhang DY, Wang J, Dokholyan NV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42094593&quot;&gt;42094593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanistic-role-apoe-lipidation-alzheimers-disease-pathogenesis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanistic-role-apoe-lipidation-alzheimers-disease-pathogenesis#comments</comments>
</item>
<item>
 <title>Resveratrol and the neuroinflammation axis in Alzheimer&#039;s disease, Parkinson&#039;s disease, multiple sclerosis, and cerebral ischemia.</title>
 <link>https://www.alzforum.org/papers/resveratrol-and-neuroinflammation-axis-alzheimers-disease-parkinsons-disease-multiple</link>
 <description>Front Immunol. 2026;17:1758356.  Epub 2026 Apr 21&lt;br&gt;Authors: Wang H, Li F, Wang H, Tian Z, Fan H, Shi Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093988&quot;&gt;42093988&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resveratrol-and-neuroinflammation-axis-alzheimers-disease-parkinsons-disease-multiple#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resveratrol-and-neuroinflammation-axis-alzheimers-disease-parkinsons-disease-multiple#comments</comments>
</item>
<item>
 <title>Ziziphus jujuba Mill. Suspension Ameliorates Scopolamine-Induced Cognitive Impairment via PTGS2-Centered Neuroinflammatory Signaling.</title>
 <link>https://www.alzforum.org/papers/ziziphus-jujuba-mill-suspension-ameliorates-scopolamine-induced-cognitive-impairment-ptgs2</link>
 <description>Mediators Inflamm. 2026;2026(1):e8871660. &lt;br&gt;Authors: Liu Q, Wang Y, Wang B, Wang J, Zhang M, Liu Y, Min X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093362&quot;&gt;42093362&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ziziphus-jujuba-mill-suspension-ameliorates-scopolamine-induced-cognitive-impairment-ptgs2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ziziphus-jujuba-mill-suspension-ameliorates-scopolamine-induced-cognitive-impairment-ptgs2#comments</comments>
</item>
<item>
 <title>Oral Health in Alzheimer&#039;s Disease: A Life-Course Perspective on Clinical Management and Caregiver Support.</title>
 <link>https://www.alzforum.org/papers/oral-health-alzheimers-disease-life-course-perspective-clinical-management-and-caregiver</link>
 <description>Spec Care Dentist. 2026;46(3):e70179. &lt;br&gt;Authors: Silva MG, Vasconcelos MB, Silva RG, Feitosa MÁ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42093338&quot;&gt;42093338&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oral-health-alzheimers-disease-life-course-perspective-clinical-management-and-caregiver#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oral-health-alzheimers-disease-life-course-perspective-clinical-management-and-caregiver#comments</comments>
</item>
<item>
 <title>Exploring the Involvement of PINK1 in Parkinson&#039;s Disease: A Scanning Tunnelling Microscopy Study of Electron Transfer in Synthetic DNA Samples.</title>
 <link>https://www.alzforum.org/papers/exploring-involvement-pink1-parkinsons-disease-scanning-tunnelling-microscopy-study-electron</link>
 <description>Malays J Med Sci. 2025 Aug;32(4):129-144.  Epub 2025 Aug 30&lt;br&gt;Authors: Che Lah MH, Reza MF, Shamsuddin S, Watanabe I, Abdullah JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42077341&quot;&gt;42077341&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-involvement-pink1-parkinsons-disease-scanning-tunnelling-microscopy-study-electron#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-involvement-pink1-parkinsons-disease-scanning-tunnelling-microscopy-study-electron#comments</comments>
</item>
<item>
 <title>Instrument for Assessment of Neurodegenerative Aphasia in Indonesia or Instrumen Afasia Neurodegeneratif Indonesia (IRFANI): Development and pilot study.</title>
 <link>https://www.alzforum.org/papers/instrument-assessment-neurodegenerative-aphasia-indonesia-or-instrumen-afasia</link>
 <description>J Alzheimers Dis Rep. 2025;9:25424823251366640.  Epub 2025 Aug 4&lt;br&gt;Authors: Fitri FI, Rambe AS, Effendy E, Kadri A, Prawiroharjo P, Lubis IN, Surbakti KP, Amin MM, Rusda M, Gustianingsih&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42063523&quot;&gt;42063523&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/instrument-assessment-neurodegenerative-aphasia-indonesia-or-instrumen-afasia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/instrument-assessment-neurodegenerative-aphasia-indonesia-or-instrumen-afasia#comments</comments>
</item>
</channel>
</rss>
